0001213900-22-026582.txt : 20220513 0001213900-22-026582.hdr.sgml : 20220513 20220513172529 ACCESSION NUMBER: 0001213900-22-026582 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovative Payment Solutions, Inc. CENTRAL INDEX KEY: 0001591913 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-CATALOG & MAIL-ORDER HOUSES [5961] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55648 FILM NUMBER: 22924140 BUSINESS ADDRESS: STREET 1: 19355 BUSINESS CENTER DRIVE, #9 CITY: NORTHRIDGE STATE: CA ZIP: 91324 BUSINESS PHONE: (818) 864-4004 MAIL ADDRESS: STREET 1: 19355 BUSINESS CENTER DRIVE, #9 CITY: NORTHRIDGE STATE: CA ZIP: 91324 FORMER COMPANY: FORMER CONFORMED NAME: QPAGOS DATE OF NAME CHANGE: 20160615 FORMER COMPANY: FORMER CONFORMED NAME: Asiya Pearls, Inc. DATE OF NAME CHANGE: 20131113 10-Q 1 f10q0322_innovativepay.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark one)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2022

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission file number 000-55648

 

INNOVATIVE PAYMENT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   33-1230229
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

56B 5th AvenueLot 1 #AT, Carmel By The SeaCA 93921
(Address of Principal Executive Offices, including zip code)

 

(866) 477-4729
(Registrant’s telephone number, including area code)

 

n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files.) Yes  No

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer   Accelerated Filer
Non-accelerated Filer   Smaller Reporting Company
Emerging growth company      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
         

 

As of May 13, 2022, there were 367,901,679 shares of the Company’s common stock issued and outstanding.

 

 

 

 

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Form 10-Q

For the Quarter Ended March 31, 2022

 

Index

 

    Page No.
     
Cautionary Note Regarding Forward-Looking Statements ii
     
Part I. Financial Information 1
     
Item 1. Financial Statements (Unaudited) 1
     
  Condensed Consolidated Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021 1
     
  Condensed Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021 (Unaudited) 2
     
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2022 and 2021 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021 (Unaudited) 4
     
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
     
Item 4. Controls and Procedures 27
     
Part II. Other Information 28
     
Item 1. Legal Proceedings 28
     
Item 1A. Risk Factors 28
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
     
Item 3. Defaults Upon Senior Securities 28
     
Item 4. Mine Safety Disclosures 28
     
Item 5. Other Information 28
     
Item 6. Exhibits 29
     
Signatures 30

 

i

 

 

 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “report”) contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this report entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in report and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”)) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

 

  our ability to implement our business plan (including our ability to fully launch our IPSIPay digital payment solution) and scale our Beyond Wallet and IPSIPay business;
     
  acceptance by the marketplace of our products and services, notably Beyond Wallet and IPSIPay;
     
  our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;
     
  the viability of our current intellectual property and intellectual property created in the future;
     
  our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;
     
  our ability to retain key employees;
     
  adverse changes in general market conditions for payment solutions such as Beyond Wallet and IPSIPay and other products and services we offer;
     
  our ability to generate cash flow and profitability and continue as a going concern;
     
  our future financing plans; and
     
  our ability to adapt to changes in market conditions (including as a result of the COVID-19 pandemic) which could impair our operations and financial performance.

 

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” section contain in this report and in the “Business,” “Risk Factors” and other sections of the 2021 Form 10-K. You should thoroughly read this report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

The forward-looking statements made in this report relate only to events or information as of the date of this report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this report completely and with the understanding that our actual future results may be materially different from what we expect

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Balance Sheets

 

   March 31,   December 31, 
   2022   2021 
Assets  (Unaudited)     
         
Current Assets        
Cash  $3,362,740   $5,449,751 
Other current assets   39,326    85,034 
Total Current Assets   3,402,066    5,534,785 
           
Non-current assets          
Plant and equipment   24,302    28,799 
Intangible assets   867,300    625,000 
Security deposit   34,800    34,800 
Investment   500,001    500,001 
Total Non-Current Assets   1,426,403    1,188,600 
Total Assets  $4,828,469   $6,723,385 
           
Liabilities and Equity          
           
Current Liabilities          
Accounts payable  $522,253   $465,205 
Convertible debt, net of unamortized discount of $0 and $263,200, respectively   1,753,178    1,961,354 
Derivative liability   315,000    407,161 
Total Current Liabilities   2,590,431    2,833,720 
           
Non-Current Liabilities          
Federal relief loans   159,740    158,353 
Total Non-Current Liabilities   159,740    158,353 
           
Total Liabilities   2,750,171    2,992,073 
           
Equity          
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021.   
 
    
-
 
Common stock, $0.0001 par value; 750,000,000 and 500,000,000 shares authorized, 367,901,679 shares issued and outstanding as of March 31, 2022 and December 31, 2021.   36,790    36,790 
Additional paid-in-capital   45,928,244    45,771,012 
Accumulated deficit   (43,913,195)   (42,111,701)
Total equity attributable to Innovative Payment Solutions, Inc. Stockholders   2,051,839    3,696,101 
Non-controlling interest   26,459    35,211 
Total Equity   2,078,298    3,731,312 
Total Liabilities and Equity  $4,828,469   $6,723,385 

 

See accompanying notes to condensed consolidated financial statements.

 

1

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

   Three months ended   Three months ended 
   March 31,   March 31, 
   2022   2021 
Net Revenue  $
-
   $
-
 
           
Cost of Goods Sold   
-
    
-
 
           
Gross profit   
-
    
-
 
           
General and administrative   869,387    4,989,672 
Depreciation   4,496    4,167 
Total Expense   873,883    4,993,839 
           
Loss from Operations   (873,883)   (4,993,839)
           
Loss on debt conversion   
-
    (5,184,447)
Penalty on convertible notes   (719,558)   
-
 
Interest expense   (45,766)   (67,312)
Amortization of debt discount   (263,200)   (2,113,652)
Derivative liability movements   92,161    965,144 
Loss before Income Taxes   
(1810,246
)   (11,394,106)
Income Taxes   
-
    
-
 
Net loss   (1,810,246)   (11,394,106)
Net loss attributable to non-controlling interest   8,752    
-
 
Net loss attributable to Innovative Payment Solutions, Inc. stockholders  $(1,801,494)  $(11,394,106)
           
Basic and Diluted loss per share  $(0.00)  $(0.04)
           
Weighted Average Number of Shares Outstanding – Basic and Diluted   367,901,679    255,272,113 

 

See accompanying notes to condensed consolidated financial statements.

 

2

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

For the Three Months Ended March 31, 2022

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount   Additional
Paid-in
Capital
   Accumulated
Deficit
   Non-controlling shareholders interest   Total
Stockholders’
Equity (Deficit)
 
                                 
Balance at December 31, 2021   
       -
    
            -
    367,901,679   $36,790   $45,771,012   $(42,111,701)  $35,211   $3,731,312 
Stock based option expense   -    
-
    -    
-
    94,466    
-
    
                  -
    94,466 
Restricted stock awards   -    
-
    -    
-
    62,766    
-
    
-
    62,766 
Net loss   -    
-
    -    
-
    
-
    (1,801,494)   (8,752)   (1,810,246)
Balance at March 31, 2022   -   $
-
    367,901,679   $36,790   $45,928,244   $(43,913,195)  $26,459   $2,078,298 

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount   Additional
Paid-in
Capital
   Accumulated
Deficit
   Non-controlling shareholders interest   Total
Stockholders’
Equity (Deficit)
 
                                 
Balance at December 31, 2020            -    
         -
    193,637,747   $19,363   $23,179,399   $(27,629,575)  $
                  -
   $(4,430,813)
Warrants exercised   -    
-
    44,074,284    4,407    2,199,307    
-
    
-
    2,203,714 
Share subscriptions   -    
-
    30,333,334    3,033    4,546,967    
-
    
-
    4,550,000 
Share issue expenses   -    
-
    -    
-
    (501,100)   
-
    
-
    (501,100)
Conversion of debt to equity   -    
-
    61,793,616    6,180    7,437,488    
-
    
-
    7,443,668 
Fair value of warrants issued as compensation   -    
-
    -    
-
    4,327,899    
-
    
-
    4,327,899 
Stock based compensation   -    
-
    2,500,000    250    213,499    
-
    
-
    213,749 
Net loss   -    
-
    -    
-
    
-
    (11,394,106)   
-
    (11,394,106)
Balance at March 31, 2021   
-
   $
-
    332,338,981   $33,233   $41,403,459   $(39,023,681)  $
-
   $2,413,011 

 

See accompanying notes to condensed consolidated financial statements.

 

3

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Three months ended   Three months ended 
   March 31,   March 31, 
   2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(1,810,246)  $(11,394,106)
Adjustments to reconcile net loss to net cash used in operating activities:          
Derivative liability movements   (92,161)   (965,144)
Depreciation   4,496    4,167 
Amortization of debt discount   263,200    2,113,652 
Loss on conversion of debt to equity   
-
    5,184,447 
Penalty on convertible note   719,558    
-
 
Fair value of warrants issued as compensation   
-
    4,327,899 
Stock based compensation   157,232    213,749 
Amortization of right of use asset   
-
    10,625 
Changes in Assets and Liabilities          
Other current assets   45,708    (2,994)
Accounts payable and accrued expenses   (6,221)   (293,900)
Operating lease liabilities   
-
    (10,625)
Interest accruals   (42,484)   38,050 
CASH USED IN OPERATING ACTIVITIES   (760,918)   (774,180)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in deposits   
-
    (4,800)
Intangibles acquired   (179,030)   
-
 
NET CASH USED IN INVESTING ACTIVITIES   (179,030)   (4,800)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from share issuances   
-
    4,550,000 
Share issue expenses   
-
    (501,100)
Proceeds from warrants exercised   
-
    2,203,714 
Repayment of loans payable   
-
    (22,049)
Repayment of convertible notes   (1,147,063)   (521,000)
Proceeds from short term notes and convertible notes   
-
    2,569,000 
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES   (1,147,063)   8,278,565 
           
NET (DECREASE) INCREASE IN CASH   (2,087,011)   7,499,585 
CASH AT BEGINNING OF PERIOD   5,449,751    94,703 
CASH AT END OF PERIOD  $3,362,740   $7,594,288 
           
CASH PAID FOR INTEREST AND TAXES:          
Cash paid for income taxes  $
-
   $
-
 
Cash paid for interest  $88,250   $33,030 
           
NON CASH INVESTING AND FINANCING ACTIVITIES          
Conversion of convertible debt to equity  $
-
   $2,259,221 

 

See accompanying notes to condensed consolidated financial statements.

 

4

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

5

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  b) Description of current business

 

The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational. The Company’s flagship e-wallet, IPSIPay, is fully operational and ready for commercial launch during the second quarter of 2022. Previously the Company intended to invest in physical kiosks, which required the user presence at the kiosk location. The Company still intends to use its existing kiosks in certain target markets within Southern California, but its principal focus will be on downloadable apps used via smartphones.

 

The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United states and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

c)COVID-19

 

The COVID-19 pandemic has required the Company’s management to focus its attention primarily on responding to the challenges presented by the pandemic, including ensuring continuous operations, and adjusting its operations to address changes in the virtual payments industry. Due to measures imposed by the local governments in areas affected by COVID-19 (including both in the United States and Mexico), businesses had been suspended due to quarantines intended to contain this outbreak and many people had been forced to work from home in those areas. As a result, the commercial launch of the Company’s e-wallets and the limited installation of the Company’s network of kiosks in Southern California had been delayed, which has had an adverse impact on the Company’s business and financial condition and has hampered the Company’s ability to generate revenues. As the COVID-19 pandemic evolves, the Company may face similar challenges in the future which could lead to material adverse impacts on the Company.

  

2ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.

 

All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.

 

6

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2ACCOUNTING POLICIES AND ESTIMATES (continued)

 

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

 

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

  c) Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

  d) Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

7

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  e) Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

  f) Risks and Uncertainties

 

The Company’s operations will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s products and the use by customers of such products, (iii) competition, (iv) inflation and other economic factors and (v) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

  g) Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

8

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  h) Reporting by Segment

 

No segmental information is required as the Company has not generated any revenue for the three months ended March 31, 2022 and 2021 and only has one operating segment.

 

  i) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2022 and 2021, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2022 and December 31, 2021, the balance exceed the federally insured limit by $2,848,701 and $5,117,551, respectively.

 

  j) Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2022 and December 31, 2021.

 

  k) Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

  l) Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

9

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

 

m) Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

  n) Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had no revenues during the three months ended March 31, 2022 and 2021.

 

  o) Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

10

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  p) Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

  q) Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.

 

  r) Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

  s) Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

3 LIQUIDITY MATTERS

  

The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the end of three months ended March 31, 2022, the Company had a net loss of $1,801,494 and had $3,362,740 in cash. In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2022, management evaluated the extent of the impact from the COVID-19 pandemic and other risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements. 

 

The Company had a cash balance of $3,362,740 available as of March 31, 2022. Based on its evaluation of the Company’s current business plan, management believes the Company’s existing cash is sufficient to conduct planned operations for at least one year from the date of issuance of these financial statements.

 

However, given the Company’s losses and negative cash flows, it is likely that the Company will be required to raise significant additional funds to progress its business as planned by issuing equity or equity-linked securities. Should this occur, the Company’s stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting the Company’s operations or its ability to incur additional debt. Any additional debt financing or additional equity that the Company raises may contain terms that are not favorable to the Company or its stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support the Company’s operations on favorable terms, or at all.

 

There is also a significant risk that none of the Company’s plans to raise financing will be implemented in a manner necessary to sustain the Company for an extended period of time. If adequate funds are not available to the Company when needed, the Company may be required to continue with reduced operations or to obtain funds through arrangements that may require the Company to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on the Company. In addition, the Company’s inability to secure additional funding when needed could cause the Company’s business to fail or become bankrupt or force the Company to wind down or discontinue operations.

 

11

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

  

4 INTANGIBLES

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, which is now complete. During the three months ended March 31, 2022, an additional $217,300 was spent by the Companyto facilitate the functioning of the IPSIPay software in the cloud environment, and Beyond Fintech spent an additional $25,000 on software to further enhance the Beyond Wallet product offering. 

 

   March 31, 2022   December 31,
2021
 
Purchased Technology  $867,300   $625,000 

 

5 INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On June 22, 2021, the Company entered into a Stock Purchase Agreement (the “SPA”) with Frictionless, to purchase 150 common shares for gross proceeds of $500,000, representing 10.0% of the outstanding common shares. In terms of the SPA, Frictionless agreed to deliver to the Company on or before August 30, 2021, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United states and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate to Company’s anticipated product offerings.

 

The Company has undertaken to issue Frictionless a non-restricted, non-dilutable 5 year warrant to purchase 30,000,000 shares of Common Stock at an exercise price of $0.15 per share, upon delivery of the financial payment software. Frictionless delivered the software and the warrants will be issued in accordance with the agreement.

 

The Company has the right to appoint, and has appointed, one member to the board of directors of Frictionless, which appointee will remain on the board as long as the Company is the holder of the Frictionless common stock.

 

The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

The shares in Frictionless are unlisted as of March 31, 2022.

 

Investment in Vivi Holdings, Inc.

 

Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.

 

As consideration for the disposal, Vivi issued an aggregate of 2,250,000 Vivi Shares as follows: 2,047,500  Vivi Shares to the Company; 56,250 Vivi Shares to the Company’s designee, Mr. Andrey Novikov; 33,750 Vivi Shares to the Company’s designee, the Joseph W. & Patricia G. Abrams Family Trust; and 112,500 Vivi Shares to the Company’s designee, Mr. Gaston Pereira.

 

Due to the lack of available information, the Vivi Shares were valued by a modified market method, whereby the value of the assets disposed of were determined by management using the enterprise value of the entire Company less the liabilities and assets retained by the Company.

 

As of March 31, 2022 and December 31, 2021, the Company maintained the impairment of the carrying value of the investment in Vivi Holdings based on no activity by Vivi’s management for its proposed initial public offering and fund raising activities. The total impairment as of March 31, 2022 and December 31, 2021 was $1,019,960.

 

The shares in Vivi Holdings are unlisted as of March 31, 2022.

 

   March 31,
2022
   December 31,
2021
 
Investment in Frictionless Financial Technologies, Inc.  $500,000   $500,000 
Investment in Vivi Holdings, Inc.   1    1 
   $500,001   $500,001 

 

12

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

6 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Avenue, Lot 1 #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month.

  

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

  

Three months ended
March 31,

2022

   Three months ended
March 31,
2021
 
Operating lease expense  $14,400   $11,835 

 

Other lease information:

 

  

Three months ended
March 31,

2022

   Three months ended
March 31,
2021
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(14,400)  $(11,835)
           
Remaining lease term – operating lease   
-
    11 months 

 

Maturity of Operating Leases

 

The amount of future minimum lease payments under operating leases are as follows:

 

    Amount  
Undiscounted minimum future lease payments under leases with terms twelve months or less      
Total instalments due:      
2022   $
          -
 

 

7 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The Company has accrued interest of $9,740 on this loan as of March 31, 2022.

 

13

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

8 CONVERTIBLE NOTES PAYABLE

 

Convertible notes payable consists of the following:

 

Description  Effective Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
  

March 31, 2022

Amount,
net

  

December 31,
2021

Amount,
net

 
Cavalry Fund I LP   28.7%  August 16,
2022
   866,242    10,347    
     -
    876,589    548,872 
                                  
Mercer Street Global Opportunity Fund, LLC   28.7%  August 16,
2022
   866,242    10,347    
-
    876,589    548,872 
                                  
Bellridge Capital LP.   10%  February 16,
2022
   
-
    
-
    
-
    
-
    863,609 
                                  
Total convertible notes payable          $1,732,484   $20,694   $-   $1,753,178   $1,961,353 

 

Interest expense totaled $44,379 and $65,792 and amortization of debt discount totaled $263,200 and $2,113,652 for the three months ended March 31, 2022 and 2021, respectively.

 

Cavalry Fund I LP

 

  On February 16, 2021, the Company closed a transaction with Cavalry Fund I LP (“Cavalry”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Cavalry Note”). The Cavalry Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Cavalry Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.

 

The balance of the Cavalry Note plus accrued interest at March 31, 2022 was $876,589.

 

Mercer Street Global Opportunity Fund, LLC

   

  On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Mercer Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.

 

The balance of the Mercer Note plus accrued interest at March 31, 2022 was $876,589.

 

14

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

8CONVERTIBLE NOTES PAYABLE (continued)

 

Bellridge Capital LP.

  

  On February 16, 2021, the Company closed a transaction with Bellridge Capital LP., pursuant to which the Company received net proceeds of $787,500, after an original issue discount of $112,500 in exchange for the issuance of a $900,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Bellridge Note”). The Bellridge Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 3,913,044 shares of Common Stock at an initial exercise price of $0.24 per share.

 

The Bellridge Note was repaid on February 4, 2022 for gross proceeds of $1,235,313, including interest thereon of $88,250, thereby extinguishing the Bellridge Note.

 

9DERIVATIVE LIABILITY

 

Certain of the short-term convertible notes disclosed in note 8 above and certain warrants disclosed in note 10 below have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

The value of this derivative financial liability was re-assessed at March 31, 2022 at $315,000, and $92,161 was credited to the statement of operations. The value of the derivative liability will be re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred.

 

The following assumptions were used in the Black-Scholes valuation model:

 

    Three months ended
March 31,
2022
    Year ended
December 31,
2021
 
Conversion price   $ 0.05 to $0.15     $ 0.05 to $0.24  
Risk free interest rate     0.79 to 2.45 %     0.05 to 1.12 %
Expected life of derivative liability     4.6 to 46.6 months       1.6 to 49.6 months  
Expected volatility of underlying stock     151.07 to 194.99     161.19 to 215.33
Expected dividend rate     0 %     0 %

 

The movement in derivative liability is as follows:

 

   March 31,
2022
   December 31,
2021
 
Opening balance  $407,161   $2,966,416 
Derivative financial liability arising from convertible note   
-
    2,569,000 
Fair value adjustment to derivative liability   (92,161)   (5,128,255)
   $315,000   $407,161 

 

  10 STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company has issued and outstanding 367,901,679 shares of Common Stock as of March 31, 2022 and December 31, 2021, respectively.

 

15

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10 STOCKHOLDERS’ EQUITY (continued)

 

  b. Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2021 to March 31, 2022 is as follows:

 

   Total restricted shares   Weighted
average
fair market value per share
   Total
unvested
restricted
shares
   Weighted
average
fair market value per share
   Total vested restricted shares   Weighted
average
fair market value per share
 
Outstanding January 1, 2021   20,495,000   $0.049    15,371,250   $0.049    5,123,750   $0.049 
Granted   2,500,000    0.050    2,500,000    0.050    
-
    
-
 
Forfeited/Cancelled   (1,500,000)   (0.050)   (1,500,000)   (0.050)   
-
    
-
 
Vested   
-
    
-
    (6,123,750)   (0.049)   6,123,750    0.049 
Outstanding December 31, 2021   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding March 31, 2022   21,495,000   $0.049    5,123,750   $0.049    16,371,250   $0.049 

 

The restricted stock granted and exercisable at March 31, 2022 is as follows:

 

    Restricted Stock Granted   Restricted Stock Vested 
Grant date
Price
   Number
Granted
   Weighted
Average
Fair Value
per
Share
   Number
Vested
   Weighted
Average
Fair Value
per
Share
 
$0.049    20,495,000   $0.049    15,371,250   $0.049 
$0.050    1,000,000    0.050    1,000,000    0.050 
      21,495,000   $0.049    16,371,250   $0.049 

 

The Company has recorded an expense of $62,766 and $122,141 for the three months ended March 31, 2022 and 2021, respectively.

 

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized, no preferred stock is issued and outstanding as of March 31, 2022 and December 31, 2021.

 

16

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants

  

A summary of warrant activity during the period January 1, 2021 to March 31, 2022 is as follows:

 

   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021   51,188,572   $0.05   $0.05 
Granted   66,302,515       0.05 to 0.24    0.16 
Forfeited/Cancelled   (20,000,000)   0.24    0.24 
Exercised   (60,186,982)   0.05    0.05 
Outstanding December 31, 2021   37,304,105    0.05 – 0.1875   $0.12 
Granted   
-
    -    
-
 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding March 31, 2022   37,304,105    0.05 – 0.1875   $0.12 

 

The warrants outstanding and exercisable at March 31, 2022 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.05    10,823,813    3.53         10,823,813         3.53 
 0.15    24,053,625    3.94         24,053,625         3.94 
 0.1875    2,426,667    3.96         2,426,667         3.96 
      37,304,105    3.82    0.12    37,304,105    0.12    3.82 

 

The warrants outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

 

17

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10STOCKHOLDERS’ EQUITY (continued)

  

  e. Stock options

 

Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

No options were granted for the three months ended March 31, 2022.

 

A summary of option activity during the period January 1, 2021 to March 31, 2022 is as follows:

 

   Shares
Underlying
options
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021   100,000    0.40    0.40 
Granted   30,416,666    0.15 – 0.24    0.15 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding December 31, 2021   30,516,666     $ 0.15 to 0.40   $0.15 
Granted   
-
    -    
-
 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding March 31, 2022   30,516,666     $ 0.15 to 0.40   $0.15 

 

The options outstanding and exercisable at March 31, 2022 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
 0.15    30,208,333    9.39         18,125,000         9.89 
 0.24    208,333    8.90         208,333         9.40 
 0.40    100,000    6.75         100,000         7.25 
      30,516,666    9.38   $0.15    18,433,333   $0.15    9.37 

 

The options outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021, respectively. The option expense was $94,466 and $91,608 for the three months ended March 31, 2022 and 2021, respectively.

 

11NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2022 and 2021 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31 2022 and 2021 are as follows:

 

   Three
months ended
March 31,
2022
(Shares)
   Three
months ended
March 31,
2021
(Shares)
 
Convertible debt   11,687,855    8,993,106 
Stock options   30,516,666    516,666 
Warrants to purchase shares of Common Stock   37,304,104    73,416,802 
    79,508,625    82,926,574 

 

18

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On February 22, 2021, the Board awarded James Fuller options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share.

 

On July 22. 2021, the Company granted Mr. Fuller 2,000,000 shares of Common Stock, valued at $154,000

 

Additionally, the Board approved the repricing of the options exercisable for 208,333 shares of Common Stock granted to Mr. Fuller on February 22, 2021, from $0.24 per share to $0.15 per share.

 

Andrey Novikov

 

On February 22, 2021, the Board awarded Andrey Novikov options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share. 

 

On May 31, 2021, Mr. Novikov notified the Board of his decision to resign as a member of the Board and as Secretary of the Company, effective as of June 1, 2021. Since August 2021, Mr. Novikov has been on suspension from service as the Company’s Chief Technology Officer.

 

William Corbett

 

On February 22, 2021, the Board appointed William Corbett as the Company’s Chief Executive Officer and Interim Chief Financial Officer, as its Chairman of the Board and issued him a five-year warrant to purchase 20,000,000 shares of the Common Stock at an exercise price of $0.24 per share. The Board also agreed to increase Mr. Corbett’s monthly base salary to $30,000. The warrant expense for Mr. Corbett for the year ended December 31, 2021 was $4,327,899.

 

On August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous executive employment agreement (the “August 2021 Corbett Employment Agreement”). The purpose of the August 2021 Corbett Employment Agreement was to provide a replacement grant for warrants previously granted to Mr. Corbett under the terms of his previous employment agreement with the Company. Pursuant to the August 2021 Corbett Employment Agreement, Mr. Corbett would continue to serve as the Company’s Chief Executive Officer on a full time basis effective as of the date of the August 2021 Corbett Employment Agreement until the close of business on December 31, 2024. Mr. Corbett’s base salary will be $30,000 per month, which shall be paid in accordance with the Company’s standard payroll practice for its executives, managers and salaried employees. In addition, the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The option expense for Mr. Corbett for the three months ended March 31, 2022 was $66,587 and for the year ended December 31, 2021 was $910,019.

 

In addition, the Company and Mr. Corbett entered into an Indemnification Agreement on August 16, 2021 (the “August 2021 Corbett Indemnification Agreement”), pursuant to which the Company agreed to indemnify Mr. Corbett to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses. The August 2021 Corbett Indemnification Agreement amends the indemnification agreement in effect prior to entering into the August 2021 Corbett Indemnification Agreement to provide that unless Company shall pay Mr. Corbett’s attorneys’ fees and costs, including the compensation and expenses of any arbitrator, unless the arbitrator or the court determines that (a) Company has no liability in such dispute, or (b) the action or claims by Executive are frivolous in nature. In any other case or matter, the Company and Mr. Corbett shall each bear its or his own attorney fees and costs.

 

19

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12RELATED PARTY TRANSACTIONS (continued)

 

Clifford Henry

 

On May 1, 2021, the Company appointed Mr. Henry to the Board.

 

On July 22, 2021, the Company granted Mr. Henry 2,000,000 shares of Common Stock, valued at $154,000.

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022   

 

Madisson Corbett

 

On May 1, 2021, the Company appointed Ms. Corbett to the Board. Ms. Corbett is the daughter of Mr. William Corbett, the Company’s Chief Executive Officer and Chairman of the Board.

 

On July 22, 2021, the Company granted Ms. Corbett 2,000,000 shares of Common Stock, valued at $154,000

 

David Rios

 

On July 22, 2021, the Company appointed David Rios to the Board.

 

On July 22, 2021, the Company granted Mr. Rios 1,000,000 shares of Common Stock, valued at $77,000.  

 

Richard Rosenblum

 

On July 22, 2021, the Company appointed Richard Rosenblum as President and Chief Financial Officer of the Company. In addition, Mr. Rosenblum was elected to the Board to serve until the Company’s next annual meeting of shareholders.

 

On July 27, 2021, the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Company’s common stock, as reflected in the closing price of the Company’s common stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan. The option expense for Mr. Rosenblum for the three months ended March 31, 2022 was $27,879 and for the year ended December 31, 2021 was $381,006.

 

20

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12 RELATED PARTY TRANSACTIONS (continued)

 

Richard Rosenblum (continued)

 

If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, then Mr. Rosenblum shall be entitled to severance equal to fifty percent (50%) of his annual base salary rate in effect as of the date of termination. If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, within 12 months following an Acquisition (as defined in the Employment Agreement), then Mr. Rosenblum shall be entitled to severance equal to 100% of his annual base salary rate in effect as of the date of termination. Severance payments shall be subject to execution and delivery of a general release in favor of the Company.

 

On August 16, 2021, the Company entered into an amendment to the Rosenblum Executive Employment Agreement (the “First Amendment”) with Mr. Rosenblum. Under the terms of the Executive Employment Agreement, the Company had agreed to grant to Mr. Rosenblum an option to purchase 10,000,000 (ten million) common shares of Company Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is uplisted, on a national stock exchange, on the date of grant (the “Option”).” The First Amendment provided that the Option was granted on August 31, 2021 at an exercise price of $0.15 per share.

 

In addition, the Company and Mr. Rosenblum entered into an Indemnification Agreement, pursuant to which the Company agreed to indemnify Mr. Rosenblum to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses.

 

13COMMITMENTS AND CONTINGENCIES

 

The Company has convertible notes, disclosed under note 8 above which mature on August 16, 2022. Should these notes not be converted to Common Stock prior to that date, the Company may need to repay the principal and interest outstanding on these notes.

   

14SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

21

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

All references to “we,” “us,” “our” and the “Company” refer to Innovative Payment Solutions, Inc., a Delaware corporation and its consolidated subsidiaries unless the context requires otherwise.

 

Overview

 

We are a provider of digital payment solutions and services to businesses and consumers. We are focused on operating and developing “e-wallets” that enable consumers to deposit cash, convert it into a digital form, and remit the funds to Mexico and other countries quickly and securely. Our first e-wallet, the Beyond Wallet, is currently operational. Our flagship e-wallet, IPSIPay, was soft launched in December 2021 and will be fully launched during the second quarter of 2022. Our platform (which can be used both business-to-business and business-to-consumer) will facilitate the transfer of funds in digital form to other countries, initially Mexico but also, India and the Philippines, primarily from hand-held devices as well as on desktop or laptop computers.

 

Our launch plan for IPSIPay and Beyond Wallet is to target lower income, migrant communities in California (notably in the agriculture industry), and expanding to other states with large migrant populations such as Texas and Florida. We not only believe the addressable market for our products and services is large and growing, but that servicing this market is socially responsible. We believe our digital payment facilitation platform and related apps will empower and enable the unbanked and under-served and payment providers who service these users, acting as a bridge to provide access to comprehensive and easy to use payment solutions. Given the large size of our addressable market, our ability to capture even a very small share of the market represents a significant revenue opportunity for our company.

 

Previously, we intended to invest in physical kiosks which required the user presence at digital payment kiosk locations, and we still intend to use our existing kiosks in certain target markets within Southern California.

 

We acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”), on June 22, 2021. Frictionless agreed to deliver to us, a live fully compliant financial payment Software as a Service solution for use by us as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate our anticipated product offerings. We have an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, we formed a new majority owned subsidiary, Beyond Fintech Inc. (“Beyond Fintech”), in which we own a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to our Beyond Wallet offering to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business

 

COVID-19

 

The novel coronavirus (“COVID-19”) pandemic has resulted in government authorities and businesses throughout the world implementing numerous measures intended to contain and limit the spread of COVID-19, including travel restrictions, border closures, quarantines, shelter-in-place and lock-down orders, mask and social distancing requirements, and business limitations and shutdowns. The spread of COVID-19 and increased variants has caused, and may continue to cause us to make significant modifications to our business practices, including enabling most of our workforce to work from home, establishing strict health and safety protocols for our offices, restricting physical participation in meetings, events, and conferences, and imposing restrictions on employee travel. We will continue to actively monitor the situation and may take further actions that alter our business practices as may be required by federal, state, or local authorities or that we determine are in the best interests of our employees, customers, or business partners.

 

The rapidly changing global market and economic conditions as a result of the COVID-19 pandemic have impacted, and are expected to continue to impact, our operations and business. For example, COVID-19 related issues has caused a delay in our ability to launch our products and services. The broader implications of the COVID-19 pandemic and related global economic unpredictability on our business, financial condition, and results of operations remain uncertain.

 

Russia’s Invasion of Ukraine

 

In February 2022, Russia invaded Ukraine, with Belarus complicit in the invasion. As of the date of this report, the conflict between these two countries is ongoing. We do not have any direct or indirect exposure to Ukraine, Belarus or Russia, through our operations, employee base or any investments in any of these countries. In addition, our securities are not traded on any stock exchanges in these three countries. We do not believe that the sanction levied against Russia or Belarus or individuals and entities associated with these two countries will have a material impact on our operations or business, if any. Further, we do not believe that we have any direct or indirect reliance on goods sourced from Russia, Ukraine or Belarus or countries that are supportive of Russia.

 

22

 

 

We have not fully commercially launched or e-wallet platforms to date, however we will be providing online money transfer and payment services to our customers in the future which may expose us to cybersecurity risks. We employ the latest encryption techniques and firewall practices and constantly monitor the usage of our software, however, this may not be sufficient to prevent the heightened risk of cybersecurity attacks emanating from Russia, Ukraine, Belarus, or any other country.

 

The impact of the invasion by Russia of Ukraine has increased volatility in stock trading prices and commodities throughout the world. To date, we have not seen a material impact on our operations; however, a prolonged conflict may impact on consumer spending, in general, which could have an adverse impact on the payment services industry as a whole and our business.

 

Inflation

 

Macro-economic conditions could affect consumer spending adversely and consequently our future operations when we fully launch our e-wallet products commercially. We believe the U.S. has entered a period of significant inflation, and this may impact consumer’s desire to adopt our products and services and may increase our costs overall. However, as of the date of this report, we do not expect there to be any material impact on our liquidity as forecast in our business plan due to recent inflationary concerns in the U.S.

 

Foreign Exchange Risks

 

We intend to operate in several foreign countries, including Mexico. Changes and fluctuations in the foreign exchange rate between the US Dollar and other foreign currencies, including the Mexican Peso, may in future have an effect our results of operations.

 

Critical Accounting Estimates

 

Preparation of our consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP") requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Consolidated Financial Statements included in Part I, Item I of this Form 10-Q for further information.

 

The critical accounting policies that involved significant estimation included the following:

 

Derivative liabilities

 

We have certain short-term convertible notes and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

 

The derivative liability is valued using the following inputs:

 

Conversion prices;

 

Current market prices of our equity

 

23

 

 

Risk free interest rates;

 

Expected remaining life of the derivative liability;

 

Expected volatility of the underlying stock; and expected dividend rates

 

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our common stock may result in a significant increase or decrease in the derivative liability.

 

Impairment of Investments and Intangible assets

 

We carried investments of $500,001 and Intangible assets of $867,300 as more fully described in Notes 4 and 5 to the condensed consolidated financial statements. The Company tests its Investments and intangible assets with an indefinite useful life annually for impairment or more frequently if indicators for impairment exist. The value of our Investments and intangibles is based upon our mutual goal of providing payment services to an underserved market. Currently our investments or our intangible assets have not produced any revenues on which to assess whether the income generated from these assets can support the carrying value of these assets. For impairment testing of investments and intangibles we determine the fair value of the underlying assets using an income-based approach which estimates the fair value using a discounted cash flow model. Key assumptions in estimating fair values include projected revenue growth and the weighted average cost of capital. In addition, management recently reviewed the future revenue and profit projections of our e-wallet services based on management forecasts of the size of the market and expected customer growth and retention, we determined that no impairment charges were necessary, however if we are unable to achieve our forecasts once operations begin, we may need to re-evaluate our forecasts which could result in an impairment charge. Since performing this analysis we have no reason to believe that further impairment is necessary as of March 31, 2022.

 

Results of Operations

 

Results of Operations for the Three Months Ended March 31, 2022 and 2021

 

Net revenue

 

We did not have revenues during the three months ended March 31, 2022 and 2021. We anticipate that we will recommence generating revenue when we launch our e-wallets once we have determined our deployment strategy, the timing of which is uncertain. We currently anticipate fully launching our e-wallets in the second quarter of 2022, but this is subject to change.

 

Cost of goods sold

 

As we did not have revenues during the three months ended March 31, 2022 and 2021, we anticipate that we will begin to recognize cost of goods sold when we launch our e-wallets once we have determined our deployment strategy.

 

24

 

 

General and administrative expenses

 

General and administrative expenses were $869,387 and $4,989,672 for the three months ended March 31, 2022 and 2021, respectively, a decrease of $4,120,285 or 82.6%. The decrease is primarily due to the following:

 

  (i) Payroll expenses was $377,596 and $4,559,753 for the three months ended March 31, 2022 and 2021, respectively, a decrease of $4,182,157 or  91.7%. The decrease is primarily due to the issue of warrants exercisable for 20,000,000 shares to our CEO in the prior period with a fair value of $4,327,899 and restricted stock of 1,000,000 shares with a fair value of $50,000 issued to one of our previous employees, offset by an increase in base salaries over the prior period due to an improvement in the caliber of employees, including the hiring of a CFO.
     
  (iv) The balance of the general and administrative expenses decreased by $61,872, which is made up of several individually insignificant expenses.

 

Depreciation

 

Depreciation was $4,496 and $4,167 for the three months ended March 31, 2022 and 2021, respectively, an increase of $329 or 7.9%, which amount is immaterial.

 

Loss on debt conversion

 

Loss on debt conversion was $0 and $5,184,447 for the three months ended March 31, 2022 and 2021, respectively, a decrease of $5,184,447 or 100%. The loss on debt conversion represents a loss realized on the conversion of convertible notes into equity at fixed conversion prices of $0.035 to $0.05 per share, when the stock price was ranging from $0.05 per share to $0.22 per share, resulting in a significant loss. A total of $2,259,221 was converted from convertible debt to equity during the three months ended March 31, 2021.

 

Penalty on convertible notes

 

Penalty on convertible notes was $719,558 and $0 for the three months ended March 31, 2022 and 2021, an increase of $719,558 or 100.0%. The increase is due to the repayment of one convertible note and the modification of the maturity date of two convertible notes, resulting in the triggering of the repayment penalty per the convertible note agreements as well as an additional 10% penalty for the extension of the maturity date.

 

Interest expense, net

 

Interest expense was $45,766 and $67,312 for the three months ended March 31, 2022 and 2021, respectively, a. decrease of $21,546 or 32.0%. The decrease is due to the repayment of our convertible note with Bellridge, offset by an increase in the principal due on the two remaining convertible notes.

 

Amortization of debt discount

 

Amortization of debt discount was $263,200 and $2,113,652 for the three months ended March 31, 2022 and 2021, respectively, a decrease of $1,850,452 or 87.5%. The decrease is primarily due to the acceleration of the amortization of debt discount which arose during the prior year due to the early repayment and the conversion of several convertible. A total of $2,259,221 of convertible debt was converted during the prior period and a total of $521,000 of convertible debt was repaid during that period.

 

25

 

 

Derivative liability movements

 

Derivative liability movements were $92,161 and $965,144 for the three months ended March 31, 2022 and 2021, respectively, a decrease of $872,983 or 90.5%. The derivative liability arose due to the issuance of convertible securities with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The charge during the current period represents the reduction in the mark -to -market value of the derivative liability outstanding as of March 31, 2022.

 

Net loss

 

Net loss was $1,810,246 and $11,394,106 for the three months ended March 31, 2022 and 2021, respectively, a decrease in loss of $9,583,860 or 84.1%. The decrease is primarily due to the decrease in general and administrative expenses, the decrease in the loss on debt conversion and the decrease in the amortization of debt discount offset by the penalty on convertible notes, discussed in detail above.

  

Liquidity and Capital Resources

 

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

 

We have an accumulated deficit of $43,913,195 through March 31, 2022 and incurred negative cash flow from operations of $697,648 for the three months ended March 31, 2022. Our primary focus is on launching and operating e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely, which will require us to spend, substantial amounts in connection with implementing our business strategy.

 

At March 31, 2022, we had cash of $3,362,740 and working capital of $811,635 including a derivative liability of $315,000. After eliminating the derivative liability our working capital is $1,126,635.

 

We utilized cash of $760,918 and $774,180 in operations for the three months ended March 31, 2022 and 2021, respectively. Overall cash utilized in operations decreased by $13,262, which amount is immaterial.

 

We invested a further $179,030 in our e-wallet platforms to enhance the product offering we will be launching to the market during the second quarter of the current year.

 

We utilized cash of $1,147,063 during the current period to repay a convertible note together with a prepayment penalty. Cash provided by financing activities for the three months ended March 31, 2021 was primarily comprised of gross proceeds of $4,550,000 from the private placement on March 17, 2021, $2,203,714 from warrants exercised and $2,569,000 from convertible debt issued, we utilized $501,100 for share issue expenses and repaid convertible debt of $521,000 during the period.

 

At March 31, 2022, we had outstanding notes in the principal amount of $1,732,484. The notes were issued on February 16, 2021, and the maturity date was extended from February 16, 2022 to August 16, 2022. The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at a rate of 10% per annum. and are convertible into our common stock at a conversion price of $0.15 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). Upon the occurrence of an event of default under the notes, the respective holder has the right to be prepaid at 140% of the outstanding principal balance and accrued interest, and interest accrues at 18% per annum (or the maximum amount permitted by law). In addition, if an event of default under a note has occurred, regardless of whether it has been cured or remains ongoing, such Note will thereafter be convertible at 65% of the lowest closing price of our common stock for the last 10 consecutive trading days. Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

 

We expect to invest an additional $150,000 to enhance our e-wallet products, other capital expenditure is expected to be less than $100,000 during the next twelve month period. Accordingly, we expect to meet our cash requirements for the next twelve months, Beyond twelve months we expect to raise either debt or equity funding and generate revenue from operations to meet cash requirements. We will also incur costs and expenses on sales and marketing initiatives and for our general working capital.

 

However, given our losses and negative cash flows, it is likely that we will be required to raise significant additional funds to progress our business as planned by issuing equity or equity-linked securities. Should this occur, our stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

 

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations.

 

We do not have any off balance sheet financing arrangements as of the date of this report.

 

26

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

(a) Evaluation of disclosure controls and procedures

 

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), our management carried out an evaluation, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures as of March 31, 2022 are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, was recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

 

(b) Changes in Internal Control over Financial Reporting

 

There has been a change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended March 31, 2022 that has materially affected, our internal control over financial reporting, thereby remedying the weaknesses identified in previous periods.

 

27

 

 

Part II. Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business.

 

On October 20, 2021, a complaint was filed against our company and certain of its officers and directors with the Occupational Safety and Health Administration of the United Stated Department of Labor, captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleges that complainants, former employees of our company, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A, including reporting concerns about the adequacy of our internal controls. The complaint seeks reinstatement of complainants’ employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation. While the outcome of this action is presently uncertain at this point, we intend to vigorously defend against the action. To date, this matter has proceeded in the ordinary course of litigation. We may engage in alternative dispute resolution with the plaintiffs but there can be no assurance that these efforts will be successful.

 

Other than as set forth above, we are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

 

Item 1A. Risk Factors.

 

Not applicable to smaller reporting companies.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

28

 

 

Item 6. Exhibits

 

Exhibit No.   Exhibit Description
31.1*   Certification of William Corbett, Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*   Certification of Richard Rosenblum, Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)
32.1*   Certification of William Corbett, Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Richard Rosenblum, Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

 

* Filed herewith

 

29

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Innovative Payment Solutions, Inc.
   
Date: May 13, 2022 By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

Date: May 13, 2022 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President & Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

30

 

 

1810246 false --12-31 Q1 0001591913 NONE N/A N/A 0001591913 2022-01-01 2022-03-31 0001591913 2022-05-13 0001591913 2022-03-31 0001591913 2021-12-31 0001591913 2021-01-01 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 us-gaap:PreferredStockMember 2020-12-31 0001591913 us-gaap:CommonStockMember 2020-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001591913 us-gaap:RetainedEarningsMember 2020-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2020-12-31 0001591913 2020-12-31 0001591913 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-03-31 0001591913 2021-03-31 0001591913 2019-10-25 2019-11-01 0001591913 qpag:StockPurchaseAgreementMember 2019-01-01 2019-12-31 0001591913 qpag:FrictionlessMember 2021-06-22 0001591913 qpag:FrictionlessMember 2022-03-31 0001591913 qpag:FrictionlessMember 2022-01-01 2022-03-31 0001591913 qpag:BeyondFintechMember 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 qpag:BeyondFintechIncMember 2022-03-31 0001591913 qpag:KiosksMember 2022-01-01 2022-03-31 0001591913 us-gaap:ComputerEquipmentMember 2022-01-01 2022-03-31 0001591913 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-03-31 0001591913 us-gaap:OfficeEquipmentMember 2022-01-01 2022-03-31 0001591913 2021-01-01 2021-12-31 0001591913 qpag:StockPurchaseAgreementMember qpag:FrictionlessTechnologiesIncMember 2021-06-01 2021-06-22 0001591913 qpag:StockPurchaseAgreementMember qpag:FrictionlessTechnologiesIncMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-01 2021-06-22 0001591913 2019-01-01 2019-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-01-01 2022-03-31 0001591913 qpag:MrAndreyNovikovMember 2022-01-01 2022-03-31 0001591913 qpag:JosephWPatriciaGAbramsFamilyTrustMember 2022-01-01 2022-03-31 0001591913 qpag:MrGastonPereiraMember 2022-01-01 2022-03-31 0001591913 qpag:FrictionlessTechnologiesIncMember 2022-03-31 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-03-31 0001591913 qpag:ViviHoldingsIncMember 2021-12-31 0001591913 2020-07-07 2020-07-07 0001591913 qpag:CavalryFundILPMember 2021-02-01 2021-02-16 0001591913 qpag:CavalryFundILPMember 2021-02-16 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-02-03 0001591913 qpag:CavalryFundILPMember 2022-03-31 0001591913 qpag:CavalryFundILPMember 2022-02-01 2022-02-03 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-01 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-03-31 0001591913 qpag:BellridgeCapitalLPMember 2021-02-14 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2022-02-04 0001591913 qpag:CavalryFundILPMember 2022-03-31 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-03-31 0001591913 qpag:CavalryFundILPMember 2021-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-12-31 0001591913 qpag:BellridgeCapitalLPMember 2022-03-31 0001591913 qpag:BellridgeCapitalLPMember 2022-01-01 2022-03-31 0001591913 qpag:BellridgeCapitalLPMember 2021-12-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-03-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-03-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001591913 pf0:MinimumMember 2022-03-31 0001591913 pf0:MaximumMember 2022-03-31 0001591913 pf0:MinimumMember 2021-12-31 0001591913 pf0:MaximumMember 2021-12-31 0001591913 pf0:MinimumMember 2022-01-01 2022-03-31 0001591913 pf0:MaximumMember 2022-01-01 2022-03-31 0001591913 pf0:MinimumMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember us-gaap:CommonStockMember 2022-03-31 0001591913 pf0:MaximumMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001591913 qpag:TwoThousandTwentyOnePlanMember pf0:MaximumMember 2022-03-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001591913 qpag:TotalRestrictedSharesMember 2020-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2020-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2020-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-01-01 2022-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-03-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-01-01 2022-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-03-31 0001591913 qpag:TotalRestrictedSharesMember 2022-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-03-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-03-31 0001591913 qpag:ExercisePrice0049Member 2022-01-01 2022-03-31 0001591913 qpag:ExercisePriceRange5Member 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2020-12-31 0001591913 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 pf0:MinimumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 pf0:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 pf0:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2022-03-31 0001591913 pf0:MinimumMember us-gaap:WarrantMember 2022-03-31 0001591913 pf0:MaximumMember us-gaap:WarrantMember 2022-03-31 0001591913 qpag:ExercisePriceRange5Member 2022-03-31 0001591913 qpag:ExercisePrice015Member 2022-03-31 0001591913 qpag:ExercisePrice015Member 2022-01-01 2022-03-31 0001591913 qpag:ExercisePrice0187Member 2022-03-31 0001591913 qpag:ExercisePrice0187Member 2022-01-01 2022-03-31 0001591913 us-gaap:StockOptionMember 2020-12-31 0001591913 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 pf0:MinimumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 pf0:MinimumMember us-gaap:StockOptionMember 2021-12-31 0001591913 pf0:MaximumMember us-gaap:StockOptionMember 2021-12-31 0001591913 us-gaap:StockOptionMember 2022-03-31 0001591913 pf0:MinimumMember us-gaap:StockOptionMember 2022-03-31 0001591913 pf0:MaximumMember us-gaap:StockOptionMember 2022-03-31 0001591913 qpag:ExercisePrice024Member 2022-03-31 0001591913 qpag:ExercisePrice024Member 2022-01-01 2022-03-31 0001591913 qpag:ExercisePrice040Member 2022-03-31 0001591913 qpag:ExercisePrice040Member 2022-01-01 2022-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-03-31 0001591913 qpag:StockOptionsMember 2022-01-01 2022-03-31 0001591913 qpag:StockOptionsMember 2021-01-01 2021-03-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001591913 qpag:JamesFullerMember 2021-02-21 2021-02-22 0001591913 qpag:JamesFullerMember 2021-02-22 0001591913 qpag:MrFullerMember 2021-07-22 2021-07-22 0001591913 qpag:MrFullerMember 2021-07-22 0001591913 2021-02-22 0001591913 pf0:MaximumMember qpag:MrFullerMember 2021-02-22 0001591913 pf0:MinimumMember qpag:MrFullerMember 2021-02-22 0001591913 qpag:MrAndreyNovikovMember 2021-02-21 2021-02-22 0001591913 2021-02-21 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-01-01 2021-12-31 0001591913 qpag:MrCorbettMember 2021-08-01 2021-08-31 0001591913 qpag:MrCorbettMember 2021-08-31 0001591913 2021-08-01 2021-08-31 0001591913 qpag:MrHenryMember 2021-07-22 2021-07-22 0001591913 qpag:CliffordHenryMember 2021-07-22 0001591913 2021-07-22 0001591913 qpag:MrCorbettMember 2021-07-22 2021-07-22 0001591913 qpag:MrCorbettMember 2021-07-22 0001591913 qpag:MrRiosMember 2021-07-22 2021-07-22 0001591913 qpag:MrRiosMember 2021-07-22 0001591913 2021-07-27 2021-07-27 0001591913 qpag:MrRosenblumMember 2022-03-31 0001591913 qpag:MrRosenblumMember 2021-12-31 0001591913 qpag:MrRosenblumMember 2022-01-01 2022-03-31 0001591913 qpag:MrRosenblumMember 2021-08-01 2021-08-16 0001591913 qpag:MrRosenblumMember 2021-08-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0322ex31-1_innovative.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, William Corbett, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 13, 2022 /s/ William Corbett
  William Corbett
  Chief Executive Officer
  (Principal Executive Officer)

 

EX-31.2 3 f10q0322ex31-2_innovative.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Rosenblum, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 13, 2022 /s/ Richard Rosenblum
  Richard Rosenblum
  President and Chief Financial Officer
  (Principal Financial and Accounting Officer)
EX-32.1 4 f10q0322ex32-1_innovative.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the period ending March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Corbett, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: May 13, 2022 By: /s/ William Corbett
    William Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

EX-32.2 5 f10q0322ex32-2_innovative.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the period ending March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Rosenblum, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

  

Date: May 13, 2022 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President and Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

EX-101.SCH 6 qpag-20220331.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - LIQUIDITY MATTERS link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - INTANGIBLES link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - INVESTMENTS link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - LEASES link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - FEDERAL RELIEF LOANS link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - CONVERTIBLE NOTES PAYABLE link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - DERIVATIVE LIABILITY link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - NET LOSS PER SHARE link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - INTANGIBLES (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - LEASES (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - DERIVATIVE LIABILITY (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - NET LOSS PER SHARE (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - LIQUIDITY MATTERS (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - INTANGIBLES (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - INTANGIBLES (Details) - Schedule of facilitate the functioning of the software link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - INVESTMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - INVESTMENTS (Details) - Schedule of investment link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - LEASES (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - LEASES (Details) - Schedule of total lease cost link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - LEASES (Details) - Schedule of other lease information link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - LEASES (Details) - Schedule of maturity of operating leases link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - FEDERAL RELIEF LOANS (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - DERIVATIVE LIABILITY (Details) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - STOCKHOLDERS’ EQUITY (Details) link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock granted and exercisable link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of warrant activity link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of warrants outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of option activity link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of options outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - NET LOSS PER SHARE (Details) - Schedule of dilutive shares link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 qpag-20220331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 qpag-20220331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 qpag-20220331_lab.xml XBRL LABEL FILE EX-101.PRE 10 qpag-20220331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 13, 2022
Document Information Line Items    
Entity Registrant Name INNOVATIVE PAYMENT SOLUTIONS, INC.  
Trading Symbol N/A  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   367,901,679
Amendment Flag false  
Entity Central Index Key 0001591913  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Mar. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-55648  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 33-1230229  
Entity Address, Address Line One 56B 5th Avenue  
Entity Address, Address Line Two Lot 1 #AT  
Entity Address, City or Town Carmel By The Sea  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93921  
City Area Code (866)  
Local Phone Number 477-4729  
Entity Interactive Data Current Yes  
Security Exchange Name NONE  
Title of 12(b) Security N/A  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash $ 3,362,740 $ 5,449,751
Other current assets 39,326 85,034
Total Current Assets 3,402,066 5,534,785
Non-current assets    
Plant and equipment 24,302 28,799
Intangible assets 867,300 625,000
Security deposit 34,800 34,800
Investment 500,001 500,001
Total Non-Current Assets 1,426,403 1,188,600
Total Assets 4,828,469 6,723,385
Current Liabilities    
Accounts payable 522,253 465,205
Convertible debt, net of unamortized discount of $0 and $263,200, respectively 1,753,178 1,961,354
Derivative liability 315,000 407,161
Total Current Liabilities 2,590,431 2,833,720
Non-Current Liabilities    
Federal relief loans 159,740 158,353
Total Non-Current Liabilities 159,740 158,353
Total Liabilities 2,750,171 2,992,073
Equity    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021.
Common stock, $0.0001 par value; 750,000,000 and 500,000,000 shares authorized, 367,901,679 shares issued and outstanding as of March 31, 2022 and December 31, 2021. 36,790 36,790
Additional paid-in-capital 45,928,244 45,771,012
Accumulated deficit (43,913,195) (42,111,701)
Total equity attributable to Innovative Payment Solutions, Inc. Stockholders 2,051,839 3,696,101
Non-controlling interest 26,459 35,211
Total Equity 2,078,298 3,731,312
Total Liabilities and Equity $ 4,828,469 $ 6,723,385
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Convertible debt, net of unamortized discount (in Dollars) $ 0 $ 263,200
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, authorized 25,000,000 25,000,000
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized 750,000,000 500,000,000
Common stock, issued 367,901,679 367,901,679
Common stock, outstanding 367,901,679 367,901,679
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Net Revenue
Cost of Goods Sold
Gross profit
General and administrative 869,387 4,989,672
Depreciation 4,496 4,167
Total Expense 873,883 4,993,839
Loss from Operations (873,883) (4,993,839)
Loss on debt conversion (5,184,447)
Penalty on convertible notes (719,558)
Interest expense (45,766) (67,312)
Amortization of debt discount (263,200) (2,113,652)
Derivative liability movements 92,161 965,144
Loss before Income Taxes (1,810,246) (11,394,106)
Income Taxes
Net loss (1,810,246) (11,394,106)
Net loss attributable to non-controlling interest 8,752
Net loss attributable to Innovative Payment Solutions, Inc. stockholders $ (1,801,494) $ (11,394,106)
Basic and Diluted loss per share (in Dollars per share) $ 0 $ (0.04)
Weighted Average Number of Shares Outstanding – Basic and Diluted (in Shares) 367,901,679 255,272,113
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling shareholders interest
Total
Balance at Dec. 31, 2020 $ 19,363 $ 23,179,399 $ (27,629,575) $ (4,430,813)
Balance (in Shares) at Dec. 31, 2020   193,637,747        
Warrants exercised $ 4,407 2,199,307 2,203,714
Warrants exercised (in Shares)   44,074,284        
Share subscriptions $ 3,033 4,546,967 4,550,000
Share subscriptions (in Shares)   30,333,334        
Share issue expenses (501,100) (501,100)
Conversion of debt to equity $ 6,180 7,437,488 7,443,668
Conversion of debt to equity (in Shares)   61,793,616        
Fair value of warrants issued as compensation 4,327,899 4,327,899
Stock based option expense $ 250 213,499 213,749
Stock based option expense (in Shares)   2,500,000        
Net loss (11,394,106) (11,394,106)
Balance at Mar. 31, 2021 $ 33,233 41,403,459 (39,023,681) 2,413,011
Balance (in Shares) at Mar. 31, 2021 332,338,981        
Balance at Dec. 31, 2021 $ 36,790 45,771,012 (42,111,701) 35,211 3,731,312
Balance (in Shares) at Dec. 31, 2021 367,901,679        
Stock based option expense 94,466 94,466
Restricted stock awards 62,766 62,766
Net loss (1,801,494) (8,752) (1,810,246)
Balance at Mar. 31, 2022 $ 36,790 $ 45,928,244 $ (43,913,195) $ 26,459 $ 2,078,298
Balance (in Shares) at Mar. 31, 2022   367,901,679        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,810,246) $ (11,394,106)
Adjustments to reconcile net loss to net cash used in operating activities:    
Derivative liability movements (92,161) (965,144)
Depreciation 4,496 4,167
Amortization of debt discount 263,200 2,113,652
Loss on conversion of debt to equity 5,184,447
Penalty on convertible note 719,558
Fair value of warrants issued as compensation 4,327,899
Stock based compensation 157,232 213,749
Amortization of right of use asset 10,625
Changes in Assets and Liabilities    
Other current assets 45,708 (2,994)
Accounts payable and accrued expenses (6,221) (293,900)
Operating lease liabilities (10,625)
Interest accruals (42,484) 38,050
CASH USED IN OPERATING ACTIVITIES (760,918) (774,180)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in deposits (4,800)
Plant and equipment purchased (179,030)
NET CASH USED IN INVESTING ACTIVITIES (179,030) (4,800)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from share issuances 4,550,000
Share issue expenses (501,100)
Proceeds from warrants exercised 2,203,714
Repayment of loans payable (22,049)
Repayment of convertible notes (1,147,063) (521,000)
Proceeds from short term notes and convertible notes 2,569,000
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (1,147,063) 8,278,565
NET (DECREASE) INCREASE IN CASH (2,087,011) 7,499,585
CASH AT BEGINNING OF PERIOD 5,449,751 94,703
CASH AT END OF PERIOD 3,362,740 7,594,288
CASH PAID FOR INTEREST AND TAXES:    
Cash paid for income taxes
Cash paid for interest 88,250 33,030
NON CASH INVESTING AND FINANCING ACTIVITIES    
Conversion of convertible debt to equity $ 2,259,221
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
ORGANIZATION AND DESCRIPTION OF BUSINESS
3 Months Ended
Mar. 31, 2022
ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS
1ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

  b) Description of current business

The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational. The Company’s flagship e-wallet, IPSIPay, is fully operational and ready for commercial launch during the second quarter of 2022. Previously the Company intended to invest in physical kiosks, which required the user presence at the kiosk location. The Company still intends to use its existing kiosks in certain target markets within Southern California, but its principal focus will be on downloadable apps used via smartphones.

The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United states and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

c)COVID-19

 

The COVID-19 pandemic has required the Company’s management to focus its attention primarily on responding to the challenges presented by the pandemic, including ensuring continuous operations, and adjusting its operations to address changes in the virtual payments industry. Due to measures imposed by the local governments in areas affected by COVID-19 (including both in the United States and Mexico), businesses had been suspended due to quarantines intended to contain this outbreak and many people had been forced to work from home in those areas. As a result, the commercial launch of the Company’s e-wallets and the limited installation of the Company’s network of kiosks in Southern California had been delayed, which has had an adverse impact on the Company’s business and financial condition and has hampered the Company’s ability to generate revenues. As the COVID-19 pandemic evolves, the Company may face similar challenges in the future which could lead to material adverse impacts on the Company.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTING POLICIES AND ESTIMATES
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
ACCOUNTING POLICIES AND ESTIMATES
2ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.

 

All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.

 

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

  c) Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

  d) Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

  e) Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

  f) Risks and Uncertainties

 

The Company’s operations will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s products and the use by customers of such products, (iii) competition, (iv) inflation and other economic factors and (v) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

  g) Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

  h) Reporting by Segment

 

No segmental information is required as the Company has not generated any revenue for the three months ended March 31, 2022 and 2021 and only has one operating segment.

 

  i) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2022 and 2021, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2022 and December 31, 2021, the balance exceed the federally insured limit by $2,848,701 and $5,117,551, respectively.

 

  j) Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2022 and December 31, 2021.

 

  k) Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

  l) Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

 

m) Long-Term Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

  n) Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had no revenues during the three months ended March 31, 2022 and 2021.

 

  o) Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

  p) Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

  q) Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.

 

  r) Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

  s) Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
LIQUIDITY MATTERS
3 Months Ended
Mar. 31, 2022
Liquidity Matters [Abstract]  
LIQUIDITY MATTERS
3 LIQUIDITY MATTERS

  

The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the end of three months ended March 31, 2022, the Company had a net loss of $1,801,494 and had $3,362,740 in cash. In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2022, management evaluated the extent of the impact from the COVID-19 pandemic and other risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements. 

 

The Company had a cash balance of $3,362,740 available as of March 31, 2022. Based on its evaluation of the Company’s current business plan, management believes the Company’s existing cash is sufficient to conduct planned operations for at least one year from the date of issuance of these financial statements.

 

However, given the Company’s losses and negative cash flows, it is likely that the Company will be required to raise significant additional funds to progress its business as planned by issuing equity or equity-linked securities. Should this occur, the Company’s stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting the Company’s operations or its ability to incur additional debt. Any additional debt financing or additional equity that the Company raises may contain terms that are not favorable to the Company or its stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support the Company’s operations on favorable terms, or at all.

 

There is also a significant risk that none of the Company’s plans to raise financing will be implemented in a manner necessary to sustain the Company for an extended period of time. If adequate funds are not available to the Company when needed, the Company may be required to continue with reduced operations or to obtain funds through arrangements that may require the Company to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on the Company. In addition, the Company’s inability to secure additional funding when needed could cause the Company’s business to fail or become bankrupt or force the Company to wind down or discontinue operations.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLES
3 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLES
4 INTANGIBLES

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, which is now complete. During the three months ended March 31, 2022, an additional $217,300 was spent by the Companyto facilitate the functioning of the IPSIPay software in the cloud environment, and Beyond Fintech spent an additional $25,000 on software to further enhance the Beyond Wallet product offering. 

 

   March 31, 2022   December 31,
2021
 
Purchased Technology  $867,300   $625,000 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENTS
3 Months Ended
Mar. 31, 2022
Investments, All Other Investments [Abstract]  
INVESTMENTS
5 INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On June 22, 2021, the Company entered into a Stock Purchase Agreement (the “SPA”) with Frictionless, to purchase 150 common shares for gross proceeds of $500,000, representing 10.0% of the outstanding common shares. In terms of the SPA, Frictionless agreed to deliver to the Company on or before August 30, 2021, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United states and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate to Company’s anticipated product offerings.

 

The Company has undertaken to issue Frictionless a non-restricted, non-dilutable 5 year warrant to purchase 30,000,000 shares of Common Stock at an exercise price of $0.15 per share, upon delivery of the financial payment software. Frictionless delivered the software and the warrants will be issued in accordance with the agreement.

 

The Company has the right to appoint, and has appointed, one member to the board of directors of Frictionless, which appointee will remain on the board as long as the Company is the holder of the Frictionless common stock.

 

The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

The shares in Frictionless are unlisted as of March 31, 2022.

 

Investment in Vivi Holdings, Inc.

 

Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.

 

As consideration for the disposal, Vivi issued an aggregate of 2,250,000 Vivi Shares as follows: 2,047,500  Vivi Shares to the Company; 56,250 Vivi Shares to the Company’s designee, Mr. Andrey Novikov; 33,750 Vivi Shares to the Company’s designee, the Joseph W. & Patricia G. Abrams Family Trust; and 112,500 Vivi Shares to the Company’s designee, Mr. Gaston Pereira.

 

Due to the lack of available information, the Vivi Shares were valued by a modified market method, whereby the value of the assets disposed of were determined by management using the enterprise value of the entire Company less the liabilities and assets retained by the Company.

 

As of March 31, 2022 and December 31, 2021, the Company maintained the impairment of the carrying value of the investment in Vivi Holdings based on no activity by Vivi’s management for its proposed initial public offering and fund raising activities. The total impairment as of March 31, 2022 and December 31, 2021 was $1,019,960.

 

The shares in Vivi Holdings are unlisted as of March 31, 2022.

 

   March 31,
2022
   December 31,
2021
 
Investment in Frictionless Financial Technologies, Inc.  $500,000   $500,000 
Investment in Vivi Holdings, Inc.   1    1 
   $500,001   $500,001 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES
3 Months Ended
Mar. 31, 2022
Leases [Abstract]  
LEASES
6 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Avenue, Lot 1 #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month.

  

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

  

Three months ended
March 31,

2022

   Three months ended
March 31,
2021
 
Operating lease expense  $14,400   $11,835 

 

Other lease information:

 

  

Three months ended
March 31,

2022

   Three months ended
March 31,
2021
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(14,400)  $(11,835)
           
Remaining lease term – operating lease   
-
    11 months 

 

Maturity of Operating Leases

 

The amount of future minimum lease payments under operating leases are as follows:

 

    Amount  
Undiscounted minimum future lease payments under leases with terms twelve months or less      
Total instalments due:      
2022   $
          -
 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
FEDERAL RELIEF LOANS
3 Months Ended
Mar. 31, 2022
Federal Relief Loans [Abstract]  
FEDERAL RELIEF LOANS
7 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The Company has accrued interest of $9,740 on this loan as of March 31, 2022.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE NOTES PAYABLE
3 Months Ended
Mar. 31, 2022
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE
8 CONVERTIBLE NOTES PAYABLE

 

Convertible notes payable consists of the following:

 

Description  Effective Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
  

March 31, 2022

Amount,
net

  

December 31,
2021

Amount,
net

 
Cavalry Fund I LP   28.7%  August 16,
2022
   866,242    10,347    
     -
    876,589    548,872 
                                  
Mercer Street Global Opportunity Fund, LLC   28.7%  August 16,
2022
   866,242    10,347    
-
    876,589    548,872 
                                  
Bellridge Capital LP.   10%  February 16,
2022
   
-
    
-
    
-
    
-
    863,609 
                                  
Total convertible notes payable          $1,732,484   $20,694   $-   $1,753,178   $1,961,353 

 

Interest expense totaled $44,379 and $65,792 and amortization of debt discount totaled $263,200 and $2,113,652 for the three months ended March 31, 2022 and 2021, respectively.

 

Cavalry Fund I LP

 

  On February 16, 2021, the Company closed a transaction with Cavalry Fund I LP (“Cavalry”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Cavalry Note”). The Cavalry Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Cavalry Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.

 

The balance of the Cavalry Note plus accrued interest at March 31, 2022 was $876,589.

 

Mercer Street Global Opportunity Fund, LLC

   

  On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Mercer Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.

 

The balance of the Mercer Note plus accrued interest at March 31, 2022 was $876,589.

 

Bellridge Capital LP.

  

  On February 16, 2021, the Company closed a transaction with Bellridge Capital LP., pursuant to which the Company received net proceeds of $787,500, after an original issue discount of $112,500 in exchange for the issuance of a $900,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Bellridge Note”). The Bellridge Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 3,913,044 shares of Common Stock at an initial exercise price of $0.24 per share.

 

The Bellridge Note was repaid on February 4, 2022 for gross proceeds of $1,235,313, including interest thereon of $88,250, thereby extinguishing the Bellridge Note.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
DERIVATIVE LIABILITY
3 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITY
9DERIVATIVE LIABILITY

 

Certain of the short-term convertible notes disclosed in note 8 above and certain warrants disclosed in note 10 below have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

The value of this derivative financial liability was re-assessed at March 31, 2022 at $315,000, and $92,161 was credited to the statement of operations. The value of the derivative liability will be re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred.

 

The following assumptions were used in the Black-Scholes valuation model:

 

    Three months ended
March 31,
2022
    Year ended
December 31,
2021
 
Conversion price   $ 0.05 to $0.15     $ 0.05 to $0.24  
Risk free interest rate     0.79 to 2.45 %     0.05 to 1.12 %
Expected life of derivative liability     4.6 to 46.6 months       1.6 to 49.6 months  
Expected volatility of underlying stock     151.07 to 194.99     161.19 to 215.33
Expected dividend rate     0 %     0 %

 

The movement in derivative liability is as follows:

 

   March 31,
2022
   December 31,
2021
 
Opening balance  $407,161   $2,966,416 
Derivative financial liability arising from convertible note   
-
    2,569,000 
Fair value adjustment to derivative liability   (92,161)   (5,128,255)
   $315,000   $407,161 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY
  10 STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company has issued and outstanding 367,901,679 shares of Common Stock as of March 31, 2022 and December 31, 2021, respectively.

 

  b. Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2021 to March 31, 2022 is as follows:

 

   Total restricted shares   Weighted
average
fair market value per share
   Total
unvested
restricted
shares
   Weighted
average
fair market value per share
   Total vested restricted shares   Weighted
average
fair market value per share
 
Outstanding January 1, 2021   20,495,000   $0.049    15,371,250   $0.049    5,123,750   $0.049 
Granted   2,500,000    0.050    2,500,000    0.050    
-
    
-
 
Forfeited/Cancelled   (1,500,000)   (0.050)   (1,500,000)   (0.050)   
-
    
-
 
Vested   
-
    
-
    (6,123,750)   (0.049)   6,123,750    0.049 
Outstanding December 31, 2021   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding March 31, 2022   21,495,000   $0.049    5,123,750   $0.049    16,371,250   $0.049 

 

The restricted stock granted and exercisable at March 31, 2022 is as follows:

 

    Restricted Stock Granted   Restricted Stock Vested 
Grant date
Price
   Number
Granted
   Weighted
Average
Fair Value
per
Share
   Number
Vested
   Weighted
Average
Fair Value
per
Share
 
$0.049    20,495,000   $0.049    15,371,250   $0.049 
$0.050    1,000,000    0.050    1,000,000    0.050 
      21,495,000   $0.049    16,371,250   $0.049 

 

The Company has recorded an expense of $62,766 and $122,141 for the three months ended March 31, 2022 and 2021, respectively.

 

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized, no preferred stock is issued and outstanding as of March 31, 2022 and December 31, 2021.

 

  d. Warrants

  

A summary of warrant activity during the period January 1, 2021 to March 31, 2022 is as follows:

 

   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021   51,188,572   $0.05   $0.05 
Granted   66,302,515       0.05 to 0.24    0.16 
Forfeited/Cancelled   (20,000,000)   0.24    0.24 
Exercised   (60,186,982)   0.05    0.05 
Outstanding December 31, 2021   37,304,105    $ 0.05 – 0.1875   $0.12 
Granted   
-
    -    
-
 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding March 31, 2022   37,304,105    $ 0.05 – 0.1875   $0.12 

 

The warrants outstanding and exercisable at March 31, 2022 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.05    10,823,813    3.53         10,823,813         3.53 
 0.15    24,053,625    3.94         24,053,625         3.94 
 0.1875    2,426,667    3.96         2,426,667         3.96 
      37,304,105    3.82    0.12    37,304,105    0.12    3.82 

 

The warrants outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

 

Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

No options were granted for the three months ended March 31, 2022.

 

A summary of option activity during the period January 1, 2021 to March 31, 2022 is as follows:

 

   Shares
Underlying
options
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021   100,000    0.40    0.40 
Granted   30,416,666    0.15 – 0.24    0.15 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding December 31, 2021   30,516,666     $ 0.15 to 0.40   $0.15 
Granted   
-
    -    
-
 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding March 31, 2022   30,516,666     $ 0.15 to 0.40   $0.15 

 

The options outstanding and exercisable at March 31, 2022 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
 0.15    30,208,333    9.39         18,125,000         9.89 
 0.24    208,333    8.90         208,333         9.40 
 0.40    100,000    6.75         100,000         7.25 
      30,516,666    9.38   $0.15    18,433,333   $0.15    9.37 

 

The options outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021, respectively. The option expense was $94,466 and $91,608 for the three months ended March 31, 2022 and 2021, respectively.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
NET LOSS PER SHARE
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
NET LOSS PER SHARE
11NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2022 and 2021 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31 2022 and 2021 are as follows:

 

   Three
months ended
March 31,
2022
(Shares)
   Three
months ended
March 31,
2021
(Shares)
 
Convertible debt   11,687,855    8,993,106 
Stock options   30,516,666    516,666 
Warrants to purchase shares of Common Stock   37,304,104    73,416,802 
    79,508,625    82,926,574 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
12RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On February 22, 2021, the Board awarded James Fuller options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share.

 

On July 22. 2021, the Company granted Mr. Fuller 2,000,000 shares of Common Stock, valued at $154,000. 

 

Additionally, the Board approved the repricing of the options exercisable for 208,333 shares of Common Stock granted to Mr. Fuller on February 22, 2021, from $0.24 per share to $0.15 per share.

 

Andrey Novikov

 

On February 22, 2021, the Board awarded Andrey Novikov options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share. 

 

On May 31, 2021, Mr. Novikov notified the Board of his decision to resign as a member of the Board and as Secretary of the Company, effective as of June 1, 2021. Since August 2021, Mr. Novikov has been on suspension from service as the Company’s Chief Technology Officer.

 

William Corbett

 

On February 22, 2021, the Board appointed William Corbett as the Company’s Chief Executive Officer and Interim Chief Financial Officer, as its Chairman of the Board and issued him a five-year warrant to purchase 20,000,000 shares of the Common Stock at an exercise price of $0.24 per share. The Board also agreed to increase Mr. Corbett’s monthly base salary to $30,000. The warrant expense for Mr. Corbett for the year ended December 31, 2021 was $4,327,899.

 

On August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous executive employment agreement (the “August 2021 Corbett Employment Agreement”). The purpose of the August 2021 Corbett Employment Agreement was to provide a replacement grant for warrants previously granted to Mr. Corbett under the terms of his previous employment agreement with the Company. Pursuant to the August 2021 Corbett Employment Agreement, Mr. Corbett would continue to serve as the Company’s Chief Executive Officer on a full time basis effective as of the date of the August 2021 Corbett Employment Agreement until the close of business on December 31, 2024. Mr. Corbett’s base salary will be $30,000 per month, which shall be paid in accordance with the Company’s standard payroll practice for its executives, managers and salaried employees. In addition, the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The option expense for Mr. Corbett for the three months ended March 31, 2022 was $66,587 and for the year ended December 31, 2021 was $910,019.

 

In addition, the Company and Mr. Corbett entered into an Indemnification Agreement on August 16, 2021 (the “August 2021 Corbett Indemnification Agreement”), pursuant to which the Company agreed to indemnify Mr. Corbett to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses. The August 2021 Corbett Indemnification Agreement amends the indemnification agreement in effect prior to entering into the August 2021 Corbett Indemnification Agreement to provide that unless Company shall pay Mr. Corbett’s attorneys’ fees and costs, including the compensation and expenses of any arbitrator, unless the arbitrator or the court determines that (a) Company has no liability in such dispute, or (b) the action or claims by Executive are frivolous in nature. In any other case or matter, the Company and Mr. Corbett shall each bear its or his own attorney fees and costs.

Clifford Henry

 

On May 1, 2021, the Company appointed Mr. Henry to the Board.

 

On July 22, 2021, the Company granted Mr. Henry 2,000,000 shares of Common Stock, valued at $154,000.

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022   

 

Madisson Corbett

 

On May 1, 2021, the Company appointed Ms. Corbett to the Board. Ms. Corbett is the daughter of Mr. William Corbett, the Company’s Chief Executive Officer and Chairman of the Board.

 

On July 22, 2021, the Company granted Ms. Corbett 2,000,000 shares of Common Stock, valued at $154,000. 

 

David Rios

 

On July 22, 2021, the Company appointed David Rios to the Board.

 

On July 22, 2021, the Company granted Mr. Rios 1,000,000 shares of Common Stock, valued at $77,000.  

 

Richard Rosenblum

 

On July 22, 2021, the Company appointed Richard Rosenblum as President and Chief Financial Officer of the Company. In addition, Mr. Rosenblum was elected to the Board to serve until the Company’s next annual meeting of shareholders.

 

On July 27, 2021, the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Company’s common stock, as reflected in the closing price of the Company’s common stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan. The option expense for Mr. Rosenblum for the three months ended March 31, 2022 was $27,879 and for the year ended December 31, 2021 was $381,006.

If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, then Mr. Rosenblum shall be entitled to severance equal to fifty percent (50%) of his annual base salary rate in effect as of the date of termination. If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, within 12 months following an Acquisition (as defined in the Employment Agreement), then Mr. Rosenblum shall be entitled to severance equal to 100% of his annual base salary rate in effect as of the date of termination. Severance payments shall be subject to execution and delivery of a general release in favor of the Company.

 

On August 16, 2021, the Company entered into an amendment to the Rosenblum Executive Employment Agreement (the “First Amendment”) with Mr. Rosenblum. Under the terms of the Executive Employment Agreement, the Company had agreed to grant to Mr. Rosenblum an option to purchase 10,000,000 (ten million) common shares of Company Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is uplisted, on a national stock exchange, on the date of grant (the “Option”).” The First Amendment provided that the Option was granted on August 31, 2021 at an exercise price of $0.15 per share.

 

In addition, the Company and Mr. Rosenblum entered into an Indemnification Agreement, pursuant to which the Company agreed to indemnify Mr. Rosenblum to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
13COMMITMENTS AND CONTINGENCIES

 

The Company has convertible notes, disclosed under note 8 above which mature on August 16, 2022. Should these notes not be converted to Common Stock prior to that date, the Company may need to repay the principal and interest outstanding on these notes.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
14SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation
a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.

 

All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.

 

Principles of Consolidation
b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

Use of Estimates
  c) Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

Contingencies
  d) Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

Fair Value of Financial Instruments
  e) Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

Risks and Uncertainties
  f) Risks and Uncertainties

 

The Company’s operations will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s products and the use by customers of such products, (iii) competition, (iv) inflation and other economic factors and (v) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

Recent accounting pronouncements
  g) Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

Reporting by Segment
  h) Reporting by Segment

 

No segmental information is required as the Company has not generated any revenue for the three months ended March 31, 2022 and 2021 and only has one operating segment.

 

Cash and Cash Equivalents
  i) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2022 and 2021, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2022 and December 31, 2021, the balance exceed the federally insured limit by $2,848,701 and $5,117,551, respectively.

 

Accounts Receivable and Allowance for Doubtful Accounts
  j) Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2022 and December 31, 2021.

 

Investments
  k) Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

Plant and Equipment
  l) Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

Long-Term Assets

 

m) Long-Term Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

Revenue Recognition
  n) Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had no revenues during the three months ended March 31, 2022 and 2021.

 

Share-Based Payment Arrangements
  o) Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

Derivative Liabilities
  p) Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

Income Taxes
  q) Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.

 

Comprehensive income
  r) Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

Reclassification of prior year presentation
  s) Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTING POLICIES AND ESTIMATES (Tables)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of estimated useful lives of the assets
Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLES (Tables)
3 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of facilitate the functioning of the software
   March 31, 2022   December 31,
2021
 
Purchased Technology  $867,300   $625,000 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENTS (Tables)
3 Months Ended
Mar. 31, 2022
Investments, All Other Investments [Abstract]  
Schedule of investment
   March 31,
2022
   December 31,
2021
 
Investment in Frictionless Financial Technologies, Inc.  $500,000   $500,000 
Investment in Vivi Holdings, Inc.   1    1 
   $500,001   $500,001 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES (Tables)
3 Months Ended
Mar. 31, 2022
Leases [Abstract]  
Schedule of total lease cost
  

Three months ended
March 31,

2022

   Three months ended
March 31,
2021
 
Operating lease expense  $14,400   $11,835 

 

Schedule of other lease information
  

Three months ended
March 31,

2022

   Three months ended
March 31,
2021
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(14,400)  $(11,835)
           
Remaining lease term – operating lease   
-
    11 months 

 

Schedule of maturity of operating leases
    Amount  
Undiscounted minimum future lease payments under leases with terms twelve months or less      
Total instalments due:      
2022   $
          -
 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE NOTES PAYABLE (Tables)
3 Months Ended
Mar. 31, 2022
Convertible Notes Payable [Abstract]  
Schedule of convertible notes payable
Description  Effective Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
  

March 31, 2022

Amount,
net

  

December 31,
2021

Amount,
net

 
Cavalry Fund I LP   28.7%  August 16,
2022
   866,242    10,347    
     -
    876,589    548,872 
                                  
Mercer Street Global Opportunity Fund, LLC   28.7%  August 16,
2022
   866,242    10,347    
-
    876,589    548,872 
                                  
Bellridge Capital LP.   10%  February 16,
2022
   
-
    
-
    
-
    
-
    863,609 
                                  
Total convertible notes payable          $1,732,484   $20,694   $-   $1,753,178   $1,961,353 

 

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
DERIVATIVE LIABILITY (Tables)
3 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of assumptions were used in the Black-Scholes valuation model
    Three months ended
March 31,
2022
    Year ended
December 31,
2021
 
Conversion price   $ 0.05 to $0.15     $ 0.05 to $0.24  
Risk free interest rate     0.79 to 2.45 %     0.05 to 1.12 %
Expected life of derivative liability     4.6 to 46.6 months       1.6 to 49.6 months  
Expected volatility of underlying stock     151.07 to 194.99     161.19 to 215.33
Expected dividend rate     0 %     0 %

 

Schedule of movement in derivative liability
   March 31,
2022
   December 31,
2021
 
Opening balance  $407,161   $2,966,416 
Derivative financial liability arising from convertible note   
-
    2,569,000 
Fair value adjustment to derivative liability   (92,161)   (5,128,255)
   $315,000   $407,161 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of restricted stock activity
   Total restricted shares   Weighted
average
fair market value per share
   Total
unvested
restricted
shares
   Weighted
average
fair market value per share
   Total vested restricted shares   Weighted
average
fair market value per share
 
Outstanding January 1, 2021   20,495,000   $0.049    15,371,250   $0.049    5,123,750   $0.049 
Granted   2,500,000    0.050    2,500,000    0.050    
-
    
-
 
Forfeited/Cancelled   (1,500,000)   (0.050)   (1,500,000)   (0.050)   
-
    
-
 
Vested   
-
    
-
    (6,123,750)   (0.049)   6,123,750    0.049 
Outstanding December 31, 2021   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding March 31, 2022   21,495,000   $0.049    5,123,750   $0.049    16,371,250   $0.049 

 

Schedule of restricted stock granted and exercisable
    Restricted Stock Granted   Restricted Stock Vested 
Grant date
Price
   Number
Granted
   Weighted
Average
Fair Value
per
Share
   Number
Vested
   Weighted
Average
Fair Value
per
Share
 
$0.049    20,495,000   $0.049    15,371,250   $0.049 
$0.050    1,000,000    0.050    1,000,000    0.050 
      21,495,000   $0.049    16,371,250   $0.049 

 

Schedule of warrant activity
   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021   51,188,572   $0.05   $0.05 
Granted   66,302,515       0.05 to 0.24    0.16 
Forfeited/Cancelled   (20,000,000)   0.24    0.24 
Exercised   (60,186,982)   0.05    0.05 
Outstanding December 31, 2021   37,304,105    $ 0.05 – 0.1875   $0.12 
Granted   
-
    -    
-
 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding March 31, 2022   37,304,105    $ 0.05 – 0.1875   $0.12 

 

Schedule of warrants outstanding and exercisable
    Warrants Outstanding   Warrants Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.05    10,823,813    3.53         10,823,813         3.53 
 0.15    24,053,625    3.94         24,053,625         3.94 
 0.1875    2,426,667    3.96         2,426,667         3.96 
      37,304,105    3.82    0.12    37,304,105    0.12    3.82 

 

Schedule of option activity
   Shares
Underlying
options
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021   100,000    0.40    0.40 
Granted   30,416,666    0.15 – 0.24    0.15 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding December 31, 2021   30,516,666     $ 0.15 to 0.40   $0.15 
Granted   
-
    -    
-
 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding March 31, 2022   30,516,666     $ 0.15 to 0.40   $0.15 

 

Schedule of options outstanding and exercisable
    Options Outstanding   Options Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
 0.15    30,208,333    9.39         18,125,000         9.89 
 0.24    208,333    8.90         208,333         9.40 
 0.40    100,000    6.75         100,000         7.25 
      30,516,666    9.38   $0.15    18,433,333   $0.15    9.37 

 

XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of dilutive shares
   Three
months ended
March 31,
2022
(Shares)
   Three
months ended
March 31,
2021
(Shares)
 
Convertible debt   11,687,855    8,993,106 
Stock options   30,516,666    516,666 
Warrants to purchase shares of Common Stock   37,304,104    73,416,802 
    79,508,625    82,926,574 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.1
ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 01, 2019
Aug. 26, 2021
Mar. 31, 2022
Dec. 31, 2019
Jun. 22, 2021
Organization and Description of Business (Textual)          
Description of changed its name November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.        
Percentage of ownership     1.00%    
Percentage of remaining shares owned   49.00%      
Common Stock [Member]          
Organization and Description of Business (Textual)          
Reverse stock split, description     Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.     
Beyond Fintech [Member]          
Organization and Description of Business (Textual)          
Stake owned percentage   51.00%      
Frictionless [Member]          
Organization and Description of Business (Textual)          
Strategic interest         10.00%
Outstanding common stock percentage     41.00%    
Purchase price (in Dollars)     $ 300,000    
Stock Purchase Agreement [Member]          
Organization and Description of Business (Textual)          
Business Acquisition, Planned Restructuring Activities, Description       On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%).  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTING POLICIES AND ESTIMATES (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Accounting Policies and Estimates (Textual)    
Ownership percentage 20.00%  
Federally insured limit $ 2,848,701 $ 5,117,551
Plant and equipment costs $ 1,000  
Beyond Fintech Inc. [Member]    
Accounting Policies and Estimates (Textual)    
Ownership percentage 51.00%  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets
3 Months Ended
Mar. 31, 2022
Kiosks [Member]  
Estimated useful lives 7 years
Computer equipment [Member]  
Estimated useful lives 3 years
Leasehold improvements [Member]  
Estimated useful lives of property Lesser of estimated useful life or life of lease
Office equipment [Member]  
Estimated useful lives 10 years
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
LIQUIDITY MATTERS (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
Liquidity Matters (Textual)  
Net loss $ 1,801,494
Cash 3,362,740
Cash balance $ 3,362,740
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLES (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 26, 2021
Mar. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]      
Gross proceeds $ 250,000 $ 25,000 $ 375,000
Beyond fintech percentage 51.00%    
Owned frictionless financial technologies 49.00%    
Additional product offering   $ 217,300  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLES (Details) - Schedule of facilitate the functioning of the software - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Schedule of facilitate the functioning of the software [Abstract]    
Purchased Technology $ 867,300 $ 625,000
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENTS (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 22, 2021
Mar. 31, 2022
Dec. 31, 2019
Feb. 16, 2021
Investment (Textual)        
Exercise price (in Dollars per share)       $ 0.24
Investment, description     Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.   
Number of common stock issued   2,047,500    
Impairment charges (in Dollars)   $ 1,019,960    
Vivi Holdings, Inc. [Member]        
Investment (Textual)        
Number of common stock issued   2,250,000    
Mr. Andrey Novikov [Member]        
Investment (Textual)        
Number of common stock issued   56,250    
Joseph W [Member]        
Investment (Textual)        
Number of common stock issued   33,750    
Mr. Gaston Pereira [Member]        
Investment (Textual)        
Number of common stock issued   112,500    
Frictionless Technologies, Inc. [Member]        
Investment (Textual)        
Warrants term 5 years      
Warrant purchase 30,000,000      
Exercise price (in Dollars per share) $ 0.15      
Right to acquire 41.00%      
Purchase price to acquire outstanding common stock for 1% acquired (in Dollars) $ 300,000      
Frictionless Technologies, Inc. [Member] | Stock Purchase Agreement [Member]        
Investment (Textual)        
Purchase of common shares 150      
Gross proceed (in Dollars) $ 500,000      
Common shares outstanding percentage 10.00%      
Right to acquire 1.00%      
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENTS (Details) - Schedule of investment - USD ($)
Mar. 31, 2022
Dec. 31, 2021
INVESTMENTS (Details) - Schedule of investment [Line Items]    
Investment $ 500,001 $ 500,001
Frictionless Financial Technologies, Inc. [Member]    
INVESTMENTS (Details) - Schedule of investment [Line Items]    
Investment 500,000 500,000
Vivi Holdings, Inc. [Member]    
INVESTMENTS (Details) - Schedule of investment [Line Items]    
Investment $ 1 $ 1
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
Leases (Textual)  
Lease, description The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.
Expiry of lease term $ 4,800
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES (Details) - Schedule of total lease cost - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Leases [Abstract]    
Operating lease expense $ 14,400 $ 11,835
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES (Details) - Schedule of other lease information - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ (14,400) $ (11,835)
Remaining lease term – operating lease 11 months
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES (Details) - Schedule of maturity of operating leases
Mar. 31, 2022
USD ($)
Total instalments due:  
2022
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.1
FEDERAL RELIEF LOANS (Details) - USD ($)
3 Months Ended
Jul. 07, 2020
Mar. 31, 2022
Federal Relief Loans [Abstract]    
Disaster loan amount $ 150,000  
Earning interest, percentage 3.75%  
Repayable installments $ 731  
Accrued interest   $ 9,740
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE NOTES PAYABLE (Details) - USD ($)
1 Months Ended 3 Months Ended
Feb. 03, 2022
Feb. 16, 2021
Feb. 03, 2022
Feb. 16, 2021
Mar. 31, 2022
Mar. 31, 2021
Feb. 04, 2022
Convertible Notes Payable (Textual)              
Interest expense         $ 44,379 $ 65,792  
Amortization of debt discount         $ 263,200 $ 2,113,652  
Warrant exercisable (in Shares)   2,486,957   2,486,957      
Exercise price per share (in Dollars per share)   $ 0.24   $ 0.24      
Cavalry Fund I LP [Member]              
Convertible Notes Payable (Textual)              
Net proceeds       $ 500,500      
Senior secured convertible note   $ 71,500   71,500      
Original issue discount       $ 572,000      
Original issue discount rate       10.00%      
initial conversion price per share (in Dollars per share)       $ 0.23      
Warrant exercisable (in Shares)   2,486,957   2,486,957      
Exercise price per share (in Dollars per share)   $ 0.24   $ 0.24      
Description of conversion terms On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Mercer Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.    On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Cavalry Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.         
Conversion price (in Dollars per share)         $ 876,589    
Mercer Street Global Opportunity Fund, LLC [Member]              
Convertible Notes Payable (Textual)              
Net proceeds       $ 500,500      
Senior secured convertible note   $ 572,000   572,000      
Original issue discount       $ 71,500      
Conversion price (in Dollars per share)   $ 0.23   $ 0.23      
Interest rate   10.00%   10.00%      
Accrued interest and penalty interest         $ 876,589    
Bellridge Capital LP. [Member]              
Convertible Notes Payable (Textual)              
Net proceeds   $ 787,500          
Senior secured convertible note   900,000   $ 900,000      
Original issue discount   $ 112,500          
Warrant exercisable (in Shares)   3,913,044   3,913,044      
Exercise price per share (in Dollars per share)   $ 0.24   $ 0.24      
Conversion price (in Dollars per share)   $ 0.23   $ 0.23      
Interest rate   10.00%   10.00%      
Aggregate principal amount             $ 1,235,313
Common stock shares (in Shares)             88,250
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.1
CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable - USD ($)
3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Unamortized debt discount $ 0 $ (263,200)
Cavalry Fund I LP [Member]    
Interest Rate 28.70%  
Maturity date August 16, 2022  
Principal $ 866,242  
Accrued Interest 10,347  
Unamortized debt discount  
Convertible notes payable $ 876,589 548,872
Mercer Street Global Opportunity Fund, LLC [Member]    
Interest Rate 28.70%  
Maturity date August 16, 2022  
Principal $ 866,242  
Accrued Interest 10,347  
Unamortized debt discount  
Convertible notes payable $ 876,589 548,872
Bellridge Capital LP., [Member]    
Interest Rate 10.00%  
Maturity date February 16, 2022  
Principal  
Accrued Interest  
Unamortized debt discount  
Convertible notes payable 863,609
Convertible Notes Payable [Member]    
Principal 1,732,484  
Accrued Interest 20,694  
Convertible notes payable $ 1,753,178 $ 1,961,353
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.1
DERIVATIVE LIABILITY (Details)
Mar. 31, 2022
USD ($)
Derivative Liability (Textual)  
Derivative liability was re-assessed $ 315,000
Derivative liability was credited $ 92,161
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.1
DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Expected dividend rate 0.00% 0.00%
Minimum [Member]    
Conversion price (in Dollars per share) $ 0.05 $ 0.05
Risk free interest rate 0.79% 0.05%
Expected life of derivative liability 4 years 7 months 6 days 1 month 18 days
Expected volatility of underlying stock 151.07% 161.19%
Maximum [Member]    
Conversion price (in Dollars per share) $ 0.15 $ 0.24
Risk free interest rate 2.45% 1.12%
Expected life of derivative liability 46 years 7 months 6 days 49 months 18 days
Expected volatility of underlying stock 194.99% 215.33%
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.1
DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Opening balance $ 407,161 $ 2,966,416
Derivative financial liability arising from convertible note 2,569,000
Fair value adjustment to derivative liability (92,161) (5,128,255)
Closing balance $ 315,000 $ 407,161
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Feb. 22, 2021
Stockholders' Equity (Textual)        
Restricted stock awards expense (in Dollars) $ 62,766 $ 122,141    
Preferred stock, shares authorized 25,000,000   25,000,000  
Preferred stock, par value (in Dollars per share) $ 0.0001   $ 0.0001  
Warrants outstanding an intrinsic value (in Dollars) $ 0   $ 0  
Terminates period 10 years      
Shares of common stock       208,333
Common Stock [Member]        
Stockholders' Equity (Textual)        
Common stock, shares authorized 750,000,000      
Common stock, shares par value (in Dollars per share) $ 0.0001      
Common stock, shares issued 367,901,679      
Maximum [Member] | Common Stock [Member]        
Stockholders' Equity (Textual)        
Shares of common stock 800,000      
Common stock awarded 100,000      
Options [Member]        
Stockholders' Equity (Textual)        
Options outstanding, description The options outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021, respectively. The option expense was $94,466 and $91,608 for the three months ended March 31, 2022 and 2021, respectively.      
Options [Member]        
Stockholders' Equity (Textual)        
Terminates period 10 years      
2021 Plan [Member] | Maximum [Member]        
Stockholders' Equity (Textual)        
Shares of common stock 53,000,000      
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Total restricted shares [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Total restricted shares, Outstanding at beginning (in Shares) 21,495,000 20,495,000
Total restricted shares, Outstanding at ending (in Shares) 21,495,000 21,495,000
Total restricted shares, Granted (in Shares) 2,500,000
Total restricted shares, Forfeited/Cancelled (in Shares) (1,500,000)
Total restricted shares, Vested (in Shares)
Weighted average fair market value per share [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning $ 0.049 $ 0.049
Weighted average fair market value per share, Outstanding at ending 0.049 0.049
Weighted average fair market value per share, Granted 0.05
Weighted average fair market value per share, Forfeited/Cancelled (0.05)
Weighted average fair market value per share, Vested
Total unvested restricted shares [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Total unvested restricted shares, Outstanding at beginning (in Shares) 10,247,500 15,371,250
Total unvested restricted shares, Outstanding at ending (in Shares) 5,123,750 10,247,500
Total unvested restricted shares, Granted (in Shares) 2,500,000
Total unvested restricted shares, Forfeited/Cancelled (in Shares) (1,500,000)
Total unvested restricted shares, Vested (in Shares) (5,123,750) (6,123,750)
Unvested restricted Weighted average fair market value per share [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning $ 0.049 $ 0.049
Weighted average fair market value per share, Outstanding at ending 0.049 0.049
Weighted average fair market value per share, Granted 0.05
Weighted average fair market value per share, Forfeited/Cancelled (0.05)
Weighted average fair market value per share, Vested $ (0.049) $ (0.049)
Total vested restricted shares [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Total vested restricted shares, Outstanding at beginning (in Shares) 11,247,500 5,123,750
Total vested restricted shares, Outstanding at ending (in Shares) 16,371,250 11,247,500
Total vested restricted shares, Granted
Total vested restricted shares, Forfeited/Cancelled
Total vested restricted shares, Vested 5,123,750 6,123,750
Vested restricted Weighted average fair market value per share [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning 0.049 0.049
Weighted average fair market value per share, Outstanding at ending 0.049 0.049
Weighted average fair market value per share, Granted
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested $ 0.049 $ 0.049
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock granted and exercisable
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Restricted stock granted, number granted (in Shares) | shares 21,495,000
Restricted stock granted, weighted average fair value per share $ 0.049
Restricted stock vested, number vested (in Shares) | shares 16,371,250
Restricted stock vested, weighted average fair value per share $ 0.049
Grant date Price 0.049 [Member]  
Restricted stock granted, grant date price $ 0.049
Restricted stock granted, number granted (in Shares) | shares 20,495,000
Restricted stock granted, weighted average fair value per share $ 0.049
Restricted stock vested, number vested (in Shares) | shares 15,371,250
Restricted stock vested, weighted average fair value per share $ 0.049
Grant date Price 0.050 [Member]  
Restricted stock granted, grant date price $ 0.05
Restricted stock granted, number granted (in Shares) | shares 1,000,000
Restricted stock granted, weighted average fair value per share $ 0.05
Restricted stock vested, number vested (in Shares) | shares 1,000,000
Restricted stock vested, weighted average fair value per share $ 0.05
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details) - Schedule of warrant activity - Warrant [Member] - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Shares Underlying Warrants, Outstanding at beginning (in Shares) 37,304,105 51,188,572
Exercise price per share, Outstanding at beginning   $ 0.05
Weighted average exercise price, Outstanding at beginning $ 0.12 $ 0.05
Shares Underlying Warrants, Outstanding at ending (in Shares) 37,304,105 37,304,105
Weighted average exercise price, Outstanding at ending $ 0.12 $ 0.12
Shares Underlying Warrants, Granted (in Shares) 66,302,515
Exercise price per share, Granted  
Weighted average exercise price, Granted $ 0.16
Shares Underlying Warrants, Forfeited/Cancelled (in Shares) (20,000,000)
Exercise price per share, Forfeited/Cancelled $ 0.24
Weighted average exercise price, Forfeited/Cancelled $ 0.24
Shares Underlying Warrants, Exercised (in Shares) (60,186,982)
Exercise price per share, Exercised $ 0.05
Weighted average exercise price, Exercised 0.05
Minimum [Member]    
Exercise price per share, Outstanding at beginning 0.05  
Exercise price per share, Outstanding at ending 0.05 0.05
Exercise price per share, Granted   0.05
Maximum [Member]    
Exercise price per share, Outstanding at beginning 0.1875  
Exercise price per share, Outstanding at ending $ 0.1875 0.1875
Exercise price per share, Granted   $ 0.24
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details) - Schedule of warrants outstanding and exercisable
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Warrants Outstanding, Number Outstanding 37,304,105
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 9 months 25 days
Warrants Outstanding, Weighted Average Exercise Price | $ / shares $ 0.12
Warrants Exercisable, Number Exercisable 37,304,105
Warrants Exercisable ,Weighted Average Exercise Price | $ / shares $ 0.12
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 9 months 25 days
Exercise Price 0.05 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.05
Warrants Outstanding, Number Outstanding 10,823,813
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 6 months 10 days
Warrants Exercisable, Number Exercisable 10,823,813
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 6 months 10 days
Exercise Price 0.15 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.15
Warrants Outstanding, Number Outstanding 24,053,625
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 11 months 8 days
Warrants Exercisable, Number Exercisable 24,053,625
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 11 months 8 days
Exercise Price 0.1875 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.1875
Warrants Outstanding, Number Outstanding 2,426,667
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 11 months 15 days
Warrants Exercisable, Number Exercisable 2,426,667
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 11 months 15 days
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details) - Schedule of option activity - Stock Options [Member] - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Shares Underlying options, Outstanding at beginning (in Shares) 30,516,666 100,000
Exercise price per share, Outstanding at beginning   $ 0.4
Weighted average exercise price, Outstanding at beginning $ 0.15 $ 0.4
Shares Underlying options, Outstanding at ending (in Shares) 30,516,666 30,516,666
Weighted average exercise price, Outstanding at ending $ 0.15 $ 0.15
Shares Underlying options, Granted (in Shares) 30,416,666
Exercise price per share, Granted
Weighted average exercise price, Granted $ 0.15
Shares Underlying options, Forfeited/Cancelled (in Shares)
Exercise price per share, Forfeited/Cancelled
Weighted average exercise price, Forfeited/Cancelled
Shares Underlying options, Exercised (in Shares)
Exercise price per share, Exercised
Weighted average exercise price, Exercised
Minimum [Member]    
Exercise price per share, Outstanding at beginning 0.15  
Exercise price per share, Outstanding at ending 0.15 0.15
Exercise price per share, Granted   0.15
Maximum [Member]    
Exercise price per share, Outstanding at beginning 0.4  
Exercise price per share, Outstanding at ending $ 0.4 0.4
Exercise price per share, Granted   $ 0.24
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details) - Schedule of options outstanding and exercisable
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
Options Outstanding, Number Outstanding (in Dollars) | $ $ 30,516,666
Options Outstanding, Weighted Average Remaining Contractual life in years 9 years 4 months 17 days
Options Outstanding, Weighted Average Exercise Price (in Dollars per share) $ 0.15
Options Exercisable, Number Exercisable (in Dollars per share) $ 18,433,333
Options Exercisable ,Weighted Average Exercise Price 1 month 24 days
Options Exercisable, Weighted Average Remaining Contractual life in years 9 years 4 months 13 days
Exercise Price 0.15 [Member]  
Options Outstanding, Exercise Price (in Dollars per share) $ 0.15
Options Outstanding, Number Outstanding (in Dollars) | $ $ 30,208,333
Options Outstanding, Weighted Average Remaining Contractual life in years 9 years 4 months 20 days
Options Exercisable, Number Exercisable (in Dollars per share) $ 18,125,000
Options Exercisable, Weighted Average Remaining Contractual life in years 9 years 10 months 20 days
Exercise Price 0.24 [Member]  
Options Outstanding, Exercise Price (in Dollars per share) $ 0.24
Options Outstanding, Number Outstanding (in Dollars) | $ $ 208,333
Options Outstanding, Weighted Average Remaining Contractual life in years 8 years 10 months 24 days
Options Exercisable, Number Exercisable (in Dollars per share) $ 208,333
Options Exercisable, Weighted Average Remaining Contractual life in years 9 years 4 months 24 days
Exercise Price 0.40 [Member]  
Options Outstanding, Exercise Price (in Dollars per share) $ 0.4
Options Outstanding, Number Outstanding (in Dollars) | $ $ 100,000
Options Outstanding, Weighted Average Remaining Contractual life in years 6 years 9 months
Options Exercisable, Number Exercisable (in Dollars per share) $ 100,000
Options Exercisable, Weighted Average Remaining Contractual life in years 7 years 3 months
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.1
NET LOSS PER SHARE (Details) - Schedule of dilutive shares - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Anti-dilutive shares 79,508,625 82,926,574
Convertible debt [Member]    
Anti-dilutive shares 11,687,855 8,993,106
Stock options [Member]    
Anti-dilutive shares 30,516,666 516,666
Warrants to purchase shares of common stock [Member]    
Anti-dilutive shares 37,304,104 73,416,802
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 27, 2021
Jul. 22, 2021
Feb. 22, 2021
Aug. 31, 2021
Aug. 16, 2021
Mar. 31, 2022
Dec. 31, 2021
Feb. 16, 2021
Related Party Transactions (Textual)                
Options exercisable (in Shares)     208,333          
Exercise price per share (in Dollars per share)     $ 0.24          
Warrant to purchase shares (in Shares)               2,486,957
Shares subject to the options       50.00%        
Option expense           $ 66,587 $ 910,019  
Consulting agreement   $ 3,500            
Related party transactions description the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Company’s common stock, as reflected in the closing price of the Company’s common stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan.              
Annual base salary percentage           50.00%    
James Fuller [Member]                
Related Party Transactions (Textual)                
Purchase of shares (in Shares)     208,333          
Exercise price (in Dollars per share)     $ 0.24          
Mr Fuller [Member]                
Related Party Transactions (Textual)                
Restricted share (in Shares)   2,000,000            
Common stock, valued   $ 154,000            
Mr Fuller [Member] | Maximum [Member]                
Related Party Transactions (Textual)                
Common stock granted, per share (in Dollars per share)     0.24          
Mr Fuller [Member] | Minimum [Member]                
Related Party Transactions (Textual)                
Common stock granted, per share (in Dollars per share)     $ 0.15          
Andrey Novikov [Member]                
Related Party Transactions (Textual)                
Purchase of shares (in Shares)     208,333          
William Corbett [Member]                
Related Party Transactions (Textual)                
Warrant to purchase shares (in Shares)     20,000,000          
Exercise price (in Dollars per share)     $ 0.24          
Salary expense     $ 30,000          
Warrant expense             $4,327,899  
Mr. Corbett [Member]                
Related Party Transactions (Textual)                
Common stock, valued   $ 154,000            
Salary per month       $ 30,000        
Options to purchase (in Shares)       20,000,000        
Exercise price per share (in Dollars per share)       $ 0.15        
Car allowance       $ 800        
Shares subject to the options       50.00%        
Granted shares (in Shares)   2,000,000            
Mr. Henry [Member]                
Related Party Transactions (Textual)                
Granted shares (in Shares)   2,000,000            
Clifford Henry [Member]                
Related Party Transactions (Textual)                
Common stock, valued   $ 154,000            
Mr. Rios [Member]                
Related Party Transactions (Textual)                
Common stock, valued   $ 77,000            
Granted shares (in Shares)   1,000,000            
Mr. Rosenblum [Member]                
Related Party Transactions (Textual)                
Common stock granted, per share (in Dollars per share)       $ 0.15        
Options to purchase (in Shares)         10,000,000      
Option expense           $ 27,879 $ 381,006  
Annual base salary percentage           100.00%    
XML 67 f10q0322_innovativepay_htm.xml IDEA: XBRL DOCUMENT 0001591913 2022-01-01 2022-03-31 0001591913 2022-05-13 0001591913 2022-03-31 0001591913 2021-12-31 0001591913 2021-01-01 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 us-gaap:PreferredStockMember 2020-12-31 0001591913 us-gaap:CommonStockMember 2020-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001591913 us-gaap:RetainedEarningsMember 2020-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2020-12-31 0001591913 2020-12-31 0001591913 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-03-31 0001591913 2021-03-31 0001591913 2019-10-25 2019-11-01 0001591913 qpag:StockPurchaseAgreementMember 2019-01-01 2019-12-31 0001591913 qpag:FrictionlessMember 2021-06-22 0001591913 qpag:FrictionlessMember 2022-03-31 0001591913 qpag:FrictionlessMember 2022-01-01 2022-03-31 0001591913 qpag:BeyondFintechMember 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 qpag:BeyondFintechIncMember 2022-03-31 0001591913 qpag:KiosksMember 2022-01-01 2022-03-31 0001591913 us-gaap:ComputerEquipmentMember 2022-01-01 2022-03-31 0001591913 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-03-31 0001591913 us-gaap:OfficeEquipmentMember 2022-01-01 2022-03-31 0001591913 2021-01-01 2021-12-31 0001591913 qpag:FrictionlessTechnologiesIncMember qpag:StockPurchaseAgreementMember 2021-06-01 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember qpag:StockPurchaseAgreementMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-01 2021-06-22 0001591913 2019-01-01 2019-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-01-01 2022-03-31 0001591913 qpag:MrAndreyNovikovMember 2022-01-01 2022-03-31 0001591913 qpag:JosephWPatriciaGAbramsFamilyTrustMember 2022-01-01 2022-03-31 0001591913 qpag:MrGastonPereiraMember 2022-01-01 2022-03-31 0001591913 qpag:FrictionlessTechnologiesIncMember 2022-03-31 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-03-31 0001591913 qpag:ViviHoldingsIncMember 2021-12-31 0001591913 2020-07-07 2020-07-07 0001591913 qpag:CavalryFundILPMember 2021-02-01 2021-02-16 0001591913 qpag:CavalryFundILPMember 2021-02-16 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-02-03 0001591913 qpag:CavalryFundILPMember 2022-03-31 0001591913 qpag:CavalryFundILPMember 2022-02-01 2022-02-03 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-01 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-03-31 0001591913 qpag:BellridgeCapitalLPMember 2021-02-14 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2022-02-04 0001591913 qpag:CavalryFundILPMember 2022-03-31 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-03-31 0001591913 qpag:CavalryFundILPMember 2021-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-12-31 0001591913 qpag:BellridgeCapitalLPMember 2022-03-31 0001591913 qpag:BellridgeCapitalLPMember 2022-01-01 2022-03-31 0001591913 qpag:BellridgeCapitalLPMember 2021-12-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-03-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-03-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001591913 pf0:MinimumMember 2022-03-31 0001591913 pf0:MaximumMember 2022-03-31 0001591913 pf0:MinimumMember 2021-12-31 0001591913 pf0:MaximumMember 2021-12-31 0001591913 pf0:MinimumMember 2022-01-01 2022-03-31 0001591913 pf0:MaximumMember 2022-01-01 2022-03-31 0001591913 pf0:MinimumMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember us-gaap:CommonStockMember 2022-03-31 0001591913 pf0:MaximumMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001591913 qpag:TwoThousandTwentyOnePlanMember pf0:MaximumMember 2022-03-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001591913 qpag:TotalRestrictedSharesMember 2020-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2020-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2020-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-01-01 2022-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-03-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-01-01 2022-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-03-31 0001591913 qpag:TotalRestrictedSharesMember 2022-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-03-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-03-31 0001591913 qpag:ExercisePrice0049Member 2022-01-01 2022-03-31 0001591913 qpag:ExercisePriceRange5Member 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2020-12-31 0001591913 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 pf0:MinimumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 pf0:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 pf0:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2022-03-31 0001591913 pf0:MinimumMember us-gaap:WarrantMember 2022-03-31 0001591913 pf0:MaximumMember us-gaap:WarrantMember 2022-03-31 0001591913 qpag:ExercisePriceRange5Member 2022-03-31 0001591913 qpag:ExercisePrice015Member 2022-03-31 0001591913 qpag:ExercisePrice015Member 2022-01-01 2022-03-31 0001591913 qpag:ExercisePrice0187Member 2022-03-31 0001591913 qpag:ExercisePrice0187Member 2022-01-01 2022-03-31 0001591913 us-gaap:StockOptionMember 2020-12-31 0001591913 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 pf0:MinimumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 pf0:MaximumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 pf0:MinimumMember us-gaap:StockOptionMember 2021-12-31 0001591913 pf0:MaximumMember us-gaap:StockOptionMember 2021-12-31 0001591913 us-gaap:StockOptionMember 2022-03-31 0001591913 pf0:MinimumMember us-gaap:StockOptionMember 2022-03-31 0001591913 pf0:MaximumMember us-gaap:StockOptionMember 2022-03-31 0001591913 qpag:ExercisePrice024Member 2022-03-31 0001591913 qpag:ExercisePrice024Member 2022-01-01 2022-03-31 0001591913 qpag:ExercisePrice040Member 2022-03-31 0001591913 qpag:ExercisePrice040Member 2022-01-01 2022-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-03-31 0001591913 qpag:StockOptionsMember 2022-01-01 2022-03-31 0001591913 qpag:StockOptionsMember 2021-01-01 2021-03-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001591913 qpag:JamesFullerMember 2021-02-21 2021-02-22 0001591913 qpag:JamesFullerMember 2021-02-22 0001591913 qpag:MrFullerMember 2021-07-22 2021-07-22 0001591913 qpag:MrFullerMember 2021-07-22 0001591913 2021-02-22 0001591913 pf0:MaximumMember qpag:MrFullerMember 2021-02-22 0001591913 pf0:MinimumMember qpag:MrFullerMember 2021-02-22 0001591913 qpag:MrAndreyNovikovMember 2021-02-21 2021-02-22 0001591913 2021-02-21 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-01-01 2021-12-31 0001591913 qpag:MrCorbettMember 2021-08-01 2021-08-31 0001591913 qpag:MrCorbettMember 2021-08-31 0001591913 2021-08-01 2021-08-31 0001591913 qpag:MrHenryMember 2021-07-22 2021-07-22 0001591913 qpag:CliffordHenryMember 2021-07-22 0001591913 2021-07-22 0001591913 qpag:MrCorbettMember 2021-07-22 2021-07-22 0001591913 qpag:MrCorbettMember 2021-07-22 0001591913 qpag:MrRiosMember 2021-07-22 2021-07-22 0001591913 qpag:MrRiosMember 2021-07-22 0001591913 2021-07-27 2021-07-27 0001591913 qpag:MrRosenblumMember 2022-03-31 0001591913 qpag:MrRosenblumMember 2021-12-31 0001591913 qpag:MrRosenblumMember 2022-01-01 2022-03-31 0001591913 qpag:MrRosenblumMember 2021-08-01 2021-08-16 0001591913 qpag:MrRosenblumMember 2021-08-31 shares iso4217:USD iso4217:USD shares pure 10-Q true 2022-03-31 2022 false 000-55648 INNOVATIVE PAYMENT SOLUTIONS, INC. NV 33-1230229 56B 5th Avenue Lot 1 #AT Carmel By The Sea CA 93921 (866) 477-4729 Yes Yes Non-accelerated Filer true false false 367901679 3362740 5449751 39326 85034 3402066 5534785 24302 28799 867300 625000 34800 34800 500001 500001 1426403 1188600 4828469 6723385 522253 465205 0 263200 1753178 1961354 315000 407161 2590431 2833720 159740 158353 159740 158353 2750171 2992073 0.0001 0.0001 25000000 25000000 0 0 0 0 0.0001 0.0001 750000000 500000000 367901679 367901679 367901679 367901679 36790 36790 45928244 45771012 -43913195 -42111701 2051839 3696101 26459 35211 2078298 3731312 4828469 6723385 869387 4989672 4496 4167 873883 4993839 -873883 -4993839 -5184447 719558 45766 67312 263200 2113652 -92161 -965144 -11394106 -1810246 -11394106 -8752 1801494 11394106 0 -0.04 367901679 255272113 367901679 36790 45771012 -42111701 35211 3731312 94466 94466 62766 62766 -1801494 -8752 -1810246 367901679 36790 45928244 -43913195 26459 2078298 193637747 19363 23179399 -27629575 -4430813 44074284 4407 2199307 2203714 30333334 3033 4546967 4550000 -501100 -501100 61793616 6180 7437488 7443668 4327899 4327899 2500000 250 213499 213749 -11394106 -11394106 332338981 33233 41403459 -39023681 2413011 -1810246 -11394106 -92161 -965144 4496 4167 263200 2113652 5184447 -719558 4327899 157232 213749 10625 -45708 2994 6221 293900 -10625 -42484 38050 -760918 -774180 4800 179030 -179030 -4800 4550000 501100 2203714 22049 1147063 521000 2569000 -1147063 8278565 -2087011 7499585 5449751 94703 3362740 7594288 88250 33030 2259221 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>1</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>ORGANIZATION AND DESCRIPTION OF BUSINESS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt"><b>a)</b></span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Organizational History</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “</span>QPAGOS”.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On November 1, 2019, the Company changed its corporate name from “</span>QPAGOS<span>” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in </span>Carmel By The Sea<span>, California.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt"><b>b)</b></span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Description of current business</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational. The Company’s flagship e-wallet, IPSIPay, is fully operational and ready for commercial launch during the second quarter of 2022. Previously the Company intended to invest in physical kiosks, which required the user presence at the kiosk location. The Company still intends to use its existing kiosks in certain target markets within Southern California, but its principal focus will be on downloadable apps used via smartphones.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company acquired a 10% strategic interest in </span>Frictionless Financial Technologies, Inc. (“Frictionless”) <span>on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United states and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>c)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>COVID-19</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The COVID-19 pandemic has required the Company’s management to focus its attention primarily on responding to the challenges presented by the pandemic, including ensuring continuous operations, and adjusting its operations to address changes in the virtual payments industry. Due to measures imposed by the local governments in areas affected by COVID-19 (including both in the United States and Mexico), businesses had been suspended due to quarantines intended to contain this outbreak and many people had been forced to work from home in those areas. As a result, the commercial launch of the Company’s e-wallets and the limited installation of the Company’s network of kiosks in Southern California had been delayed, which has had an adverse impact on the Company’s business and financial condition and has hampered the Company’s ability to generate revenues. As the COVID-19 pandemic evolves, the Company may face similar challenges in the future which could lead to material adverse impacts on the Company.</span></p> Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.  November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares. On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). 0.10 0.41 300000 0.01 0.51 0.49 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>2</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>ACCOUNTING POLICIES AND ESTIMATES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Innovative Payment Solutions, Inc. - Parent Company</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span>Beyond Fintech Inc., 51% owned. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>c)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>d)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>e)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-size: 10pt"><b>f)</b></span></td> <td style="width: 94%; text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s operations will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s products and the use by customers of such products, (iii) competition, (iv) inflation and other economic factors and (v) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-size: 10pt"><b>g)</b></span></td> <td style="width: 94%; text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>h)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span>No segmental information is required as the Company has not generated any revenue for the three months ended March 31, 2022 and 2021 and only has one operating segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>i)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2022 and 2021, respectively, the Company had no cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2022 and December 31, 2021, the balance exceed the federally insured limit by $2,848,701 and $5,117,551, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>j)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>k)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>l)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 2%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.5pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/></td> <td style="width: 0.25in; padding-right: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m)</b></span></td> <td style="padding-right: 0.5pt; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-Term Assets</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify"><span>Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"> </td> <td style="width: 0.25in; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>n)</b></span></td> <td style="padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue Recognition</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, <i>Revenue Recognition</i>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company had no revenues during the three months ended March 31, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>o)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>p)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>q)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>r)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>s)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reclassification of prior year presentation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Innovative Payment Solutions, Inc. - Parent Company</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span>Beyond Fintech Inc., 51% owned. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 0.51 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>c)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>d)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>e)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-size: 10pt"><b>f)</b></span></td> <td style="width: 94%; text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s operations will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s products and the use by customers of such products, (iii) competition, (iv) inflation and other economic factors and (v) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "> </p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-size: 10pt"><b>g)</b></span></td> <td style="width: 94%; text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>h)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span>No segmental information is required as the Company has not generated any revenue for the three months ended March 31, 2022 and 2021 and only has one operating segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>i)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2022 and 2021, respectively, the Company had no cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2022 and December 31, 2021, the balance exceed the federally insured limit by $2,848,701 and $5,117,551, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 2848701 5117551 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>j)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>k)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 0.20 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>l)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 2%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 1000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 2%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> P7Y P3Y Lesser of estimated useful life or life of lease P10Y <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.5pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/></td> <td style="width: 0.25in; padding-right: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m)</b></span></td> <td style="padding-right: 0.5pt; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-Term Assets</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify"><span>Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"> </td> <td style="width: 0.25in; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>n)</b></span></td> <td style="padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue Recognition</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, <i>Revenue Recognition</i>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td> <td style="width: 90%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company had no revenues during the three months ended March 31, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>o)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>p)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>q)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>r)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>s)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reclassification of prior year presentation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>3</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>LIQUIDITY MATTERS</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the end of three months ended March 31, 2022, the Company had a net loss of $1,801,494 and had $3,362,740 in cash. In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2022, management evaluated the extent of the impact from the COVID-19 pandemic and other risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company had a cash balance of $3,362,740 available as of March 31, 2022. Based on its evaluation of the Company’s current business plan, management believes the Company’s existing cash is sufficient to conduct planned operations for at least one year from the date of issuance of these financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>However, given the Company’s losses and negative cash flows, it is likely that the Company will be required to raise significant additional funds to progress its business as planned by issuing equity or equity-linked securities. Should this occur, the Company’s stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting the Company’s operations or its ability to incur additional debt. Any additional debt financing or additional equity that the Company raises may contain terms that are not favorable to the Company or its stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support the Company’s operations on favorable terms, or at all.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">There is also a significant risk that none of the Company’s plans to raise financing will be implemented in a manner necessary to sustain the Company for an extended period of time. If adequate funds are not available to the Company when needed, the Company may be required to continue with reduced operations or to obtain funds through arrangements that may require the Company to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on the Company. In addition, the Company’s inability to secure additional funding when needed could cause the Company’s business to fail or become bankrupt or force the Company to wind down or discontinue operations.</p> 1801494 3362740 3362740 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTANGIBLES</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, which is now complete. During the three months ended March 31, 2022, an additional $217,300 was spent by the Companyto facilitate the functioning of the IPSIPay software in the cloud environment, and Beyond Fintech spent an additional $25,000 on software to further enhance the Beyond Wallet product offering.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased Technology</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">867,300</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">625,000</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 250000 0.51 0.49 375000 217300 25000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased Technology</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">867,300</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">625,000</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 867300 625000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTMENTS</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Investment in Frictionless Financial Technologies Inc.</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 22, 2021, the Company entered into a Stock Purchase Agreement (the “SPA”) with Frictionless, to purchase 150 common shares for gross proceeds of $500,000, representing 10.0% of the outstanding common shares. In terms of the SPA, Frictionless agreed to deliver to the Company on or before August 30, 2021, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United states and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate to Company’s anticipated product offerings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has undertaken to issue Frictionless a non-restricted, non-dilutable 5 year warrant to purchase 30,000,000 shares of Common Stock at an exercise price of $0.15 per share, upon delivery of the financial payment software. Frictionless delivered the software and the warrants will be issued in accordance with the agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has the right to appoint, and has appointed, one member to the board of directors of Frictionless, which appointee will remain on the board as long as the Company is the holder of the Frictionless common stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shares in Frictionless are unlisted as of March 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment in Vivi Holdings, Inc.</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As consideration for the disposal, Vivi issued an aggregate of 2,250,000 Vivi Shares as follows: 2,047,500  Vivi Shares to the Company; 56,250 Vivi Shares to the Company’s designee, Mr. Andrey Novikov; 33,750 Vivi Shares to the Company’s designee, the Joseph W. &amp; Patricia G. Abrams Family Trust; and 112,500 Vivi Shares to the Company’s designee, Mr. Gaston Pereira.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the lack of available information, the Vivi Shares were valued by a modified market method, whereby the value of the assets disposed of were determined by management using the enterprise value of the entire Company less the liabilities and assets retained by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022 and December 31, 2021, the Company maintained the impairment of the carrying value of the investment in Vivi Holdings based on no activity by Vivi’s management for its proposed initial public offering and fund raising activities. The total impairment as of March 31, 2022 and December 31, 2021 was $1,019,960.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shares in Vivi Holdings are unlisted as of March 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,<br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in Frictionless Financial Technologies, Inc.</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in Vivi Holdings, Inc.</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 150 500000 0.10 P5Y 30000000 0.15 0.41 300000 0.01 Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.  2250000 2047500 56250 33750 112500 1019960 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,<br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in Frictionless Financial Technologies, Inc.</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in Vivi Holdings, Inc.</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 500000 500000 1 1 500001 500001 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in"><span style="font-size: 10pt"><b>6</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>LEASES</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5<sup>th</sup> Avenue, Lot 1 #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Total Lease Cost</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Individual components of the total lease cost incurred by the Company is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended<br/> March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,835</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Other lease information:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended<br/> March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash flows from operating leases</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(14,400</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(11,835</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term – operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">11 months</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Maturity of Operating Leases</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The amount of future minimum lease payments under operating leases are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt"><b>Undiscounted minimum future lease payments under leases with terms twelve months or less</b></span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">Total instalments due:</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 88%; padding-bottom: 1.5pt"><span style="font-size: 10pt">2022</span></td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">          <span style="font-size: 10pt">-</span></div></td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> </table> The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. 4800 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended<br/> March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,835</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p> 14400 11835 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended<br/> March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash flows from operating leases</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(14,400</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(11,835</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term – operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">11 months</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> -14400 -11835 P11M <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt"><b>Undiscounted minimum future lease payments under leases with terms twelve months or less</b></span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">Total instalments due:</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 88%; padding-bottom: 1.5pt"><span style="font-size: 10pt">2022</span></td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">          <span style="font-size: 10pt">-</span></div></td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>7</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>FEDERAL RELIEF LOANS</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Small Business Administration Disaster Relief loan</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has accrued interest of $9,740 on this loan as of March 31, 2022.</span></p> 150000 0.0375 731 9740 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt"><b>8</b></span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>CONVERTIBLE NOTES PAYABLE</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Convertible notes payable consists of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Effective Interest<br/> Rate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maturity <br/> date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Principal</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accrued<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unamortized<br/> debt<br/> discount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31, 2022</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount,<br/> net</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount,<br/> net</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cavalry Fund I LP</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">28.7</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 9%; text-align: center">August 16,<br/> 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">866,242</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">10,347</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">     -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">876,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">548,872</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Mercer Street Global Opportunity Fund, LLC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: center">August 16,<br/> 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">866,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">876,589</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">548,872</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Bellridge Capital LP.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: center">February 16,<br/> 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">863,609</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total convertible notes payable</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,732,484</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,694</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,753,178</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,961,353</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Interest expense totaled $44,379 and $65,792 and amortization of debt discount totaled $263,200 and $2,113,652 for the three months ended March 31, 2022 and 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; "><b><i>Cavalry Fund I LP</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 16, 2021, the Company closed a transaction with Cavalry Fund I LP (“Cavalry”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Cavalry Note”). The Cavalry Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Cavalry Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The balance of the Cavalry Note plus accrued interest at March 31, 2022 was $876,589.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b><i>Mercer Street Global Opportunity Fund, LLC</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span> </span>  </p><table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 16, 2021, the Company closed a transaction with <span>Mercer Street Global Opportunity Fund, LLC</span> (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Mercer Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The balance of the Mercer Note plus accrued interest at March 31, 2022 was $876,589.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b><i>Bellridge Capital LP.</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span> </span> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 16, 2021, the Company closed a transaction with Bellridge Capital LP., pursuant to which the Company received net proceeds of $787,500, after an original issue discount of $112,500 in exchange for the issuance of a $900,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Bellridge Note”). The Bellridge Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 3,913,044 shares of Common Stock at an initial exercise price of $0.24 per share.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif">The Bellridge Note was repaid on February 4, 2022 for gross proceeds of $1,235,313, including interest thereon of $88,250, thereby extinguishing the Bellridge Note.</span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Effective Interest<br/> Rate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maturity <br/> date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Principal</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accrued<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unamortized<br/> debt<br/> discount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31, 2022</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount,<br/> net</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount,<br/> net</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cavalry Fund I LP</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">28.7</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 9%; text-align: center">August 16,<br/> 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">866,242</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">10,347</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">     -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">876,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right">548,872</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Mercer Street Global Opportunity Fund, LLC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: center">August 16,<br/> 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">866,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">876,589</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">548,872</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Bellridge Capital LP.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: center">February 16,<br/> 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">863,609</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total convertible notes payable</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,732,484</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,694</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,753,178</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,961,353</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.287 August 16, 2022 866242 10347 876589 548872 0.287 August 16, 2022 866242 10347 876589 548872 0.10 February 16, 2022 863609 1732484 20694 1753178 1961353 44379 65792 263200 2113652 500500 71500 572000 0.10 0.23 2486957 0.24 On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Cavalry Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.  876589 On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. This change to the maturity date of the Mercer Note was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in the additional $78,749 being expensed.  500500 71500 572000 0.10 0.23 2486957 0.24 876589 787500 112500 900000 0.10 0.23 3913044 0.24 1235313 88250 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>9</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>DERIVATIVE LIABILITY</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Certain of the short-term convertible notes disclosed in note 8 above and certain warrants disclosed in note 10 below have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The value of this derivative financial liability was re-assessed at March 31, 2022 at $315,000, and $92,161 was credited to the statement of operations. The value of the derivative liability will be re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The following assumptions were used in the Black-Scholes valuation model:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Three months ended<br/> March 31,<br/> 2022</b></span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Year ended<br/> December 31,<br/> 2021</b></span></td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 65%; padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Conversion price</span></td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right"><span style="font-size: 10pt">0.05 to $0.15</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">0.05 to $0.24</span></td> <td style="width: 2%"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Risk free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.79 to 2.45</span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.05 to 1.12</span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="white-space: nowrap; padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Expected life of derivative liability</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">4.6 to 46.6 months</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">1.6 to 49.6 months</span></td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Expected volatility of underlying stock</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">151.07 to 194.99</span></td> <td><span style="font-size: 10pt">% </span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">161.19 to 215.33</span></td> <td><span style="font-size: 10pt">% </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Expected dividend rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0</span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0</span></td> <td><span style="font-size: 10pt">%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The movement in derivative liability is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,966,416</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Derivative financial liability arising from convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(92,161</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,128,255</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">315,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">407,161</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 315000 92161 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Three months ended<br/> March 31,<br/> 2022</b></span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Year ended<br/> December 31,<br/> 2021</b></span></td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 65%; padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Conversion price</span></td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right"><span style="font-size: 10pt">0.05 to $0.15</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">0.05 to $0.24</span></td> <td style="width: 2%"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Risk free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.79 to 2.45</span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.05 to 1.12</span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="white-space: nowrap; padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Expected life of derivative liability</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">4.6 to 46.6 months</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">1.6 to 49.6 months</span></td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Expected volatility of underlying stock</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">151.07 to 194.99</span></td> <td><span style="font-size: 10pt">% </span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">161.19 to 215.33</span></td> <td><span style="font-size: 10pt">% </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Expected dividend rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0</span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0</span></td> <td><span style="font-size: 10pt">%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.05 0.15 0.05 0.24 0.0079 0.0245 0.0005 0.0112 P4Y7M6D P46Y7M6D P1M18D P49M18D 1.5107 1.9499 1.6119 2.1533 0 0 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,966,416</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Derivative financial liability arising from convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(92,161</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,128,255</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">315,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">407,161</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 407161 2966416 2569000 -92161 -5128255 315000 407161 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt"><b>10</b></span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>STOCKHOLDERS’ EQUITY</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt; text-align: justify"> </td> <td style="width: 24px; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>a.</b></span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Common Stock</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company has issued </span><span style="font-family: Times New Roman, Times, Serif; ">and outstanding 367,901,679 shares of Common Stock as of March 31, 2022 and December 31, 2021, respectively.</span></p><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>b.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Restricted stock awards</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">A summary of restricted stock activity during the period January 1, 2021 to March 31, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Total restricted shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> fair market value per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Total<br/> unvested<br/> restricted<br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> fair market value per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Total vested restricted shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> fair market value per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Outstanding January 1, 2021</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">20,495,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">15,371,250</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,123,750</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(1,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(0.050</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(1,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(0.050</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(6,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">6,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Outstanding December 31, 2021</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">21,495,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">10,247,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">11,247,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-87"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-88"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-89"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-91"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-92"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-93"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-95"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-96"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-97"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-98"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-100"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(5,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">5,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Outstanding March 31, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">21,495,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">5,123,750</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">16,371,250</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">The restricted stock granted and exercisable at March 31, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Restricted Stock Granted</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Restricted Stock Vested</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Grant date<br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Granted</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Fair Value<br/> per<br/> Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Vested</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Fair Value <br/> per<br/> Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">20,495,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">15,371,250</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,000,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,000,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">21,495,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">16,371,250</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">The Company has recorded an expense of $62,766 and $122,141 for the three months ended March 31, 2022 and 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>c.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Preferred Stock</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized, no preferred stock is issued and outstanding as of March 31, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>d.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Warrants</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt; ">  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">A summary of warrant activity during the period January 1, 2021 to March 31, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Shares<br/> Underlying<br/> Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Exercise<br/> price per<br/> share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> exercise<br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold"><span style="font-size: 10pt">Outstanding January 1, 2021</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">51,188,572</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">66,302,515</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">   0.05 to 0.24</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.16</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(20,000,000</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.24</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.24</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(60,186,982</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-size: 10pt">Outstanding December 31, 2021</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">$ 0.05 – 0.1875</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-102">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-105">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-106"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-108">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt"><span style="font-size: 10pt">Outstanding March 31, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">$ 0.05 – 0.1875</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">The warrants outstanding and exercisable at March 31, 2022 are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Warrants Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Warrants Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Exercise<br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Exercise <br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Exercise<br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">10,823,813</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">3.53</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt"> </span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt">10,823,813</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt"> </span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt">3.53</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.15</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">24,053,625</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">3.94</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">24,053,625</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">3.94</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 10pt">0.1875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">2,426,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">3.96</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">2,426,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">3.96</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">3.82</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">3.82</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">The warrants outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>e.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Stock options</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock </span><span style="font-family: Times New Roman, Times, Serif; ">awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; ">The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span> </span><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>No options were granted for the three months ended March 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>A summary of option activity during the period January 1, 2021 to March 31, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Underlying<br/> options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> price per<br/> share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> exercise<br/> price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 64%">Outstanding January 1, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">0.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">0.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30,416,666</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">0.15 – 0.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Forfeited/Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-114">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Outstanding December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30,516,666</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> $ 0.15 to 0.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-117">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Forfeited/Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-120">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-123">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Outstanding March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">30,516,666</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt"> $ 0.15 to 0.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The options outstanding and exercisable at March 31, 2022 are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Options Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Options Exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">30,208,333</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">9.39</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">18,125,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">9.89</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.24</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">208,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.90</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">208,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: right">0.40</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">6.75</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">7.25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">30,516,666</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">9.38</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">18,433,333</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">9.37</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The options outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021, respectively. The option expense was $94,466 and $91,608 for the three months ended March 31, 2022 and 2021, respectively.</span></p> 750000000 0.0001 367901679 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Total restricted shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> fair market value per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Total<br/> unvested<br/> restricted<br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> fair market value per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Total vested restricted shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> fair market value per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Outstanding January 1, 2021</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">20,495,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">15,371,250</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,123,750</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(1,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(0.050</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(1,500,000</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(0.050</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(6,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">6,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Outstanding December 31, 2021</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">21,495,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">10,247,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">11,247,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-87"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-88"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-89"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-91"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-92"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-93"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-95"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-96"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-97"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-98"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-100"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(5,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">5,123,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Outstanding March 31, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">21,495,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">5,123,750</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">16,371,250</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p> 20495000 0.049 15371250 0.049 5123750 0.049 2500000 0.05 2500000 0.05 1500000 0.05 1500000 0.05 -6123750 -0.049 6123750 0.049 21495000 0.049 10247500 0.049 11247500 0.049 -5123750 -0.049 5123750 0.049 21495000 0.049 5123750 0.049 16371250 0.049 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Restricted Stock Granted</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Restricted Stock Vested</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Grant date<br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Granted</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Fair Value<br/> per<br/> Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Vested</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Fair Value <br/> per<br/> Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">20,495,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">15,371,250</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 17%; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,000,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,000,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.050</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">21,495,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">16,371,250</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.049</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"> </span></p> 0.049 20495000 0.049 15371250 0.049 0.05 1000000 0.05 1000000 0.05 21495000 0.049 16371250 0.049 62766 122141 25000000 0.0001 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Shares<br/> Underlying<br/> Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Exercise<br/> price per<br/> share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> average<br/> exercise<br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold"><span style="font-size: 10pt">Outstanding January 1, 2021</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">51,188,572</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">66,302,515</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">   0.05 to 0.24</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.16</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">(20,000,000</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.24</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.24</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(60,186,982</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-size: 10pt">Outstanding December 31, 2021</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">$ 0.05 – 0.1875</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-102">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-105">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-106"><span style="font-size: 10pt">-</span></div></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-108">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109"><span style="font-size: 10pt">-</span></div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt"><span style="font-size: 10pt">Outstanding March 31, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">$ 0.05 – 0.1875</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p> 51188572 0.05 0.05 66302515 0.05 0.24 0.16 -20000000 0.24 0.24 -60186982 0.05 0.05 37304105 0.05 0.1875 0.12 37304105 0.05 0.1875 0.12 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Warrants Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Warrants Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Exercise<br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Exercise <br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Number<br/> Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Exercise<br/> Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">10,823,813</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">3.53</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt"> </span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt">10,823,813</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt"> </span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 11%; text-align: right"><span style="font-size: 10pt">3.53</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">0.15</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">24,053,625</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">3.94</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">24,053,625</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">3.94</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 10pt">0.1875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">2,426,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">3.96</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">2,426,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">3.96</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">3.82</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">37,304,105</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">0.12</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 4pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">3.82</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt"> </span></p> 0.05 10823813 P3Y6M10D 10823813 P3Y6M10D 0.15 24053625 P3Y11M8D 24053625 P3Y11M8D 0.1875 2426667 P3Y11M15D 2426667 P3Y11M15D 37304105 P3Y9M25D 0.12 37304105 0.12 P3Y9M25D 0 0 P10Y 800000 100000 P10Y 53000000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Underlying<br/> options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> price per<br/> share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> exercise<br/> price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 64%">Outstanding January 1, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">0.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">0.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30,416,666</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">0.15 – 0.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Forfeited/Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-114">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Outstanding December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30,516,666</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> $ 0.15 to 0.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-117">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Forfeited/Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-120">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-123">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Outstanding March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">30,516,666</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt"> $ 0.15 to 0.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 100000 0.4 0.4 30416666 0.15 0.24 0.15 30516666 0.15 0.4 0.15 30516666 0.15 0.4 0.15 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Options Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Options Exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">30,208,333</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">9.39</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">18,125,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">9.89</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.24</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">208,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.90</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">208,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: right">0.40</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">6.75</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">7.25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">30,516,666</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">9.38</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">18,433,333</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">0.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">9.37</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.15 30208333 P9Y4M20D 18125000 P9Y10M20D 0.24 208333 P8Y10M24D 208333 P9Y4M24D 0.4 100000 P6Y9M 100000 P7Y3M 30516666 P9Y4M17D 0.15 18433333 P0Y1M24D P9Y4M13D The options outstanding have an intrinsic value of $0 as of March 31, 2022 and December 31, 2021, respectively. The option expense was $94,466 and $91,608 for the three months ended March 31, 2022 and 2021, respectively. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>11</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><b>NET LOSS PER SHARE</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2022 and 2021 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31 2022 and 2021 are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three<br/> months ended<br/> March 31,<br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three<br/> months ended<br/> March 31,<br/> 2021<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11,687,855</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">8,993,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">516,666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,304,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">73,416,802</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">79,508,625</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">82,926,574</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three<br/> months ended<br/> March 31,<br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three<br/> months ended<br/> March 31,<br/> 2021<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11,687,855</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">8,993,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">516,666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,304,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">73,416,802</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">79,508,625</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">82,926,574</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 11687855 11687855 8993106 8993106 30516666 30516666 516666 516666 37304104 37304104 73416802 73416802 79508625 79508625 82926574 82926574 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>12</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><b>RELATED PARTY TRANSACTIONS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The following transactions were entered into with related parties:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>James Fuller</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On February 22, 2021, the Board awarded James Fuller options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22. 2021, the Company granted Mr. Fuller 2,000,000 shares of Common Stock, valued at $154,000. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Additionally, the Board approved the repricing of the options exercisable for 208,333 shares of Common Stock granted to Mr. Fuller on February 22, 2021, from $0.24 per share to $0.15 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Andrey Novikov</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On February 22, 2021, the Board awarded Andrey Novikov options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On May 31, 2021, Mr. Novikov notified the Board of his decision to resign as a member of the Board and as Secretary of the Company, effective as of June 1, 2021. Since August 2021, Mr. Novikov has been on suspension from service as the Company’s Chief Technology Officer.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>William Corbett</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On February 22, 2021, the Board appointed William Corbett as the Company’s Chief Executive Officer and Interim Chief Financial Officer, as its Chairman of the Board and issued him a five-year warrant to purchase 20,000,000 shares of the Common Stock at an exercise price of $0.24 per share. The Board also agreed to increase Mr. Corbett’s monthly base salary to $30,000. The warrant expense for Mr. Corbett for the year ended December 31, 2021 was $4,327,899.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous executive employment agreement (the “August 2021 Corbett Employment Agreement”). The purpose of the August 2021 Corbett Employment Agreement was to provide a replacement grant for warrants previously granted to Mr. Corbett under the terms of his previous employment agreement with the Company. Pursuant to the August 2021 Corbett Employment Agreement, Mr. Corbett would continue to serve as the Company’s Chief Executive Officer on a full time basis effective as of the date of the August 2021 Corbett Employment Agreement until the close of business on December 31, 2024. Mr. Corbett’s base salary will be $30,000 per month, which shall be paid in accordance with the Company’s standard payroll practice for its executives, managers and salaried employees. In addition, the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The option expense for Mr. Corbett for the three months ended March 31, 2022 was $66,587 and for the year ended December 31, 2021 was $910,019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>In addition, the Company and Mr. Corbett entered into an Indemnification Agreement on August 16, 2021 (the “August 2021 Corbett Indemnification Agreement”), pursuant to which the Company agreed to indemnify Mr. Corbett to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses. The August 2021 Corbett Indemnification Agreement amends the indemnification agreement in effect prior to entering into the August 2021 Corbett Indemnification Agreement to provide that unless Company shall pay Mr. Corbett’s attorneys’ fees and costs, including the compensation and expenses of any arbitrator, unless the arbitrator or the court determines that (a) Company has no liability in such dispute, or (b) the action or claims by Executive are frivolous in nature. In any other case or matter, the Company and Mr. Corbett shall each bear its or his own attorney fees and costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Clifford Henry</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On May 1, 2021, the Company appointed Mr. Henry to the Board.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company granted Mr. Henry 2,000,000 shares of Common Stock, valued at $154,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022 </span>  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Madisson Corbett</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On May 1, 2021, the Company appointed Ms. Corbett to the Board. Ms. Corbett is the daughter of Mr. William Corbett, the Company’s Chief Executive Officer and Chairman of the Board.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company granted Ms. Corbett 2,000,000 shares of Common Stock, valued at $154,000. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>David Rios</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company appointed David Rios to the Board.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company granted Mr. Rios 1,000,000 shares of Common Stock, valued at $77,000.  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Richard Rosenblum</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company appointed Richard Rosenblum as President and Chief Financial Officer of the Company. In addition, Mr. Rosenblum was elected to the Board to serve until the Company’s next annual meeting of shareholders.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 27, 2021, the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Company’s common stock, as reflected in the closing price of the Company’s common stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan. The option expense for Mr. Rosenblum for the three months ended March 31, 2022 was $27,879 and for the year ended December 31, 2021 was $381,006.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, then Mr. Rosenblum shall be entitled to severance equal to fifty percent (50%) of his annual base salary rate in effect as of the date of termination. If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, within 12 months following an Acquisition (as defined in the Employment Agreement), then Mr. Rosenblum shall be entitled to severance equal to 100% of his annual base salary rate in effect as of the date of termination. Severance payments shall be subject to execution and delivery of a general release in favor of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On August 16, 2021, the Company entered into an amendment to the Rosenblum Executive Employment Agreement (the “First Amendment”) with Mr. Rosenblum. Under the terms of the Executive Employment Agreement, the Company had agreed to grant to Mr. Rosenblum an option to purchase 10,000,000 (ten million) common shares of Company Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is uplisted, on a national stock exchange, on the date of grant (the “Option”).” The First Amendment provided that the Option was granted on August 31, 2021 at an exercise price of $0.15 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>In addition, the Company and Mr. Rosenblum entered into an Indemnification Agreement, pursuant to which the Company agreed to indemnify Mr. Rosenblum to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses.</span></p> 208333 0.24 2000000 154000 208333 0.24 0.15 208333 0.24 20000000 0.24 30000 $4,327,899 30000 20000000 0.15 800 0.50 0.50 66587 910019 2000000 154000 3500 2000000 154000 1000000 77000 the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Company’s common stock, as reflected in the closing price of the Company’s common stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan. 27879 381006 0.50 1 10000000 0.15 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>13</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><b>COMMITMENTS AND CONTINGENCIES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has convertible notes, disclosed under note 8 above which mature on August 16, 2022. Should these notes not be converted to Common Stock prior to that date, the Company may need to repay the principal and interest outstanding on these notes.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>14</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><b>SUBSEQUENT EVENTS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></p> -1810246 false --12-31 Q1 0001591913 NONE N/A N/A EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( "6+K50'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " EBZU4YD<39^\ K @ $0 &1O8U!R;W!S+V-O&ULS9)1 M2\,P$,>_BN2]O39U(J'+BV-/"H(#Q;>0W+9@DX;DI-VW-ZU;A^@'\#%W__SN M=W"M#D+W$9]C'S"2Q70SNLXGH<.:'8F" $CZB$ZE,B=\;N[[Z!3E9SQ 4/I# M'1!X5=V!0U)&D8()6(2%R&1KM- 1%?7QC#=ZP8?/V,TPHP$[=.@I05W6P.0T M,9S&KH4K8((11I>^"V@6XES]$SMW@)V38[)+:AB&GQY=YW<+Z M1,IKS+^2%70*N&:7R:_-PV:W99)7G!?5JJB;':\%OQ6K^_?)]8??5=CUQN[M M/S:^",H6?MV%_ )02P,$% @ )8NM5)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" EBZU4X8WTH5D% 7%@ & 'AL+W=OZE^)+X0FKQ&89Q<=WRM=Y\L*W%]$?'D M4NY$#'YE05%H,=L>6!$/XLYDG%U;JLE8ICH,8K%4)$FC MB*O#C0CE_KI#.\<+C\'6U^:"-1GO^%:LA/ZV6RHXLTH5+XA$G 0R)DILKCM3 M^FGF."8@>^(I$/ODY)B85WF6\H7N:9)V(FPW\"3_O7G:L.\<2&IZ%^E/N_1/%"?:/GRC#) M?LD^?[;7ZQ W3;2,BF @B((X_^>O12). IS^F0!6!+ W =0Y$^ 4 5GFK)PL M>ZW/7//)6,D]4>9I4#,'66ZR:'B;(#;=N-(*[@80IR>?I9M"KV@RC3UR&^M M'\@\SH>'27.7)#Y7(AE;&EHS,99;*-_DRNR,LD.^R%C[":AZPOLUW@+*$I4= M46\8*OB%JTOBT O";,9J>&9-X0="G;KH7VB<,G%.)NXT6_?P$)EK$25( M"[VRA5[60N],"T5O/(IMD&C%H:D%CT1=1^ Z\\7BX6FZGC_=DN7T^Y?;Q9JL M'NZ_K>">$M6A^A9AG60>/S"FB(4@Y)B@*J4 MG;(^[&HSA8=3N_L5H1B6%$-49I8J92#N@L3E(?DNN#*3@, $K87"U;I=RKH. M1;BN2JZK-@-J)J,(QNI*2_?'!5EETYL\I#K1/#9]6#>UQ4XJG4TVS75:;\VXXO>WAOXK M&:O(6!NRNR 4BLQ@>&^EJD\8KK.0<9>[+A1W!2)>+H@15BY-G7:.L!0JD!XZ M#QNDCO7GMW?O&FH(K2R>XMYY<+FO MF'G1RMLI[L[%8%M%/ S)39K [:0>!]?1*D4=H[)YBCMS 70;";4UT_%/4-"^ M\=<=C^NG 2[8:&:5T]-65K_R87V, N$RC4"5S5/];*[XT)DD4:/;^UP@('%X$: MU.WW![TK#*DR>M;*Z.>Q*Q7D)UOM7F3U1Q )UB]3J)IF:>'5.FN#^N()@ZR\ MGN$&74"N^2N9>]"MP29P\W4YDD56 KXXPPLKN6:LE_=3S8,V57!P/ M\N^&A[@^=[AD?W!#^MK__3T=V'],7T2,SXVJ!C#0QE--\%,RM:?OP^J,7[/Y\#3E4E'-S'5\)-5;8D>G5]'F_%V1V+!J'% MP^(6(SK9I,']>QUH**)R0RC[\/R1' %KD7"E,QL4ULG6FUD'9CN2"7%-0@/L;*?7QQ#10[@5/_@-02P,$% @ )8NM5*'6_/; M=-TZ!K))BR[02[#NML^T1& M\Q=5?:FW0FCTKR%$\5JINBX-7K!Y&KE[L)F;P]^"2?M]H\ MF"WF._XLED)_WCU5<#?KK62R$&4M58DJL;F;W)/W#PP;A5;B3RE>ZJ-K9%Q9 M*?7%W'S,[B;8(!*Y6&MC@L//7CR(/#>6 ,?7SNBD_Z91/+Y^L_Y3ZSPXL^*U M>%#Y7S+3V[M),D&9V/ FUY_4R\^BNN*RD$K:K7,7MHO&(MH'.#Y;'_L MOBT7!D$:AZ27.X$5]+ "+ZS?]594D$ ';[G#VP/,@Y7P&&;*:'0&TI9*0LP" M-\2PAQAZ(?ZA-,^1;T$.$$,;8H ICLY!VG)AR((X"=TPHQYFY,V8WU1YXXOC MB=&X-QI[?7^"[07FR@R)KXW<05W4+M=CRR4:,$S/''=()7&:NMU.>H2)%^'' M4O/R6:YRXQ,Z+*&;X/,=ML8B&^$CL!&':(TR]")<"ED7J5ZC:.U5+9P!3 M1^XD%KY+4B?P"!Y**[X0PKVH]=C:=LHG^0HQP>0,W&6Y4WA'E9]E_> M@YVI8Q DH%& V3E:AR!)DF@TFD/A)O0*N!Z(U/IRD- DB-)SB+9@%%/&Q@H% M&:B L*O(Y1?)5S*76@I?K2!#+2?^8GZ_7JNF!![>\5<..]+IOEVC0TII:"V0 M+1=$(<5CS@_5G/C+.?0/>U'IMF)D8J6GJ(0N5&U04_)"P8N_H:_(9-VZ8IZ_ MPVT!?$\=(?!Y@$2 MIG;+YI1+V-%6.VU-!\*@?L*P*_*%A:,V-S@1.^4\B <.H==PR"64-B?0.,0D M/D\OEV":4AR/X3SJ^OUM_X_099WOU%-30Y&G_H;_">9, :N3(1C.UE^F4,=N M#1U#<:[0GN>-@&$EG,(C\X?J+8>ZAGBCMZHR-7#:5KW^A:SK!FR99S!EU]!T M9;)\AI[+E$@8GM;;?GIJA6 @$L4*>ONWH>C6&7*O#^9LX'V]XVMQ-X'AOQ;5 M7DP6R#6=_0>&3N,\D![UD]Z#*@J8\\>"_ ."%.JC;"(38NR+.HOB:8K)-(K3 M_SGVCID*/FKMR4MBIW$;>)CZ>?@^RZ0Y(8%]N>,RNY$POO"=A'WJ!&M391"F M-*%!<([7)1G'!!,Z GE@5>IG5>AOFJ+)VY.'3&SDVMW,4YLL;P*6$D;2\!RL M2Y020N*QOID.U$JOH5;15A3$M:[DJM&F+4-:H8]EJ;H&X8F_FMX?+57>F 6I MI_!V?8N6)J.W*@=2=F M1\A2"]@P[E6QISL8#$(+K"W&0EB1$:@#N5,_N1]6PU7?.W@V60.A)#0];QH= M@BQFD%PCZ;@6'C#4"\'ZCE'Z[,<>0_;'SXA]0 M2P,$% @ )8NM5(!WC,(( P )0H !@ !X;"]W;W)KVAE3IR@P 5(+6@:GN8A(JZ/4Q[,(DA5AT[ MLQW8]NEW[(0LX8[&0V(GY_+[GQQCC[9"OJN4$(U^98RKL9-JG3^ZKHI3DF'5 M$3GA\&8E9(8U3.7:5;DD.+%.&7,#SXO<#%/N3$;VV5Q.1J+0C'(RET@568;E M[V?"Q';L^,[NP2M=I]H\<">C'*_)@NBW?"YAYM91$IH1KJC@2)+5V'GR'Z>^ M=; 67RG9JL88&2E+(=[-Y',R=CQ#1!B)M0F!X;8A4\*8B00406J$EF94UPQI/1E)LD336$,T, M;&VL-ZBAW'S&A9;PEH*?GDP%3^"CD 3!2 E&$ZQA\HP9YC%!"Q-8H;LYEH3K ME&@:8Z;NT4?TMIBANP_W(U<#A8GEQE7&YS)C<"+C%RP[*/0?4. %P1'WZ7GW M&8EK=[_M[H+VN@!!78# Q@M/Q%MH$ Q]J9%8H1?*03;%#,V%HK;/OC\ME9;0 M;3_.) OK9*%-UCU=[0V1FBX9@5Y;Z@?$B4U<<)P)>/$':I]0%8L"@.XH1S/! M&);J:)W+7)'-99;K9N*-W$VSE(<6013""J_-6BJZM8KN615S6&E$2D"%]HS? M'U".)=I@5I F,LH)_%VDT#A'X; ESH5$A3 M_F.L9;!>LXP]S_[V:*\P;/%&-6]T&R]5JCC.&AT@[$.>LVC1]6NZ_FUTL%TH MC7E"^?H88O\BXCF+%N*@1AQ<6'A9!HOY/_IU<%V_7C1KX0]K_.$-^.>;=7A0 MNW[5@_M5/K3<&9ZHMN_]VU6\&X!/=VL5ILD01OVAY\-EC_8JTS9N8Q/T;\"] MT+Y5K*N8KS$MF=W&'FX.4+!-KBE7B)$5^'J=/@21Y9FDG&B1VVU]*30<$NPP MA7,OC>PW/XN(?B MY%[([VK-F$8/55FKB]%:Z\WY>*P6:U91=28VK(9_ED)65,.C7(W51C):V*2J M'),@2,85Y?5H.K'O;N5T(K:ZY#6[E4AMJXK*QRM6BON+$1X]O?C,5VMM7HRG MDPU=L3NFOVYN)3R-6Y2"5ZQ67-1(LN7%Z!*?SP@Q"3;B3\[NU<$],E+F0GPW M#S?%Q2@PC%C)%MI 4+CLV(R5I4$"'O\TH*.V39-X>/^$_IL5#V+F5+&9*+_Q M0J\O1MD(%6Q)MZ7^+.Y_9XV@V. M1*GL+[K?QZ80O-@J+:HF&1A4O-Y?Z4/3 M$0<)@.-.($T".4V(!A+")B&T0O?,K*QKJNET(L4]DB8:T,R-[1N;#6IX;8;Q M3DOXET.>GLY$7<"@L +!G1(E+ZB&ASL-%Q@MK9!8HD\;)JGI=85>?:WIMN 0 M\QJ]15_OKM&KGU]/QAJH&,#QHFGV:M\L&6@V1!]$K=<*O8/FB^/\,4AH=9 G M'5?$"_B!RC,4XC>(!(0X^,S^?SKVT G;;@TM7CB =U,O1,6Z;D1_7[&?(>SG.D;RTE9?ZY;$:2D:):%T@6D#=XF;VFXKM$KO'BBV6\9W=-$OR M,$LGX]VAEGY8E&=YDI(V[HAKUG+-O%RO&6A?<%O@7.RR?K-1GIQPB*2](0#Y0*W#DO]EOO926@J_^U M<]V8E)U.!5<+L:V=A;S!.V)"DA"VV:>478$8ATD\1+HS5.QWU&LF^&B&HM^7RKJ2F*6D!=K-]"G=12E)"S M0KRI-4XI+EL]6(2-#"^3YP\#Z5R7^%UW4.1-78MFF=_21_O9 ;OGK;7E-V89 MG2'XGEQ\7\.6&MS/I;UI.CD>Q@!'>72BWQGI'4;2>37Q>_4557QA]X[7'/C# M]ZC5"WL,I-842L(K7J-K&$HJ#]XZ/T.;E@YIGA;>)B0[5!*(0#Y2[!GNF+HX[:: UEPC3O#5Z%/6ZTTR#0S\I>?,JCVOZ*^=B-VG^!6 MV'?V,$GS +:?^:G2?BB)8Y(:FSE1.SXX4JB87-F3%H6LS>V_RMNW[6G.I3W# M.'E_A<]G^S.9#F9_1 3?W"M>*U2R)4 &9RGPDOM3E_V#%AM[<#$76HO*WJX9 MA:EK N#_I8#=3O-@&FC/OJ;_ 5!+ P04 " EBZU4F,CF "@& #N(0 M& 'AL+W=O<&DI'DUFDW;[Q[JV91O19%7[*$&S;8L:?WC(ROX[FX$1Z]??,Z?UT)] M,9E--_29/3+Q9?-0R[O) 27+2U8U.:] S59WHP_P?8*P,FA;_)NS77-R#50H M3YQ_4S=_97:52\5'4\FDN[<1L MSJM,)A;+@+QJ>)%G5,B;1R$_9,:)!O 5F*]I]JKTG:>?1Q[Q$:\.A! MYB*KZ]8)V9YH(4!Z_X" M5IINRVW1CNB"K?(T%P:0I1WD$Z_&*:]$S0OYZ!DT:UJSC@')B& U:TRPB1WV M'ZZ%-)&Y"<%>!(\QG)&!#V3@J\AXHWZI*D^:M]<0,]^C^OT!#4,2 MFATB!X>(U:&OM*ZIFD78=U:GN9QG3'EAQ;@A+X@VK(1X82\MB!8K@G&,^^WN M'3FU=(23&/Q&'@XA,3/D'QCR;V3H-'M,H^QKCJA1)B@:\"0X>!)8/6F[E#71 M4Y/6^4;-P8TI6:P@-R1+H"4+]G!_#@GT6'T2Q$$_61PYM72$DYC\]CWY,E,4 M'B@*;Z7H4K:$FB=JF.5K(%NB@RO1%:[D3;-E,G4WJH8QIHL5Y89T<82SB+3Q M&/L>A"?,[#/*47]+1SC)9;_/:(P/-,96&F75^2(+&:5*9*&9L2LK2A- M=%K1;J SUG[] 8QZ'"QB+>:0X)!$48\K1TXM'>$D)K\)#H+(S!7TCF+!^VFV M+DT$';1_-N2R' M@,.#6B8:!5K>6-*_!"RWD5"#=VKVN:.WDD ':@)27:H:@ M:L8R*A(K_@UIY0IHT0&=S> 8A9%6O+KJ<>D**+G"]7.>CU(#VK5&*^G:G8<, M\';Y>9WZC:2ZDAO0H"3\_ES1-3JO*S'1^7+DU=(54&+V/"1#=!W%"+2KD6&Z M+LX5NB!!;?DRL-K HQZ!=D'RB0E0\,98*MA-;TD81T +5T#W4%48QQ["003[K#@*(C'TB0C$LI0;X.0HWZ!=OPUL/ESFQY6B@[KJ:?F) MXF@HN*/P@7;E,[#-90[("G5+0*&><$$8:TN/KK&('X;0@ZB?<'K+,4$0PM#3 M$LX@W'P$>\T24[,00WS2]?F('_4=M N\*_:RS*/O2O%!7?*THP_EVT!P1]4# M[;+GQDK&E>IQ!;2 NL2("0F"?KZY4D:N@)*+CI]O@A^5$;(KH\^L$76>JIW^ MIN662AF2&] MA3Y76M$5T#W2E=L81AXD,>FM#J:64>CWUIO$# @]1(8H.CEVNOKO_G@OV-X)OV M;/N)"\'+]G+-:,9JU4 ^7W$N7F_4O0KYO=QRKM!;GA7E]6BKU.YR/"[C+<]9^4GL> '_>1(R M9PINY?.XW$G.DFI2GHV)X_CCG*7%Z.:J>K:2-U=BK[*TX"N)RGV>,_GCEF?B M]7J$1S\?K-/GK=(/QC=7._;,-UQ]W:TDW(T;*TF:\Z),18$D?[H>3?#EE$9Z M0C7B6\I?RZ-KI*D\"O%=W\R3ZY&C$?&,QTJ;8/#SPJ<\R[0EP/'WP>BH65-/ M/+[^:?V^(@]D'EG)IR+[*TW4]GH4CE#"G]@^4VOQ^B<_$/*TO5AD9?47O=9C M W^$XGVI1'Z8# CRM*A_V=O!$4<3P(YY CE,(-T)[L $>IA *Z(ULHK6'5/L MYDJ*5R3U:+"F+RK?5+.!35KH,&Z4A/^F,$_=3$610%!X@N"J%%F:, 4W&P4_ M$"U5(O&$IJS(D^?"W8/DEAS$=T@;YN[M"'?WV\&BN H@V.X\.RM_6R M9&!9BKZ(0FU+-(/ED]/Y8Z#0\" _>=P2J\$O3'Y"%/\;$8<0 Y[IKT_'%CBT M<2NM[-$AMTXV?Z+[S\N_-NA^O?R"EJO9>O(P7_R!)M.'^;?YPWRVN;2LXS;K MN-4Z[L Z"]CHF2A+4P3JF7XU4^_FEYL+'&*'N/[5^.78-::!F$8N=MJ1)^B\ M!IUG]<(D^1]D<)U&2L"NCT41IQE'Q0&V?JJO8YU@>YV%:8&@1$FFTN*YWN.I M2GEI\Y7?H/&MOKKC,GUANFJ@+&6/:9:J'R@7+W6>FSQ8V_..'1,1[..._TS# M? ^[KME[08,W> 1[ MX;(\!@WIQ__>0QZ84%NM:GF]+'SVSXC9P=#)OJ$D"*-H(&BD MY4BL'#=*Q-^KSB-YGP[IH0"CI1JP_CF :N$-@6Q7#]*R=+G53I"^@5D,\ M2F[<[G:CYT2!]OD[/O$&:+6BB5V[.F]9\\%\(#7:NV*P]*J=C_+S#3Z,GGA$C=T MNW[OCZ.AXPUYO553;)?3JK7]NIG=H?G"V-<:0?=%\"+PG0CWLMPT,'!Q.("; MM&I)G+-:\OGBVVQS1DM.6ADC=AF;@Q;7;:^N, G?B3(U;WV[H3-2DO3UZL(- MA[88:=6*V-5JE3%=NZ BZ#YI5W':[66\U?IE9-27H@L<1 [M-GOVA<_O,D@K M:L0N:HO9 SI)8E,F&+GUY6B FV&@)1JM;I%W=*N3PO?SQ60Q/2.%6^TB=NU: M21%SGI3H28H=6&L2(V%U>[O7,RV:2&GN,,>J\5.F(7NDW#@EMUS6[F M'"H&Y?,IM,I'[,IW&IZF4>9O7,;IT,[\7?)'^O)'B$,#/-"*D%;_B%W_ MUAQZD*K&0(N9"58T38F1D-78.80,B@J,AMIGTDHEL4OE"9_N*YHY]PSRA[$; M.#[MUAC#2(_@P7U"6Z&D[[Q6=O8^O (@Z$OR&G4E!K_$Q;[,&?&A_1=7XOG1 M,-56J:E=J1LI^'#0@H]HM5Y^F]_!S>U_C?75R-2@ON:H&4:&\%KI^0.](VV5 MFMJ56E/Y<#>;KF>3S>PC4*FOM+YIAD;8!JTF3AA B>K"[H^$M\O("X=@'WTG MM8MQY?W) [J=_3%?++2KE_<(FLKY\LX(N:^LGNM&@==#W!\804#H -Y6@JG] M@^M/O+/%W3M(W7[[37T2N-UFP3 P\"*7A.$ UE;$J?WS:X5U-9G?H?OE&A+A M8;:&/@=- /K#Y#_V5H&VLDKMLEH=#NQ8FJ G(:'AC47.D6)O T7A=XGK;S!T M2K@57VH7WR[A^IW-2+:OE&%(O%X&](=1>MQ5G@)MY92&UO@OEO7>/VYP(?;O M5[73]5JYH^^\&9Y\8#W6B/<_MMI-GY,74>\T@Q O.OXN4=,;'QV:Y5P^5V>) M^A/COE#UN5/SM#FOG%2G=)WGM_AR6I\ZMF;J0] O3#ZGT,1D_ E,.I\""+&L MSQ7K&R5VU='2VAQ1P'5M)FF;[ KA)NYL%VN3J;1>XPWV@)=KF11*UI!37 M]^OOF2'UYM@I#H?[TMH2.9R79V:>H?-F8^R]6RM5B>]Y5KBW1^NJ*G\^.7') M6N72C4VI"KQ9&IO+"E_MZL255LF4-^7923R9O#S)I2Z.WKWA9W?VW1M35YDN MU)T5KLYS:;?O568V;X^F1\V#+WJUKNC!R;LWI5RIN:J^EG<6WTY:*:G.5>&T M*815R[='L^G/[\]H/2_XIM7&]3X+LF1AS#U]N4G?'DU((96II"()$O\]J"N5 M920(:OP99!ZU1]+&_N=&^D>V';8LI%-7)OM#I]7Z[=&K(Y&JI:RSZHO9_*J" M/>AM>30YLB,.&F/7V![&6 MU[*2[]Y8LQ&65D,:?6!3>3>4TP4%95Y9O-785[V[_?++[//-WV>_W]Q^%K// MU^+ZP_SJR\T=?[_]*-Y_G=]\_C"?OSFI6&S,2O&E"S6W%; M1)_D5DQCOA;&B6BL1WER9O)3%-KQ\+HZ-U2L-;;*MH'*C MT@ARYJJL5+Y05L2GK-2IJ($H+ZF0>2MNYO16BCLE;18T:R2/!-165J5"%Y41 MLA"SE56*C9%%*NXR/#)+\4G9%00?]W3TCZ)V?:OL1E=K\3<4+N/$56-: M97(CK=KKCL=;.BU)E_">S^W\VXB,^B)I^69MR%UF4\ Z5R^<3C6**UE#5@07 MMZ<'"^?UHCEU+.YJZVH)5\ UM">L:4T>"9PU $5$RW*_;",=["RXJ%YQ=>>- QZFTRI=U+I813B;!+C:/N@'/!AX/+C BQT#V6Q$?-$@ MN^9&ZR;W0SM70F!R-[NLJ?" ?Z1R)I!$;P*2TFE)PH%D( MX(.R59,@]-92.Z.E5B6*LK_:&*^4VP%7IX[).FR1]*UXDM;54 M'5%=J-1BT?ED,D(4#^I#H4@]7JK:%N+L\F)T?GC]6F6I6&R1NG"//Z7)F*9F MD>Z]UR08)).#,'1<_,1!8_$[1!K(Y881T.DE[@*Y/2%ZVEB6"?)H+"IT'P%+ MU&*S(5ST7?H$O+C+V:%.[)FST>5E/+J<3*(#_O.XL@I,W%%S2W?@%:C ZED2 <8J5 2G0)O_K+73_90*[AIYATIDYR+3"9P%;DU%P+^$ M;6*);EXD&B5*)HFIJ6ZO.*Y0W%C^AM0NC5-N',T'C(,1T:X1NFA:%&0W?94[TGF/UJ#9 MM^!$[#S,6UJ!/%'+)<::FMYTH0H=&52U<-(//;T>.HKFX]GX;GPSQM0BKL;? MQKN\;S,N$4N$&B M:.&#Y@33%5,((O30! X:]4T=BD]5F1E?BC 'DZKB7AMW[WR2I&#-5B]J4&B)[6&ZU$$Q!4(BU[J)&3'%2]EP#,]G:N$RKFG MPO.JUR3;+V%H:=.IETJNS "3L('+W*$J*B3OHPRG]=,7 ,^+Z6049))73 _; MP?>#J'\)AWIY[ Z[XZAYH=D@VUN$X:0GX:3T9G%Q>C5R\OFCU0^#0>3<[P<'HAY+(BQH!R MS7*Y%UFO'O%EWL(9VTN2O5G133:>;&F'^BX/T,;13JGJE164,_7=PYFUB4?Q M>9]C1'U ?,,P(^;\O"T&.+#/K^D[+_L5GH6)(=/:,DSO>E-W7W"SHQ7=8]>1 M#"['& -M ;)N4D[9"[-Z5;M*G._!\?QNUN'VU@=^U\Y&[Y$H@#2!FIJ0[./+ M9\\YS,"A29I&["N"^UG\(F%T@='+*FVE.#Y_AOEP5J16;2FU]+UY$,?QF!^3 MTW]##R[78K:P,G?B>$IO/!,<] =J RHO,S8,9)2KP]V,N;&_?'@$CX L;LR( MN5LVF%^&VSJJ."W9=AY-/$*5G R2:4,FEE+;@AJ7*771S,=,/(C&/7B$[2G\ MG@^&=!I4AR%P"R,R4Q =6)-7\611@^_[$Y6'J^N:+!^_YC0+))OZP-?Q?-Q; M/A)A+,BV$=V$B2N9:4"ZT'(<+9[#92ZQL+;UBI\DVN.)=#9::B<"@>7Z M#P]Z5A3.#$0K1;W+R$\KH5YL@!!5$4E#X54%3U,^2ZFW^Y:-R08]7CIT]C#9 M4M/W=S](X14/S=3D(\]%<[PEYRU1+EA&SRE^=&#B9T%=!&AA&@(.12>]T7B\XZZ'Y MP/K(51HCA3^0 P,)C$S$QS$^ AN# @G"#.@*]/R5J@02\9YP0GT*3^=H,PAD MT4/K")BL6!HF=Q#YDD$!#&(/3ETH0F)J-D5F0!. LPBYZ01C]$%+X7!$5:[1 M)MUX@.IV=I!B.GDFZ.ZX4BM,2)IO(;V_3&"+,5^JQ:!H'ZWF6I)1EG3S=*HR MD(CV8J$=OJ2@YR'R-'5EFFIX-Y64+1E;5CPW,&6=!S[L D6+"![DUL4PRH'? M^EQI1%&II+SI9U_+O5M?DYBOA::BRL.+\]<0"PL_CHCV9S5W99]EJ%L& 4-P MF(SCU(:RR[;U>/+.]8 -QJ"H/8?#&_""JMG#($%-UN _Q/+V46=X25.T2;]F MNP%9HWS8B:2OG4(C31\ 4*HU[;U8B+*H2W_1(F3+;L79_NE[MX$/(U[Q*.W; M;@1()FS@3Z?A+H+BQ"0/LAN$,84)'3E^Z8&TPY;]*",]DVOOA]MJ])$P24/W M@#T,7W97L@BN3VLBQYO"@2Z<3PGA\EZ%"]N!35C3%!E4660G?3N[?#;>.;Z7 M,LR3,C0+8#N##PK' Z]L0W5?0"JQ@YUZ2H$//)1RVBS^Y>EW0$G SX.V&)L[ M1+>XD(]G2'<90\%U>WWVZN7X J,)*:+XA& MBD:3A"[;JXJ[^,QE(5<>]V035R2R2%85#="&*+Y&[=%4\>F745!2CZ_F:F]- M+D'S;[LKR$Q([T:-?A["Q[X9A)MUE/Q!U^?L3?]5^XK+SNTH!,4F!1%SS9TY M%V,Z:L?5]#R%#+L=1]2PA3=#-8N](WMM2K1PV1BD7!-G5- MC]S$G6:-SHO\7D"S>Y:?4\J5RI0H%*U34-W;&1:7P! M-B1SC[OV@9OWCA8U-#+3N?;W*DC.+)-[[N^Z'SU4Q9KAM6^GT?Z&V9F$GB2W M]&./KP8$:7K'1=#/IHBHI+I:[#VQ)8/#>[3NDCK0400G+]6A1)$+*O-;\NQ* M%?YVA@;XHE:>&O.F1PF(4IZ!M0SK9"ZWU#?0%^&X3-I^$NDB\NRP EB#R4CY M+!49"!8#&4=;ON82?I]?@?+F;$E5(UJ2X\0;.ZF2+TE< MQTE\+#MGJ[;V 9P!2<3# 3,7R7Y^=?/=QJVS[X[AE_][;[[ID;A\:VYFVG^G&[U=W^N6G<[;[;3:W-MA@^[MQU]>AAGJ>W6M+UUK>K,ZML'5Q??//\2XWG K];< M]MG?"I0LG?N(#Z_K;Q^<8T.F,=6 &33]=V->F*;!1+2-W_V<#^*2>#'_.\S^ M/=-.M"QU;UZXYI^V'C;?/GCR0-5FI<=F>.=N?S2>GL>8KW)-S_^J6QG[Z,L' MJAK[P6W]R[2#K6WE?_W)\R%[X=^R$._RI1[T=\\Z=ZLZC*;9 M\ >3RF_3YFR+0[D>.GIJZ;WANZL7+W[Y\//[US__H-[^\N;UB]>OKM75SR_5 MJ^OWKW^Z>O_J^MG#@9;!X(>5G_*Y3'EYQY2/U$^N'3:]>M76IIZ^_Y"V%_=X M&?;X_/)/)_Q)=POUZ*)4E^>7EW\RWZ-(\R.>[]%=-%>5&]O!MFOUUC6VLJ97 M_W.U[(>.9.1__V2!+^,"7_("7_X[F?KG4UZJ.R8MXJ2%/E7/=6][Y5;J;6=Z MTPZ:1?_]QA2:B-[N=+L'V6.KQ]H.IE:5HT-J>_IK95O=5E8WJJ?7#"G>T*N- MOC%J:4RK2.5WNJ-Q%JI4N:ZFT8:D==BH#XOKA5J;UG2Z:?9X;':87"=&[SI+ MD^\:TQOS_Y[H:YX][2I M9E\6-%=O[L^/VJG6#;1ZU8RU440N5I -I5UB"[7MJ\;U(YT#@=?OHP7OEGL5 MJ69J<2:-&4PQM]I"O6YY;K>S+>:EI;:Z):S$XY(?_;5CS?>OZ]\(9OC[XH3> M(P'B$W,M'26MV(*LAFBHQJ[#@^R%TU+=;FPE1_)"-J)XCMITO6I-9?J>L+YD M8K5::=M!DI)H,O<<'<$L PJ27%JY)XAEJ29;U&DY<_"XTOU&K\4= (\VE' MI@0L!2U$:#^2H!M(DOI]U!W)K:(G82=$ )TYT=571-3> ,3>'P@*L6H@PRE: M-6Q(=?\A$]&>WIF=ZP8ZAB3;477D6=2;?N/&I@85L,N8BR;^;6RKJ7I2%%R"_;Z.NVG:D^8[W_'>EZ7!L0T/C M/JXA2G8 [.(47WVJ-KI=LP!M;<_F_@3C/+'7KUY$2NG1]#A)G9NFT%O@#!1M M93HH&B&"WQD=M6&$P(=[*P@A'2;XT/+@:SSHU4O7-)K$^N2+4YJ)H*R75VKE M:/+NUO9F42Q/"7L#UH&K+TA:RD MCI:T$!2)NMJ!D+TO-(GV;XZ.8J]N'"L]HZ_I!V:KZNVZM2M2BW:0)V=5F%R0 M70Z0[&;;:X_%R6*8QI+#P@3YL_@@('@&;6*).92\SP+@YSF+PX:4TO$2 ME'Q#J-NZ&X:"XJW>8XRZ=LW(])7TM%JH,_66WJ('@=O/S9Y65-^#3<1@#"K5 MXXN_%>Z6U'NAJE/UH6=H>47PNF5Y EUB5B,6_E71P"# "HXRF60V,][X])GI M@#IL]4?"J+"7 N>H>W+-=YY,$12PQMSH9A0QAVFC?]<.S%["UR@%(O5J1=@H M!Q)U$5AP_\-/I!7YV;3U](A9GQ>$ I$8..4]BWHD!SLE-!U(M@&^0.[.&O@K MF(\>WA#NN[$7Q7NQ MQIFI$O[A3/@),XO!E1@/.GX;Z[4G<4G!DLRHNXZ)!,<%/6AK1MA0-%8O;9-P M,V[41Z5YW;>A[T;NPJ#N0C6-"2R9W@+PDCOBO,R-_*63D ' MN2/YJ3Z2SR&"L<8#;_U[T]W8"B?4%9!-XC6K<)F+H,#QKG-+.3>!Y!W)+V$9 M<7BKB3,#Z*:A\ 3HY'$HV3F7%&!V5K!H^CVF%KUDAQ/(!3EDKM31"NI/08!J MHH^T7I89V;\37XK^(C>USV4J3,:DUFY<#N!Z@'SH'B2X2*3> 3'FD^DJ,HH3 M&0BG3H)">D:K$L&D74/2L3WQB+P *!M+;RX#@:M&\,:MR(8!3JQPOR=^>BS% M(0W,V5Q-94;SB; !\8E,7F<3_R4 +@O1]HS\X 0+_@$&. :!BG@JQ:1W3V[TLQ+F$_/0&;FG3X*^U6$MJ8.%@9SR!8# M_1)(!HN82:R74PJB:%CA+6^IEH2>,M>M13S6BD-/D[H&*G^[,>T<#X5QRE7D MC;+CKFW#[,87XG7X->!^7GS]="+?T"O>#D4!FSO5EV$$ V0XOVE;PEO#C"TE;B.A,259RENEU&(6T7K4/D8M)MHO42F GJ! 4>&BJE!"8<9:*&@3K<< P4L9@1J#_ Y#;\- 0FA1C MA*D3)N@)SN:D3SC7LUF,O((DV7X.B4H(2,Y6&EH03_#Z'6PASQ=2YCDY(R D MNH-;&[:^[+-!" YPKF-@H \1$ID(NR*0!T18=DK8>XMD1M[[% 3<[A$,R113Z=IQIDDFMY*3HC>S%!\%;VVMNYH0S-6, M>0PM(92^ND[1Y9/+<[9YF4^P)5F@8Y25/37DU] \Y((PWAD241O0*KU9_^,9L;-\,/LP).++QO8; $*^B8TE_E/4NV<3WI#8V]7>9YUV MX] 78R\J-C?W)+1Y0Z#7%!=GK_D]/EU204[HT R_CP[_[3KV;6S(F9,\=!_A M1'!^KH9:P:OVG@5]-_%,;PA&646\=:]-L+=%<23Q//.%)RL> M[;.3?F6#?;3BY1V9M6$D$Q",786$$8G^*7@ M=!+\(%O$FY\$1'$;XM?;'3SD0C28) _\ N68/Z#RD(O%GD,TCKLX%#)P&**8 M9/DP,;HQ"KHKDESJAO6PS\U=Y8]:-KX!$13T@)4AQ+%&;Z,?98 MC)FK'BG/7-YQX>:MUB%*>_;$*"*D_UB:".!V#)>DNY--+0[V6#LC]HA3*/VX M6J$TT0[%)+4<^4;3B?T3^P(SW@[QI"")V I[F^2=#_N_SERD6D2@[VI)< PCI[:\?/2A:)"R2N%@"_A#@A"$ZV)->+HS=L/)4MZ0\\OF M5W;(R6?QA[.0<1ATM9&##@^],/@D9,"%6 \0P^L3XDG>#LY@*JXS]9>0!_,6 M+QA"B@FN7Q1/+A^?79R'9.H=-G5UJM[9_J-0]J'UVV?YG?.#LSP\^]Q+R.OR M-\8;-PGWNCCK.)E50GZV5&%#99H6'SHIVSA4#SAK Z$J>+XR>YUC[.CKX3&8 MOH120S?@U)/UX>-&;H&WX_,-)7,/R1=D*@6"VT_&)FSPD'\DUO58#2GF!HP2\DO! M%Z43HH'CAC"2EZ U.-LP^'#WQ-Z< AV:5'82U3,DLFYK*R*_(@[*.BGKRH&*5(*O2,N-Q*QZ:;W24@[ M<%2*A-$@MAK1:N!$J2A,JP,->8(; (A0C0ZI82TW!%0#6W/DA4*8%T6!S3># MS7QP%P)ET,6[0_A2D^;WF%\RG%+#DWB='86UHP$ME(BD;Q>JR2PR--_.:T2C M;V7_7:Q%,N(-]BP>'[&[\+Z21\,NILJ"_P@XT9^\H!*"(XWCO1"Q*#^!,0(Z M4=J!.$M)3\^=#Z*"SC62:667@O"(@BGXHD8J<('CX,R2G;5@@&I",N&_Q PB MM$GI@Z?EU=8[T.PY6)K3BN6^B8["M(:Q4&O")1)&V):\EDS2#3A)\4!"M5G/ M_[FC_Z++__W5]?/H\TLV@B@1L:89QEW-C*_%D\9^0GEOKJ"X4#]S M3$5>K"WN..I[UQ3&'3;B=[10FU-?W./,_UY=&TY0$.VJES^GE?K"9F5OW4]( MAK4%BLQ:="\$2<\%YTT S_/BE(T%^@-[F?V\Q\L&B0SSR,(AKBY4R*J^*/ M!<<'K"(VA0PCJNQJ96J?A:"YQH[3361SD/F<9=1QU7KB6\FLK"9WS S2O[@L MGWSYI/SZ7(3LB\?EQ<77Y>/'!T>P4+^=!N3I&;'$0>:7KB;Y])6"#YD\ON#XTQ2$@HP M02-9E67TQ&UF==,J ![)4RTNNT9'B$MADJQW@QX]R84U"$TSS+>3L"*+OK1J M1SY$SJVP+W/D_,6-[[/B,WEUO"]V77Y,I4"_=G"7*-0P &"[78YDYQG2LFHA MZA.0U\&L.]AWW<74J"<.$Q'%[.*DPM5GCX7+9,'F3!587 1T@,04,\:K=&XCY8_!>0W80;)V08,@*?HOB'9UE M'SJO[E$RR@M_+-A>]#0GOE,_$4,AX5=MED,H82XR=4+JA,Z(8PE_CIS]1$%D MH[LUIEQK0,V]=I4#LO@MV4J8])80G2*+,[=:\3;@ZWF$SX?N(-MN[,D-SMXX M(E6@\KX\8TW#'@QGGW@FOWSFF'CA/S"/Q=T@N% ?3TGVDAF;\X3)U3B31 (C MCN0/R,ZGMIW.3&RA9(!NQ!/<&)2T>,K@"R/&"L7G/'$]R9SX=J]I$9R[OL;N M\UN"JH84(G$X"YC!WBQ+-NE6N2LU6.34>8WO]=87K[A<)/XKB^U)WG?DG9T\ M[:D;(KGE1,6I=-:PE$HF4XI:!".S)!:)Q-); 0_@8QL^EE'4*.[^0R!=P@)" M2@JBU(G7I5,V&^RP_CDS.5.1P!1D,#5U<2Q[K'V2D[;>!=A(!(S] MQNY@CSY*UJ0\Q?;:-)&2F_IT'81 MW.,Z=S^X VF:'F,CPKHSR4(6_LBS+B!=D9SW;'$?1N>;Y<-GYR4JV7*5*)6W M>K(L'O(H9(*RI5 Q>Y;V*_$+,Z @PU ;7Y.*>C"7+LXX7IN*C#O'6;@S<0"( MA!\D'K7EB>O@-IGZR-R([B]4QC:95Z%-1KXK)JTSX(!O:-0#GTOI(Y>J M&KE_P< VD[E#E,!AX=OC!AP?.]#;Z)DQB$Q%/+ZX*,_/SP4O)!,$L.(MQ$GA M8;[,5L"68$I&:?\)RHY6?:CA&=KD@Q1'.9]O& JSTSM"R,E)<67GUHQF*7Y _,]D"%^>R@B3]H6+LM,!D^902,K&FU=[- M]18B2 XW!2S4/P$(&1LZ,W! #X?,VACN6B4K9F14!W9ZJ-\#.]\#.*Z'DRI?] M>#N(2GQ75V;1@80&\A2:1+H\Z3=M*0JM!ZE;Z:#(PG&:YV/,FBY-<.DDS_8N M?(C>N.>[I ?8J6*S[R$Q6&1$J5K<+0KB72PY_-D>X!])=FEL47_' )J)?(,B M:ZG/\TQ+DV5KI %'YD*'2NIP\6*2-S\Q3WUC1,[AT'.0G)9$4Q%6D*W3IW3+ M8(:N3%%95R7C>,T[UZ@B:]+1-23DA1G MO:+KB&PC"C'JJ_.ORG]UW51?R3C%9CJD;5.;X=9"--:.$\59CR).A#V?S$>- M^?72&W;A9L$B[$O'?6A)P \R;[+%!YW$XN8X?T2",5-%Y!$&,CIC)QI]]PSGBVB^)RB>U-/"'@XE#YP3KNQ@9$M[0 PSX4UZ=4KLD9-,HVX6')56 MH87OV)$F)MQW47:0:<;(L4B_CY#F)V(GA/[JX8--LY8^M1GE)(M%[I\L7BAW MJJ[AMYT]9W6] _[E)HG"2D\I9AZ1CF ML(W\%VZ M2(Y$RJC)JZDN#;.[E2 ^!_\;OA!RG4B?]#R'67PA97#LC)OMKG%[$SIX A9U M.)ONR%L=0IUD'K>/7QGQ /OW%YAQ&QDE#_U$RPKN$X@AE7@B[*G,' MGTJ-M@7M#KBNF]:&)0>AZB$2W1L.@&$3G/J+8 M61FY&;57%Y>0]PNR-)#;V5US1BG*1NKU.VIO*?B^X7&LI 6GC323E;R7QV@?6Y&P'^^W! PHDZ FSZ4,<\E%U,RE0B8)]W-:U[CU M/E:4#YIG4HT[5+WS?BCB:"'7-C_Q!+Y"Y/L?.%K'8S!5ZT&G3B!VTVE3/HTSR6^)#2'P M.FM,NV8/Q7:U-'))8M@QK(K59&Z01AVVA?GF1)^8.3C/X: !JO!\ENV4/#UR M!:T7U!VDG)V0-F:+='[#AO.QJTY+F8PO6LZB;DH0Q4ND/'#"@2)EL<8^E2(/ MTH.'BWA6AK7^/QR.\'9=49!I^NS*R-;5ICGV@6;W(:J=2P1X&>IXO(*Z:X6@R4%&0I$D MW#3T70XX!10ASU8PY*FK(IJ5CDWA)$L)UA>APR 58)^*O0NXD')W&7YM<1F< M36\$PI2Q3CA.%(;Y*;"KD,!1>XO([OCN MYL'X$.Y/Q$/ A(^,7*7K<=F3A*)C\-]E0PXSDB,8^8?OD#LT#4"TG+4%O> ; M8[T/\LO[%_]X7OJRCP^;73?)C=TYVR'LB+JJ"2@HG?EP"[4[52_3]:DW68D8YM N7OK.NWON^RL8/DN:RV(#%%G[I@C_YC-A1#EM2F>9UK\CCL2G.N, MAKZ>1H9R)= P/BS-<&L\^Q/:I/L#K#&TC-RYGMQ/5H?WDR^E">*2-\'20]0XDU MW%:=LZH^'9A?S8G.#?>8$)V-=(:U$SDI.-?N1X:X$[>:XPNQ!^**F7WO+B?[B8%\+U9TRE9W9X.>W&"+X\>3+(J3?4S[.@TRZS^H]9G]G MT>?\)&VC0P%93&3N4V>-S#?Q5P"FAHRP0U(NQ>3-@Z@]K^++;1NN7X8?Z"%W M;CG&GQ"29P?YR[1([(D_V%XZ293EU@@W[D%BBR.,]+W>43M?6W?F2*(C[2AM_-BI#J-], MISXKJ9)^8FLR>%)85\F 6[><^MJ1S..B2D_GL]G+:265&9V?QK&/[OS4-D$K M0Q^=\$U52;>Y)&W79Z.CT7;@DUJ6@0>FYZ>U7-(-A<_U1X>[:1\E5Q49KZP1 MCHJST<71F\MCGA\G?%&T]H-KP4A2:^_XYBH_&\TX(=*4!8X@\;.BMZ0U!T(: M7[N8HWY+7CB\WD;_.6('EE1Z>FOU'RH/Y=GH9"1R*F2CPR>[_D =GA<<+[/: MQ_]BW7[J M[%HXGHUH?!&AQM5(3AD6Y28X/%58%\Y_N?K]\]6[J]L_Q?7%[>W[3S>GTX"P M_'":=2$NVQ#S1T(LQ+4UH?3BO2S<1BZ.QF,_F M\R?B+7J,BQAO\1A&];51N0H;<2U#(.?%7Q>I#PZ.^/N)\,=]^.,8_OC_4/AT MB(7X)HBX+2EY:ZM:FHTHI1?*9(USE N#4M76>_+"8Y"$"O$IU:W/38Z_H#)5 MRX Y@^G\R-!2.2%2M^L3J@V&7E;UXXSA[AP(Q^GPXP+.C\+<:+ ME_/QJ^,9,,74)LD5+JPQ72&O52@%.E M'6?/.S1&-A 8^V->CI;17GFK52YY MN%!&FDQ)+7S +I*V(']%S J:="B>%E"*ZF;�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end XML 69 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 70 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 196 320 1 false 58 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://innovativepaymentssolu.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Sheet http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://innovativepaymentssolu.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 007 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES Sheet http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES ACCOUNTING POLICIES AND ESTIMATES Notes 8 false false R9.htm 008 - Disclosure - LIQUIDITY MATTERS Sheet http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS LIQUIDITY MATTERS Notes 9 false false R10.htm 009 - Disclosure - INTANGIBLES Sheet http://innovativepaymentssolu.com/role/INTANGIBLES INTANGIBLES Notes 10 false false R11.htm 010 - Disclosure - INVESTMENTS Sheet http://innovativepaymentssolu.com/role/INVESTMENTS INVESTMENTS Notes 11 false false R12.htm 011 - Disclosure - LEASES Sheet http://innovativepaymentssolu.com/role/LEASES LEASES Notes 12 false false R13.htm 012 - Disclosure - FEDERAL RELIEF LOANS Sheet http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS FEDERAL RELIEF LOANS Notes 13 false false R14.htm 013 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE CONVERTIBLE NOTES PAYABLE Notes 14 false false R15.htm 014 - Disclosure - DERIVATIVE LIABILITY Sheet http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY DERIVATIVE LIABILITY Notes 15 false false R16.htm 015 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 016 - Disclosure - NET LOSS PER SHARE Sheet http://innovativepaymentssolu.com/role/NETLOSSPERSHARE NET LOSS PER SHARE Notes 17 false false R18.htm 017 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 18 false false R19.htm 018 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://innovativepaymentssolu.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 019 - Disclosure - SUBSEQUENT EVENTS Sheet http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 20 false false R21.htm 020 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 21 false false R22.htm 021 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Tables) Sheet http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables ACCOUNTING POLICIES AND ESTIMATES (Tables) Tables http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES 22 false false R23.htm 022 - Disclosure - INTANGIBLES (Tables) Sheet http://innovativepaymentssolu.com/role/INTANGIBLESTables INTANGIBLES (Tables) Tables http://innovativepaymentssolu.com/role/INTANGIBLES 23 false false R24.htm 023 - Disclosure - INVESTMENTS (Tables) Sheet http://innovativepaymentssolu.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://innovativepaymentssolu.com/role/INVESTMENTS 24 false false R25.htm 024 - Disclosure - LEASES (Tables) Sheet http://innovativepaymentssolu.com/role/LEASESTables LEASES (Tables) Tables http://innovativepaymentssolu.com/role/LEASES 25 false false R26.htm 025 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) Notes http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables CONVERTIBLE NOTES PAYABLE (Tables) Tables http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE 26 false false R27.htm 026 - Disclosure - DERIVATIVE LIABILITY (Tables) Sheet http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables DERIVATIVE LIABILITY (Tables) Tables http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY 27 false false R28.htm 027 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS??? EQUITY (Tables) Tables http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY 28 false false R29.htm 028 - Disclosure - NET LOSS PER SHARE (Tables) Sheet http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables NET LOSS PER SHARE (Tables) Tables http://innovativepaymentssolu.com/role/NETLOSSPERSHARE 29 false false R30.htm 029 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Sheet http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Details http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS 30 false false R31.htm 030 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) Sheet http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails ACCOUNTING POLICIES AND ESTIMATES (Details) Details http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables 31 false false R32.htm 031 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets Sheet http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets Details http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables 32 false false R33.htm 032 - Disclosure - LIQUIDITY MATTERS (Details) Sheet http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails LIQUIDITY MATTERS (Details) Details http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS 33 false false R34.htm 033 - Disclosure - INTANGIBLES (Details) Sheet http://innovativepaymentssolu.com/role/INTANGIBLESDetails INTANGIBLES (Details) Details http://innovativepaymentssolu.com/role/INTANGIBLESTables 34 false false R35.htm 034 - Disclosure - INTANGIBLES (Details) - Schedule of facilitate the functioning of the software Sheet http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningofthesoftwareTable INTANGIBLES (Details) - Schedule of facilitate the functioning of the software Details http://innovativepaymentssolu.com/role/INTANGIBLESTables 35 false false R36.htm 035 - Disclosure - INVESTMENTS (Details) Sheet http://innovativepaymentssolu.com/role/INVESTMENTSDetails INVESTMENTS (Details) Details http://innovativepaymentssolu.com/role/INVESTMENTSTables 36 false false R37.htm 036 - Disclosure - INVESTMENTS (Details) - Schedule of investment Sheet http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable INVESTMENTS (Details) - Schedule of investment Details http://innovativepaymentssolu.com/role/INVESTMENTSTables 37 false false R38.htm 037 - Disclosure - LEASES (Details) Sheet http://innovativepaymentssolu.com/role/LEASESDetails LEASES (Details) Details http://innovativepaymentssolu.com/role/LEASESTables 38 false false R39.htm 038 - Disclosure - LEASES (Details) - Schedule of total lease cost Sheet http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable LEASES (Details) - Schedule of total lease cost Details http://innovativepaymentssolu.com/role/LEASESTables 39 false false R40.htm 039 - Disclosure - LEASES (Details) - Schedule of other lease information Sheet http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable LEASES (Details) - Schedule of other lease information Details http://innovativepaymentssolu.com/role/LEASESTables 40 false false R41.htm 040 - Disclosure - LEASES (Details) - Schedule of maturity of operating leases Sheet http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable LEASES (Details) - Schedule of maturity of operating leases Details http://innovativepaymentssolu.com/role/LEASESTables 41 false false R42.htm 041 - Disclosure - FEDERAL RELIEF LOANS (Details) Sheet http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails FEDERAL RELIEF LOANS (Details) Details http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS 42 false false R43.htm 042 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) Notes http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails CONVERTIBLE NOTES PAYABLE (Details) Details http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables 43 false false R44.htm 043 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable Notes http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable Details http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables 44 false false R45.htm 044 - Disclosure - DERIVATIVE LIABILITY (Details) Sheet http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails DERIVATIVE LIABILITY (Details) Details http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables 45 false false R46.htm 045 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model Sheet http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model Details http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables 46 false false R47.htm 046 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability Sheet http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability Details http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables 47 false false R48.htm 047 - Disclosure - STOCKHOLDERS??? EQUITY (Details) Sheet http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails STOCKHOLDERS??? EQUITY (Details) Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 48 false false R49.htm 048 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock activity Sheet http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock activity Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 49 false false R50.htm 049 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock granted and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock granted and exercisable Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 50 false false R51.htm 050 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of warrant activity Sheet http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable STOCKHOLDERS??? EQUITY (Details) - Schedule of warrant activity Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 51 false false R52.htm 051 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of warrants outstanding and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable STOCKHOLDERS??? EQUITY (Details) - Schedule of warrants outstanding and exercisable Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 52 false false R53.htm 052 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of option activity Sheet http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable STOCKHOLDERS??? EQUITY (Details) - Schedule of option activity Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 53 false false R54.htm 053 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of options outstanding and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable STOCKHOLDERS??? EQUITY (Details) - Schedule of options outstanding and exercisable Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 54 false false R55.htm 054 - Disclosure - NET LOSS PER SHARE (Details) - Schedule of dilutive shares Sheet http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable NET LOSS PER SHARE (Details) - Schedule of dilutive shares Details http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables 55 false false R56.htm 055 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS 56 false false All Reports Book All Reports f10q0322_innovativepay.htm f10q0322ex31-1_innovative.htm f10q0322ex31-2_innovative.htm f10q0322ex32-1_innovative.htm f10q0322ex32-2_innovative.htm qpag-20220331.xsd qpag-20220331_cal.xml qpag-20220331_def.xml qpag-20220331_lab.xml qpag-20220331_pre.xml http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 74 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0322_innovativepay.htm": { "axisCustom": 1, "axisStandard": 15, "contextCount": 196, "dts": { "calculationLink": { "local": [ "qpag-20220331_cal.xml" ] }, "definitionLink": { "local": [ "qpag-20220331_def.xml" ] }, "inline": { "local": [ "f10q0322_innovativepay.htm" ] }, "labelLink": { "local": [ "qpag-20220331_lab.xml" ] }, "presentationLink": { "local": [ "qpag-20220331_pre.xml" ] }, "schema": { "local": [ "qpag-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 472, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 82, "http://innovativepaymentssolu.com/20220331": 44, "http://xbrl.sec.gov/dei/2022": 7, "total": 133 }, "keyCustom": 108, "keyStandard": 212, "memberCustom": 35, "memberStandard": 14, "nsprefix": "qpag", "nsuri": "http://innovativepaymentssolu.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - INTANGIBLES", "role": "http://innovativepaymentssolu.com/role/INTANGIBLES", "shortName": "INTANGIBLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - INVESTMENTS", "role": "http://innovativepaymentssolu.com/role/INVESTMENTS", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - LEASES", "role": "http://innovativepaymentssolu.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:FederalReliefLoansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - FEDERAL RELIEF LOANS", "role": "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS", "shortName": "FEDERAL RELIEF LOANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:FederalReliefLoansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - CONVERTIBLE NOTES PAYABLE", "role": "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE", "shortName": "CONVERTIBLE NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - DERIVATIVE LIABILITY", "role": "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY", "shortName": "DERIVATIVE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - NET LOSS PER SHARE", "role": "http://innovativepaymentssolu.com/role/NETLOSSPERSHARE", "shortName": "NET LOSS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://innovativepaymentssolu.com/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "role": "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - SUBSEQUENT EVENTS", "role": "http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Tables)", "role": "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables", "shortName": "ACCOUNTING POLICIES AND ESTIMATES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - INTANGIBLES (Tables)", "role": "http://innovativepaymentssolu.com/role/INTANGIBLESTables", "shortName": "INTANGIBLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - INVESTMENTS (Tables)", "role": "http://innovativepaymentssolu.com/role/INVESTMENTSTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - LEASES (Tables)", "role": "http://innovativepaymentssolu.com/role/LEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables)", "role": "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables", "shortName": "CONVERTIBLE NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - DERIVATIVE LIABILITY (Tables)", "role": "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables", "shortName": "DERIVATIVE LIABILITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "role": "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - NET LOSS PER SHARE (Tables)", "role": "http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables", "shortName": "NET LOSS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c37", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:DscriptionOfChangedItsName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details)", "role": "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c37", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:DscriptionOfChangedItsName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "qpag:EquityMethodsInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details)", "role": "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails", "shortName": "ACCOUNTING POLICIES AND ESTIMATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "qpag:EquityMethodsInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c45", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets", "role": "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "shortName": "ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c45", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:NetIncomeLossAttributableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - LIQUIDITY MATTERS (Details)", "role": "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails", "shortName": "LIQUIDITY MATTERS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:NetIncomeLossAttributableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c43", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - INTANGIBLES (Details)", "role": "http://innovativepaymentssolu.com/role/INTANGIBLESDetails", "shortName": "INTANGIBLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c43", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:PurchasedTechnology", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - INTANGIBLES (Details) - Schedule of facilitate the functioning of the software", "role": "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningofthesoftwareTable", "shortName": "INTANGIBLES (Details) - Schedule of facilitate the functioning of the software", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:PurchasedTechnology", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c71", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - INVESTMENTS (Details)", "role": "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "shortName": "INVESTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c54", "decimals": null, "lang": "en-US", "name": "qpag:InvestmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - INVESTMENTS (Details) - Schedule of investment", "role": "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable", "shortName": "INVESTMENTS (Details) - Schedule of investment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - LEASES (Details)", "role": "http://innovativepaymentssolu.com/role/LEASESDetails", "shortName": "LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - LEASES (Details) - Schedule of total lease cost", "role": "http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable", "shortName": "LEASES (Details) - Schedule of total lease cost", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOtherLeaseInformation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:OperatingCashFlowsFromOperatingLeases", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - LEASES (Details) - Schedule of other lease information", "role": "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable", "shortName": "LEASES (Details) - Schedule of other lease information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOtherLeaseInformation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:OperatingCashFlowsFromOperatingLeases", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - LEASES (Details) - Schedule of maturity of operating leases", "role": "http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable", "shortName": "LEASES (Details) - Schedule of maturity of operating leases", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c63", "decimals": "0", "first": true, "lang": null, "name": "qpag:DisasterLoanAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - FEDERAL RELIEF LOANS (Details)", "role": "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails", "shortName": "FEDERAL RELIEF LOANS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c63", "decimals": "0", "first": true, "lang": null, "name": "qpag:DisasterLoanAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseOther", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details)", "role": "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "shortName": "CONVERTIBLE NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseOther", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable", "role": "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "shortName": "CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c76", "decimals": "3", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:DerivativeLiabilityWasReassessed", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - DERIVATIVE LIABILITY (Details)", "role": "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails", "shortName": "DERIVATIVE LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:DerivativeLiabilityWasReassessed", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model", "role": "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "shortName": "DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability", "role": "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable", "shortName": "DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c25", "decimals": "0", "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RestrictedStockExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details)", "role": "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RestrictedStockExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c113", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity", "role": "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c101", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c21", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "role": "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c21", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "qpag:ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RestrictedStockGrantedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock granted and exercisable", "role": "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock granted and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "qpag:ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RestrictedStockGrantedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c137", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrant activity", "role": "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrant activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c133", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrants outstanding and exercisable", "role": "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrants outstanding and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c153", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of option activity", "role": "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of option activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c149", "decimals": "0", "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of options outstanding and exercisable", "role": "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of options outstanding and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - NET LOSS PER SHARE (Details) - Schedule of dilutive shares", "role": "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "shortName": "NET LOSS PER SHARE (Details) - Schedule of dilutive shares", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c173", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ExcessStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c177", "decimals": "2", "lang": null, "name": "qpag:exercisePricePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS", "role": "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES", "role": "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES", "shortName": "ACCOUNTING POLICIES AND ESTIMATES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:LiquidityMattersTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - LIQUIDITY MATTERS", "role": "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS", "shortName": "LIQUIDITY MATTERS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:LiquidityMattersTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 58, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "qpag_ACCOUNTINGPOLICIESANDESTIMATESDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies and Estimates (Textual)" } } }, "localname": "ACCOUNTINGPOLICIESANDESTIMATESDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "stringItemType" }, "qpag_ACCOUNTINGPOLICIESANDESTIMATESDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCOUNTING POLICIES AND ESTIMATES (Details) [Table]" } } }, "localname": "ACCOUNTINGPOLICIESANDESTIMATESDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "stringItemType" }, "qpag_AccruedInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrued interest.", "label": "AccruedInterest", "terseLabel": "Accrued interest" } } }, "localname": "AccruedInterest", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage", "terseLabel": "Right to acquire" } } }, "localname": "AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "percentItemType" }, "qpag_Allowance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allowance.", "label": "Allowance", "terseLabel": "Car allowance" } } }, "localname": "Allowance", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AmortizationDebtDiscount": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "AmortizationDebtDiscount", "negatedLabel": "Amortization of debt discount" } } }, "localname": "AmortizationDebtDiscount", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_AmortizationOfRightOfUseAsset": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization of right of use asset.", "label": "AmortizationOfRightOfUseAsset", "terseLabel": "Amortization of right of use asset" } } }, "localname": "AmortizationOfRightOfUseAsset", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_AnnualBaseSalary": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AnnualBaseSalary", "terseLabel": "Annual base salary percentage" } } }, "localname": "AnnualBaseSalary", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "qpag_BaseSalary": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "BaseSalary", "terseLabel": "Salary expense" } } }, "localname": "BaseSalary", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_BellridgeCapitalLPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BellridgeCapitalLPMember", "terseLabel": "Bellridge Capital LP., [Member]", "verboseLabel": "Bellridge Capital LP. [Member]" } } }, "localname": "BellridgeCapitalLPMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_BeyondFintechIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BeyondFintechIncMember", "terseLabel": "Beyond Fintech Inc. [Member]" } } }, "localname": "BeyondFintechIncMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "domainItemType" }, "qpag_BeyondFintechMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BeyondFintechMember", "terseLabel": "Beyond Fintech [Member]" } } }, "localname": "BeyondFintechMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "qpag_CONVERTIBLENOTESPAYABLEDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable (Textual)" } } }, "localname": "CONVERTIBLENOTESPAYABLEDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "qpag_CONVERTIBLENOTESPAYABLEDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONVERTIBLE NOTES PAYABLE (Details) [Table]" } } }, "localname": "CONVERTIBLENOTESPAYABLEDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "qpag_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "stringItemType" }, "qpag_CavalryFundILPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CavalryFundILPMember", "terseLabel": "Cavalry Fund I LP [Member]", "verboseLabel": "Cavalry Fund LLP [Member]" } } }, "localname": "CavalryFundILPMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_CliffordHenryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CliffordHenryMember", "terseLabel": "Clifford Henry [Member]" } } }, "localname": "CliffordHenryMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_ConsultingAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ConsultingAgreement", "terseLabel": "Consulting agreement" } } }, "localname": "ConsultingAgreement", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_ConvertibleNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Abstract]" } } }, "localname": "ConvertibleNotesPayableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertibleNotesPayableTextBlock", "terseLabel": "CONVERTIBLE NOTES PAYABLE" } } }, "localname": "ConvertibleNotesPayableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE" ], "xbrltype": "textBlockItemType" }, "qpag_DERIVATIVELIABILITYDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability (Textual)" } } }, "localname": "DERIVATIVELIABILITYDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "stringItemType" }, "qpag_DERIVATIVELIABILITYDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DERIVATIVE LIABILITY (Details) [Table]" } } }, "localname": "DERIVATIVELIABILITYDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "stringItemType" }, "qpag_DebtInstrumentAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DebtInstrumentAccruedInterest", "terseLabel": "Accrued interest and penalty interest" } } }, "localname": "DebtInstrumentAccruedInterest", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentOriginalIssueDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "DebtInstrumentOriginalIssueDiscount", "terseLabel": "Original issue discount" } } }, "localname": "DebtInstrumentOriginalIssueDiscount", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentsConvertibleConversionPrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "DebtInstrumentsConvertibleConversionPrice1", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentsConvertibleConversionPrice1", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "perShareItemType" }, "qpag_DebtInstrumentsFaceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "DebtInstrumentsFaceAmount", "terseLabel": "Principal" } } }, "localname": "DebtInstrumentsFaceAmount", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentsInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "DebtInstrumentsInterestRateStatedPercentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentsInterestRateStatedPercentage", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "percentItemType" }, "qpag_DerivativeFinancialLiabilityArisingFromConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents as a derivative financial liability arising from convertible note.", "label": "DerivativeFinancialLiabilityArisingFromConvertibleNote", "terseLabel": "Derivative financial liability arising from convertible note" } } }, "localname": "DerivativeFinancialLiabilityArisingFromConvertibleNote", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "qpag_DerivativeLiabilityMovements": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "DerivativeLiabilityMovements", "negatedLabel": "Derivative liability movements" } } }, "localname": "DerivativeLiabilityMovements", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_DerivativeLiabilityWasCredited": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Derivative liability was credited.", "label": "DerivativeLiabilityWasCredited", "terseLabel": "Derivative liability was credited" } } }, "localname": "DerivativeLiabilityWasCredited", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DerivativeLiabilityWasReassessed": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Derivative liability was re-assessed.", "label": "DerivativeLiabilityWasReassessed", "terseLabel": "Derivative liability was re-assessed" } } }, "localname": "DerivativeLiabilityWasReassessed", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DisasterLoanAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disaster loan amount", "label": "DisasterLoanAmount", "terseLabel": "Disaster loan amount" } } }, "localname": "DisasterLoanAmount", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_DscriptionOfChangedItsName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It rpresents description of Changed its name,", "label": "DscriptionOfChangedItsName", "terseLabel": "Description of changed its name" } } }, "localname": "DscriptionOfChangedItsName", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_EarningsPerSharesBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "EarningsPerSharesBasicAndDiluted", "terseLabel": "Basic and Diluted loss per share (in Dollars per share)" } } }, "localname": "EarningsPerSharesBasicAndDiluted", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "qpag_EquityMethodInvestmentOwnershipPercentages": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stocks or equity participation in the investee accounted for under the equity method of accounting.", "label": "EquityMethodInvestmentOwnershipPercentages", "terseLabel": "Common shares outstanding percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentages", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "percentItemType" }, "qpag_EquityMethodsInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "EquityMethodsInvestmentOwnershipPercentage", "terseLabel": "Ownership percentage" } } }, "localname": "EquityMethodsInvestmentOwnershipPercentage", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "percentItemType" }, "qpag_ExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercisable weighted average exercise price.", "label": "ExercisableWeightedAverageExercisePrice", "terseLabel": "Options Exercisable, Number Exercisable (in Dollars per share)" } } }, "localname": "ExercisableWeightedAverageExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_ExercisePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePerShare", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "ExercisePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "qpag_ExercisePrice0049Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePrice0049Member", "terseLabel": "Grant date Price 0.049 [Member]" } } }, "localname": "ExercisePrice0049Member", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice015Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePrice015Member", "terseLabel": "Exercise Price 0.15 [Member]" } } }, "localname": "ExercisePrice015Member", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice0187Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePrice0187Member", "terseLabel": "Exercise Price 0.1875 [Member]" } } }, "localname": "ExercisePrice0187Member", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePrice024Member", "terseLabel": "Exercise Price 0.24 [Member]" } } }, "localname": "ExercisePrice024Member", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice040Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePrice040Member", "terseLabel": "Exercise Price 0.40 [Member]" } } }, "localname": "ExercisePrice040Member", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePricePerShareForfeitedCancelledinDollars": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "ExercisePricePerShareForfeitedCancelledinDollars", "terseLabel": "Exercise price per share, Forfeited/Cancelled" } } }, "localname": "ExercisePricePerShareForfeitedCancelledinDollars", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ExercisePriceRange5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "ExercisePriceRange5Member", "terseLabel": "Grant date Price 0.050 [Member]", "verboseLabel": "Exercise Price 0.05 [Member]" } } }, "localname": "ExercisePriceRange5Member", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExpiryOfLeaseTerm": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expiry of lease term.", "label": "ExpiryOfLeaseTerm", "terseLabel": "Expiry of lease term" } } }, "localname": "ExpiryOfLeaseTerm", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESDetails" ], "xbrltype": "monetaryItemType" }, "qpag_FairValueAdjustmentToDerivativeLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "FairValueAdjustmentToDerivativeLiability", "terseLabel": "Fair value adjustment to derivative liability" } } }, "localname": "FairValueAdjustmentToDerivativeLiability", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "qpag_FairValueAssumptionsExpectedTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "FairValueAssumptionsExpectedTerm1", "terseLabel": "Expected life of derivative liability" } } }, "localname": "FairValueAssumptionsExpectedTerm1", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "durationItemType" }, "qpag_FederalReliefLoansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Relief Loans [Abstract]" } } }, "localname": "FederalReliefLoansAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_FederalReliefLoansNonCurrent": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Federal relief loans portion of non current.", "label": "FederalReliefLoansNonCurrent", "terseLabel": "Federal relief loans" } } }, "localname": "FederalReliefLoansNonCurrent", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "qpag_FederalReliefLoansTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FederalReliefLoansTextBlock", "terseLabel": "FEDERAL RELIEF LOANS" } } }, "localname": "FederalReliefLoansTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS" ], "xbrltype": "textBlockItemType" }, "qpag_FederallyInsuredLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "FederallyInsuredLimit", "terseLabel": "Federally insured limit" } } }, "localname": "FederallyInsuredLimit", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "monetaryItemType" }, "qpag_FintechPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FintechPercentage", "terseLabel": "Beyond fintech percentage" } } }, "localname": "FintechPercentage", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "percentItemType" }, "qpag_ForgivenessOfFederalReliefLoans": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Forgiveness of federal relief loans.", "label": "ForgivenessOfFederalReliefLoans", "negatedLabel": "Penalty on convertible notes" } } }, "localname": "ForgivenessOfFederalReliefLoans", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_FrictionlessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FrictionlessMember", "terseLabel": "Frictionless [Member]" } } }, "localname": "FrictionlessMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "qpag_FrictionlessTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FrictionlessTechnologiesIncMember", "terseLabel": "Frictionless Financial Technologies, Inc. [Member]", "verboseLabel": "Frictionless Technologies, Inc. [Member]" } } }, "localname": "FrictionlessTechnologiesIncMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "domainItemType" }, "qpag_GainLossOnDebtConversion": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on debt conversion.", "label": "GainLossOnDebtConversion", "terseLabel": "Loss on debt conversion" } } }, "localname": "GainLossOnDebtConversion", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_GrantedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GrantedShares", "terseLabel": "Granted shares (in Shares)" } } }, "localname": "GrantedShares", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "qpag_GrossProceed": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of gross proceeds.", "label": "GrossProceed", "terseLabel": "Gross proceed (in Dollars)" } } }, "localname": "GrossProceed", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_INVESTMENTSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment (Textual)" } } }, "localname": "INVESTMENTSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_INVESTMENTSDetailsScheduleofinvestmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS (Details) - Schedule of investment [Line Items]" } } }, "localname": "INVESTMENTSDetailsScheduleofinvestmentLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "qpag_INVESTMENTSDetailsScheduleofinvestmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS (Details) - Schedule of investment [Table]" } } }, "localname": "INVESTMENTSDetailsScheduleofinvestmentTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "qpag_INVESTMENTSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS (Details) [Table]" } } }, "localname": "INVESTMENTSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_IncreaseDecreaseInInterestAccruals": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of interest accruals.", "label": "IncreaseDecreaseInInterestAccruals", "terseLabel": "Interest accruals" } } }, "localname": "IncreaseDecreaseInInterestAccruals", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_InitialConversionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of initial conversion price.", "label": "InitialConversionPricePerShare", "terseLabel": "initial conversion price per share (in Dollars per share)" } } }, "localname": "InitialConversionPricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "perShareItemType" }, "qpag_InterestExpenseNet": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "InterestExpenseNet", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpenseNet", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_InvestmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment, description.", "label": "InvestmentDescription", "terseLabel": "Investment, description" } } }, "localname": "InvestmentDescription", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_InvestmentInDeposits": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Investment in deposits.", "label": "InvestmentInDeposits", "negatedLabel": "Investment in deposits" } } }, "localname": "InvestmentInDeposits", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_JamesFullerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JamesFullerMember", "terseLabel": "James Fuller [Member]" } } }, "localname": "JamesFullerMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_JosephWPatriciaGAbramsFamilyTrustMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JosephWPatriciaGAbramsFamilyTrustMember", "terseLabel": "Joseph W [Member]" } } }, "localname": "JosephWPatriciaGAbramsFamilyTrustMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "qpag_KiosksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "KiosksMember", "terseLabel": "Kiosks [Member]" } } }, "localname": "KiosksMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "qpag_LEASESDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases (Textual)" } } }, "localname": "LEASESDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESDetails" ], "xbrltype": "stringItemType" }, "qpag_LEASESDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LEASES (Details) [Table]" } } }, "localname": "LEASESDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESDetails" ], "xbrltype": "stringItemType" }, "qpag_LIQUIDITYMATTERSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Matters (Textual)" } } }, "localname": "LIQUIDITYMATTERSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "stringItemType" }, "qpag_LIQUIDITYMATTERSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIQUIDITY MATTERS (Details) [Table]" } } }, "localname": "LIQUIDITYMATTERSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "stringItemType" }, "qpag_LiquidityMattersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Matters [Abstract]" } } }, "localname": "LiquidityMattersAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_LiquidityMattersTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LiquidityMattersTextBlock", "terseLabel": "LIQUIDITY MATTERS" } } }, "localname": "LiquidityMattersTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS" ], "xbrltype": "textBlockItemType" }, "qpag_LongtermAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents long term assets policy.", "label": "LongtermAssetsPolicyTextBlock", "terseLabel": "Long-Term Assets" } } }, "localname": "LongtermAssetsPolicyTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "qpag_LossOnConversionOfDebtToEquity": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss on conversion of debt to equity.", "label": "LossOnConversionOfDebtToEquity", "terseLabel": "Loss on conversion of debt to equity" } } }, "localname": "LossOnConversionOfDebtToEquity", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_MercerStreetGlobalOpportunityFundLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MercerStreetGlobalOpportunityFundLLCMember", "terseLabel": "Mercer Street Global Opportunity Fund, LLC [Member]", "verboseLabel": "Cavalry Fund LLP [Member]" } } }, "localname": "MercerStreetGlobalOpportunityFundLLCMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_MrAndreyNovikovMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MrAndreyNovikovMember", "terseLabel": "Mr. Andrey Novikov [Member]", "verboseLabel": "Andrey Novikov [Member]" } } }, "localname": "MrAndreyNovikovMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_MrCorbettMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MrCorbettMember", "terseLabel": "Mr. Corbett [Member]" } } }, "localname": "MrCorbettMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_MrFullerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MrFullerMember", "terseLabel": "Mr Fuller [Member]" } } }, "localname": "MrFullerMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_MrGastonPereiraMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MrGastonPereiraMember", "terseLabel": "Mr. Gaston Pereira [Member]" } } }, "localname": "MrGastonPereiraMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "qpag_MrHenryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MrHenryMember", "terseLabel": "Mr. Henry [Member]" } } }, "localname": "MrHenryMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_MrRiosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MrRiosMember", "terseLabel": "Mr. Rios [Member]" } } }, "localname": "MrRiosMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_MrRosenblumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MrRosenblumMember", "terseLabel": "Mr. Rosenblum [Member]" } } }, "localname": "MrRosenblumMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_NetIncomeLossAttributableNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "NetIncomeLossAttributableNoncontrollingInterest", "terseLabel": "Net loss" } } }, "localname": "NetIncomeLossAttributableNoncontrollingInterest", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_NetLossAttributableParent": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "NetLossAttributableParent", "negatedTotalLabel": "Net loss attributable to Innovative Payment Solutions, Inc. stockholders" } } }, "localname": "NetLossAttributableParent", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_NoncontrollingShareholdersInterest": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "qpag_NetLossAttributableParent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "NoncontrollingShareholdersInterest", "negatedLabel": "Net loss attributable to non-controlling interest" } } }, "localname": "NoncontrollingShareholdersInterest", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business (Textual)" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) [Table]" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract]" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS" ], "xbrltype": "stringItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS [Table]" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS" ], "xbrltype": "stringItemType" }, "qpag_OperatingCashFlowsFromOperatingLeases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "OperatingCashFlowsFromOperatingLeases", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingCashFlowsFromOperatingLeases", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "monetaryItemType" }, "qpag_OptionsOutstandingDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options outstanding description.", "label": "OptionsOutstandingDescription", "terseLabel": "Options outstanding, description" } } }, "localname": "OptionsOutstandingDescription", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "qpag_OptionsToPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options to purchase.", "label": "OptionsToPurchase", "terseLabel": "Options to purchase (in Shares)" } } }, "localname": "OptionsToPurchase", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "qpag_OriginalDiscountsRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OriginalDiscountsRatePercentage", "terseLabel": "Original issue discount rate" } } }, "localname": "OriginalDiscountsRatePercentage", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "percentItemType" }, "qpag_OwnedFrictionlessFinancialTechnologies": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OwnedFrictionlessFinancialTechnologies", "terseLabel": "Owned frictionless financial technologies" } } }, "localname": "OwnedFrictionlessFinancialTechnologies", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "percentItemType" }, "qpag_PercentageOfRemainingSharesOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining shares owned.", "label": "PercentageOfRemainingSharesOwned", "terseLabel": "Percentage of remaining shares owned" } } }, "localname": "PercentageOfRemainingSharesOwned", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "qpag_ProceedsFromSharesIssuedForServices": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from shares issued for services.", "label": "ProceedsFromSharesIssuedForServices", "terseLabel": "Fair value of warrants issued as compensation" } } }, "localname": "ProceedsFromSharesIssuedForServices", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_ProceedsFromShortTermNotesAndConvertibleNotes": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents value of cash inflow from short term and convrtible notes of entity.", "label": "ProceedsFromShortTermNotesAndConvertibleNotes", "terseLabel": "Proceeds from short term notes and convertible notes" } } }, "localname": "ProceedsFromShortTermNotesAndConvertibleNotes", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_PurchaseOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PurchaseOfCommonShares", "terseLabel": "Purchase of common shares" } } }, "localname": "PurchaseOfCommonShares", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "sharesItemType" }, "qpag_PurchaseOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PurchaseOfShares", "terseLabel": "Purchase of shares (in Shares)" } } }, "localname": "PurchaseOfShares", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "qpag_PurchasePriceToAcquireOutstandingCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "PurchasePriceToAcquireOutstandingCommonStock", "terseLabel": "Purchase price to acquire outstanding common stock for 1% acquired (in Dollars)" } } }, "localname": "PurchasePriceToAcquireOutstandingCommonStock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_PurchasedTechnology": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchased Technology", "label": "PurchasedTechnology", "terseLabel": "Purchased Technology" } } }, "localname": "PurchasedTechnology", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningofthesoftwareTable" ], "xbrltype": "monetaryItemType" }, "qpag_RELATEDPARTYTRANSACTIONSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Textual)" } } }, "localname": "RELATEDPARTYTRANSACTIONSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "qpag_RELATEDPARTYTRANSACTIONSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS (Details) [Table]" } } }, "localname": "RELATEDPARTYTRANSACTIONSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "qpag_RelatedPartyTransactionsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RelatedPartyTransactionsDescription", "terseLabel": "Related party transactions description" } } }, "localname": "RelatedPartyTransactionsDescription", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "qpag_RemainingLeaseTermOperatingLease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RemainingLeaseTermOperatingLease", "terseLabel": "Remaining lease term \u2013 operating lease" } } }, "localname": "RemainingLeaseTermOperatingLease", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "durationItemType" }, "qpag_RepayableInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rapayable installments", "label": "RepayableInstallments", "terseLabel": "Repayable installments" } } }, "localname": "RepayableInstallments", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_RestrictedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Share.", "label": "RestrictedShare", "terseLabel": "Restricted share (in Shares)" } } }, "localname": "RestrictedShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "qpag_RestrictedStockGrantedDatePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedStockGrantedDatePrice", "terseLabel": "Restricted stock granted, grant date price" } } }, "localname": "RestrictedStockGrantedDatePrice", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_RestrictedStockGrantedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedStockGrantedShares", "terseLabel": "Restricted stock granted, number granted (in Shares)" } } }, "localname": "RestrictedStockGrantedShares", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_RestrictedStockGrantedWeightedAverageFairValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedStockGrantedWeightedAverageFairValuePerShare", "terseLabel": "Restricted stock granted, weighted average fair value per share" } } }, "localname": "RestrictedStockGrantedWeightedAverageFairValuePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_RestrictedStockVestedNumbeShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedStockVestedNumbeShares", "terseLabel": "Restricted stock vested, number vested (in Shares)" } } }, "localname": "RestrictedStockVestedNumbeShares", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_RestrictedStockVestedWeightedAverageFairValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedStockVestedWeightedAverageFairValuePerShare", "terseLabel": "Restricted stock vested, weighted average fair value per share" } } }, "localname": "RestrictedStockVestedWeightedAverageFairValuePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Textual)" } } }, "localname": "STOCKHOLDERSEQUITYDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity [Line Items]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityLineItems", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity [Table]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) [Table]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "qpag_ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of assumptions were used in the Black-Scholes valuation model [Abstract]" } } }, "localname": "ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfBeyondFintechIncTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfBeyondFintechIncTableTextBlock", "terseLabel": "Schedule of facilitate the functioning of the software" } } }, "localname": "ScheduleOfBeyondFintechIncTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfConvertibleNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of convertible notes payable [Abstract]" } } }, "localname": "ScheduleOfConvertibleNotesPayableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfDilutiveSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of dilutive shares [Abstract]" } } }, "localname": "ScheduleOfDilutiveSharesAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfEstimatedUsefulLivesOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents policy estimated useful lives of assets.", "label": "ScheduleOfEstimatedUsefulLivesOfAssets", "terseLabel": "Schedule of estimated useful lives of the assets" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfAssets", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of estimated useful lives of the assets [Abstract]" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfFacilitateTheFunctioningOfTheSoftwareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of facilitate the functioning of the software [Abstract]" } } }, "localname": "ScheduleOfFacilitateTheFunctioningOfTheSoftwareAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfMaturityOfOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of maturity of operating leases [Abstract]" } } }, "localname": "ScheduleOfMaturityOfOperatingLeasesAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfMaturityOfOperatingLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfMaturityOfOperatingLeasesTableTextBlock", "terseLabel": "Schedule of maturity of operating leases" } } }, "localname": "ScheduleOfMaturityOfOperatingLeasesTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOptionActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of option activity [Abstract]" } } }, "localname": "ScheduleOfOptionActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfOptionsOutstandingAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of options outstanding and exercisable [Abstract]" } } }, "localname": "ScheduleOfOptionsOutstandingAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfOptionsOutstandingAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of options outstanding and exercisable", "label": "ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "terseLabel": "Schedule of options outstanding and exercisable" } } }, "localname": "ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOtherLeaseInformation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfOtherLeaseInformation", "terseLabel": "Schedule of other lease information" } } }, "localname": "ScheduleOfOtherLeaseInformation", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOtherLeaseInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of other lease information [Abstract]" } } }, "localname": "ScheduleOfOtherLeaseInformationAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of restricted stock activity [Abstract]" } } }, "localname": "ScheduleOfRestrictedStockActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockGrantedAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of restricted stock granted and exercisable [Abstract]" } } }, "localname": "ScheduleOfRestrictedStockGrantedAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "terseLabel": "Schedule of restricted stock granted and exercisable" } } }, "localname": "ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfWarrantActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of warrant activity [Abstract]" } } }, "localname": "ScheduleOfWarrantActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfWarrantsOutstandingAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of warrants outstanding and exercisable [Abstract]" } } }, "localname": "ScheduleOfWarrantsOutstandingAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "xbrltype": "stringItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercised or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod", "terseLabel": "Shares Underlying Warrants, Exercised (in Shares)", "verboseLabel": "Shares Underlying options, Exercised (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which other than option holders acquired shares when converting their stock options into shares.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue", "terseLabel": "Weighted average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare", "periodEndLabel": "Exercise price per share, Outstanding at ending", "periodStartLabel": "Exercise price per share, Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShare", "terseLabel": "Exercise price per share, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedForfeitedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedForfeitedExercisePricePerShare", "terseLabel": "Exercise price per share, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedForfeitedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare", "terseLabel": "Exercise price per share, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "periodEndLabel": "Shares Underlying options, Outstanding at ending (in Shares)", "periodStartLabel": "Shares Underlying options, Outstanding at beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ShareBased Compensation arrangement by share based payment award option outstanding number.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber", "terseLabel": "Options Outstanding, Number Outstanding (in Dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "monetaryItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedSharesVested": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedSharesVested", "terseLabel": "Total restricted shares, Vested (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedSharesVested", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice", "terseLabel": "Weighted average fair market value per share, Vested" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareIssueExpenses": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share issue expenses.", "label": "ShareIssueExpenses", "negatedLabel": "Share issue expenses" } } }, "localname": "ShareIssueExpenses", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesForfeitedCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesForfeitedCancelled", "negatedLabel": "Total unvested restricted shares, Forfeited/Cancelled (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesForfeitedCancelled", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesGranted", "terseLabel": "Total unvested restricted shares, Granted (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesGranted", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesVested": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesVested", "terseLabel": "Total unvested restricted shares, Vested (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesVested", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedRestrictedSharesOutstandingAtBeginning": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedRestrictedSharesOutstandingAtBeginning", "periodEndLabel": "Total vested restricted shares, Outstanding at ending (in Shares)", "periodStartLabel": "Total vested restricted shares, Outstanding at beginning (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedRestrictedSharesOutstandingAtBeginning", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareForfeitedCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareForfeitedCancelled", "negatedLabel": "Total vested restricted shares, Forfeited/Cancelled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareForfeitedCancelled", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareGranted", "terseLabel": "Total vested restricted shares, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareGranted", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareVested": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareVested", "terseLabel": "Total vested restricted shares, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareVested", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual life in years.", "label": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3", "terseLabel": "Options Exercisable ,Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "qpag_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm", "terseLabel": "Options Exercisable, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "qpag_SharesSubjectToTheOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares subject to the options.", "label": "SharesSubjectToTheOptions", "terseLabel": "Shares subject to the options" } } }, "localname": "SharesSubjectToTheOptions", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "qpag_StockBasedCompensation1": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents value in cash flow of stock based compensation of the entity.", "label": "StockBasedCompensation1", "terseLabel": "Stock based compensation" } } }, "localname": "StockBasedCompensation1", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_StockIssueDuringPeriodSharesShareSubscriptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share subscriptions.", "label": "StockIssueDuringPeriodSharesShareSubscriptions", "terseLabel": "Share subscriptions (in Shares)" } } }, "localname": "StockIssueDuringPeriodSharesShareSubscriptions", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "qpag_StockIssueDuringPeriodValueShareSubscriptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of share subscriptions.", "label": "StockIssueDuringPeriodValueShareSubscriptions", "terseLabel": "Share subscriptions" } } }, "localname": "StockIssueDuringPeriodValueShareSubscriptions", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "qpag_StockIssuedDuringPeriodValueFairValueOfWarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of warrants issued.", "label": "StockIssuedDuringPeriodValueFairValueOfWarrantsIssued", "terseLabel": "Fair value of warrants issued as compensation" } } }, "localname": "StockIssuedDuringPeriodValueFairValueOfWarrantsIssued", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "qpag_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents stock options.", "label": "StockOptionsMember", "terseLabel": "Stock options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "qpag_StockPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents member related to stock purchase agreement.", "label": "StockPurchaseAgreementMember", "terseLabel": "Stock Purchase Agreement [Member]" } } }, "localname": "StockPurchaseAgreementMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "qpag_TotalInstalmentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TotalInstalmentsDueAbstract", "terseLabel": "Total instalments due:" } } }, "localname": "TotalInstalmentsDueAbstract", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable" ], "xbrltype": "stringItemType" }, "qpag_TotalRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TotalRestrictedSharesMember", "terseLabel": "Total restricted shares [Member]" } } }, "localname": "TotalRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalUnvestedRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TotalUnvestedRestrictedSharesMember", "terseLabel": "Total unvested restricted shares [Member]" } } }, "localname": "TotalUnvestedRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalVestedRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TotalVestedRestrictedSharesMember", "terseLabel": "Total vested restricted shares [Member]" } } }, "localname": "TotalVestedRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TwoThousandTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoThousandTwentyOnePlanMember", "terseLabel": "2021 Plan [Member]" } } }, "localname": "TwoThousandTwentyOnePlanMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "qpag_TypeOfAgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TypeOfAgreementAxis", "terseLabel": "Type of Agreement [Axis]" } } }, "localname": "TypeOfAgreementAxis", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_TypeOfAgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TypeOfAgreement [Domain]" } } }, "localname": "TypeOfAgreementDomain", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "qpag_UndiscountedMinimumFutureLeasePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "UndiscountedMinimumFutureLeasePayments", "terseLabel": "2022" } } }, "localname": "UndiscountedMinimumFutureLeasePayments", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "qpag_UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember", "terseLabel": "Unvested restricted Weighted average fair market value per share [Member]" } } }, "localname": "UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_VestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VestedRestrictedWeightedAverageFairMarketValuePerShareMember", "terseLabel": "Vested restricted Weighted average fair market value per share [Member]" } } }, "localname": "VestedRestrictedWeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_ViviHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ViviHoldingsIncMember", "terseLabel": "Vivi Holdings, Inc. [Member]" } } }, "localname": "ViviHoldingsIncMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "domainItemType" }, "qpag_WarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantsExercisable", "terseLabel": "Warrant purchase" } } }, "localname": "WarrantsExercisable", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "sharesItemType" }, "qpag_WarrantsExercisablePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantsExercisablePerShare", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "WarrantsExercisablePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "qpag_WarrantsOutstandingExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantsOutstandingExercisePrice", "terseLabel": "Warrants Outstanding, Exercise Price", "verboseLabel": "Options Outstanding, Exercise Price (in Dollars per share)" } } }, "localname": "WarrantsOutstandingExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_WeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WeightedAverageFairMarketValuePerShareMember", "terseLabel": "Weighted average fair market value per share [Member]" } } }, "localname": "WeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_WeightedAverageNumberOfSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "terseLabel": "Weighted Average Number of Shares Outstanding \u2013 Basic and Diluted (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "qpag_WilliamCorbettMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WilliamCorbettMember", "terseLabel": "William Corbett [Member]" } } }, "localname": "WilliamCorbettMember", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_commonstockvalue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "commonstockvalue1", "terseLabel": "Common stock, valued" } } }, "localname": "commonstockvalue1", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_exercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share.", "label": "exercisePricePerShare", "terseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "exercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "qpag_terminatesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Terminates period.", "label": "terminatesPeriod", "terseLabel": "Terminates period" } } }, "localname": "terminatesPeriod", "nsuri": "http://innovativepaymentssolu.com/20220331", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "durationItemType" }, "srt_FinancingReceivableNonaccrualToOutstandingPercent": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Percentage of nonaccrual to total financing receivable outstanding.", "label": "Financing Receivable, Nonaccrual to Outstanding, Percent", "terseLabel": "Outstanding common stock percentage" } } }, "localname": "FinancingReceivableNonaccrualToOutstandingPercent", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "srt_MaximumMember": { "auth_ref": [ "r169", "r170", "r171", "r172", "r190", "r205", "r229", "r230", "r355", "r356", "r357", "r358", "r359", "r360", "r379", "r414", "r415", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r169", "r170", "r171", "r172", "r190", "r205", "r229", "r230", "r355", "r356", "r357", "r358", "r359", "r360", "r379", "r414", "r415", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails", "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails", "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r163", "r169", "r170", "r171", "r172", "r190", "r205", "r226", "r229", "r230", "r262", "r263", "r264", "r355", "r356", "r357", "r358", "r359", "r360", "r379", "r414", "r415", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r163", "r169", "r170", "r171", "r172", "r190", "r205", "r226", "r229", "r230", "r262", "r263", "r264", "r355", "r356", "r357", "r358", "r359", "r360", "r379", "r414", "r415", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r130", "r340" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r30", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r23", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r85", "r86", "r87", "r268", "r269", "r270", "r310" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r66", "r193", "r198", "r199", "r328" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r16", "r81", "r110", "r119", "r125", "r143", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r288", "r293", "r317", "r344", "r346", "r394", "r404" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r29", "r81", "r143", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r288", "r293", "r317", "r344", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r81", "r143", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r288", "r293", "r317", "r344" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Non-Current Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r231", "r232", "r233", "r236", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r253", "r254", "r256", "r257", "r261", "r262", "r263", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionPlannedRestructuringActivitiesDescription": { "auth_ref": [ "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Description of restructuring activities for an acquired entity, including the amount of acquisition costs allocated to restructuring activities, and the period in which such costs will be incurred. The type of major actions that comprise the plan to exit an activity or involuntarily terminate employees of the acquired entity including activities of the acquired entity that will not continue, method of disposition, and description of employee groups that will be terminated. If the entity has not finalized plans for the restructuring activities, a description of the unresolved issues, the types of additional liabilities that might arise, and how any adjustment would be reported in the financial statements. Disclosure may also include timeframe when the registrant began formulating exit plans for which accrual may be necessary, and the types and amounts of liabilities included in the acquisition cost allocation. Disclosure may include the nature and amount of losses relating to asset impairments from the exit or disposal activity.", "label": "Business Acquisition, Planned Restructuring Activities, Description", "terseLabel": "Business Acquisition, Planned Restructuring Activities, Description" } } }, "localname": "BusinessAcquisitionPlannedRestructuringActivitiesDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r12", "r346", "r421", "r422" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r12", "r68" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r62", "r68", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH AT END OF PERIOD", "periodStartLabel": "CASH AT BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r62", "r318" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET (DECREASE) INCREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r12" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash balance" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price (in Dollars per share)", "verboseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of expense or revenue offset related to the warrants or rights.", "label": "Class of Warrant or Right, Expense or Revenue Recognized", "terseLabel": "Warrant expense" } } }, "localname": "ClassOfWarrantOrRightExpenseOrRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrant exercisable (in Shares)", "verboseLabel": "Warrant to purchase shares (in Shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r166", "r167", "r168", "r173", "r428" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r174", "r429" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r85", "r86", "r310" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r218" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value; 750,000,000 and 500,000,000 shares authorized, 367,901,679 shares issued and outstanding as of March 31, 2022 and December 31, 2021." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r100", "r402" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Risks and Uncertainties" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r76", "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r71", "r72", "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "terseLabel": "Conversion of convertible debt to equity" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Debt, Current", "terseLabel": "Convertible debt, net of unamortized discount of $0 and $263,200, respectively" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Convertible debt [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of convertible notes payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Current", "terseLabel": "Convertible notes payable" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r17", "r395", "r403", "r423" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "terseLabel": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r54", "r380" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r189", "r195" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": { "auth_ref": [ "r37", "r219", "r220", "r221" ], "lang": { "en-us": { "role": { "documentation": "Description of conversion terms for debt instrument.", "label": "Debt Instrument, Convertible, Terms of Conversion Feature", "terseLabel": "Description of conversion terms" } } }, "localname": "DebtInstrumentConvertibleTermsOfConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r187", "r196", "r197", "r327", "r329", "r330" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r80" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Accrued Interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r35", "r188" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest Rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r191", "r326", "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized debt discount", "terseLabel": "Convertible debt, net of unamortized discount (in Dollars)" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r66", "r160" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r66", "r108" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r43", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r41", "r42", "r43", "r316" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r312", "r315" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Derivatives and Fair Value [Text Block]", "terseLabel": "DERIVATIVE LIABILITY" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r83", "r299", "r300", "r301", "r302", "r307" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Liabilities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r93", "r94", "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "NET LOSS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/NETLOSSPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r47", "r48", "r49", "r85", "r86", "r87", "r89", "r90", "r92", "r97", "r146", "r218", "r222", "r268", "r269", "r270", "r280", "r281", "r310", "r319", "r320", "r321", "r322", "r323", "r324", "r335", "r416", "r417", "r418" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Percentage of ownership" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ExcessStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of excess stock held by shareholders.", "label": "Excess Stock, Shares Outstanding", "terseLabel": "Shares of common stock", "verboseLabel": "Options exercisable (in Shares)" } } }, "localname": "ExcessStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of movement in derivative liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r134", "r135", "r137", "r138", "r139", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r194", "r216", "r308", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r439", "r440", "r441", "r442", "r443", "r444", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": { "auth_ref": [ "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.", "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges", "terseLabel": "Impairment charges (in Dollars)" } } }, "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r66", "r200", "r201" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Penalty on convertible note" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r55" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralPartnersOfferingCosts": { "auth_ref": [ "r224" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of offering costs allocated to the general partner.", "label": "General Partners' Offering Costs", "terseLabel": "Additional product offering" } } }, "localname": "GeneralPartnersOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "INTANGIBLES" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLES" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r53", "r81", "r110", "r118", "r121", "r124", "r126", "r143", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r317" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r51", "r110", "r118", "r121", "r124", "r126", "r393", "r399", "r400", "r412" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r82", "r91", "r92", "r109", "r275", "r282", "r283", "r413" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income Taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r46", "r273", "r274", "r276", "r277", "r278", "r279" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r65" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeLiabilities": { "auth_ref": [ "r65" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Increase (Decrease) in Derivative Liabilities", "terseLabel": "Derivative liability movements" } } }, "localname": "IncreaseDecreaseInDerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in Assets and Liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r65" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r156", "r157" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalized": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest capitalized during the period.", "label": "Interest Costs Capitalized", "terseLabel": "Amortization of debt discount" } } }, "localname": "InterestCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r60", "r63", "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r133", "r134" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Strategic interest" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentOwnedRestrictedCost": { "auth_ref": [ "r424", "r425", "r426", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cost of the restricted investment.", "label": "Investment Owned, Restricted, Cost", "terseLabel": "Option expense" } } }, "localname": "InvestmentOwnedRestrictedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r142", "r411" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTableTextBlock": { "auth_ref": [ "r136", "r140", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment.", "label": "Investment [Table Text Block]", "terseLabel": "Schedule of investment" } } }, "localname": "InvestmentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r136", "r140", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment.", "label": "Investment [Text Block]", "terseLabel": "INVESTMENTS" } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_Investments": { "auth_ref": [ "r410" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "terseLabel": "Investment" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of total lease cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeaseDescription": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Description of lessor's operating lease.", "label": "Lessor, Operating Lease, Description", "terseLabel": "Lease, description" } } }, "localname": "LessorOperatingLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r32", "r81", "r120", "r143", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r289", "r293", "r294", "r317", "r344", "r345" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r27", "r81", "r143", "r317", "r346", "r398", "r408" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r7", "r34", "r81", "r143", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r289", "r293", "r294", "r317", "r344", "r345", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r9", "r10", "r11", "r18", "r19", "r81", "r143", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r289", "r293", "r294", "r317", "r344", "r345" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r13" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-Term Investments", "terseLabel": "Investment" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r40", "r81", "r143", "r176", "r180", "r181", "r182", "r185", "r186", "r317", "r397", "r407" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Stake owned percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r62" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r62" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r62", "r64", "r67" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "NON CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r85", "r86", "r87", "r222", "r285" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling shareholders interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Expense" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r110", "r118", "r121", "r124", "r126" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r4", "r298" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r28", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r56" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Plant and equipment purchased" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r21", "r203" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r21", "r203" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r21", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021." } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassification of prior year presentation" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r57" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from share issuances" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Net proceeds" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r57" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from warrants exercised" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r3", "r44", "r45", "r49", "r61", "r81", "r88", "r91", "r92", "r110", "r118", "r121", "r124", "r126", "r143", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r287", "r291", "r292", "r296", "r297", "r311", "r317", "r400" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "qpag_NetLossAttributableParent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow", "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Estimated useful lives of property" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r14", "r161" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Plant and equipment costs" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r162", "r346", "r401", "r409" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r162", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r228", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r228", "r338", "r339", "r341" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r228", "r338", "r341", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r336", "r337", "r339", "r342", "r343" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r59" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayment of loans payable" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r59" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedLabel": "Repayment of convertible notes" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Restricted stock awards expense (in Dollars)" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r24", "r222", "r346", "r406", "r419", "r420" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r85", "r86", "r87", "r89", "r90", "r92", "r146", "r268", "r269", "r270", "r280", "r281", "r310", "r416", "r418" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r77", "r78" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r50", "r81", "r106", "r107", "r117", "r122", "r123", "r127", "r128", "r129", "r143", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r317", "r400" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold", "terseLabel": "Salary per month" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of dilutive shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative liabilities at fair value.", "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]", "terseLabel": "Schedule of assumptions were used in the Black-Scholes valuation model" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of warrant activity" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of restricted stock activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of warrants outstanding and exercisable" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r235", "r252", "r255" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r18", "r396", "r405" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "terseLabel": "Senior secured convertible note" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r15" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r111", "r112", "r113", "r114", "r115", "r116", "r128" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Reporting by Segment" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "terseLabel": "Shares Underlying Warrants, Forfeited/Cancelled (in Shares)", "verboseLabel": "Shares Underlying options, Forfeited/Cancelled (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Shares Underlying Warrants, Granted (in Shares)", "verboseLabel": "Shares Underlying options, Granted (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Shares Underlying Warrants, Outstanding at ending (in Shares)", "periodStartLabel": "Shares Underlying Warrants, Outstanding at beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average exercise price, Outstanding at ending", "periodStartLabel": "Weighted average exercise price, Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility of underlying stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options Outstanding, Weighted Average Exercise Price (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Total restricted shares, Forfeited/Cancelled (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Total restricted shares, Granted (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r267" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Warrants outstanding an intrinsic value (in Dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r236", "r238" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Total restricted shares, Outstanding at ending (in Shares)", "periodStartLabel": "Total restricted shares, Outstanding at beginning (in Shares)", "terseLabel": "Warrants Outstanding, Number Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r236", "r238" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average fair market value per share, Outstanding at ending", "periodStartLabel": "Weighted average fair market value per share, Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Common stock awarded" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted average fair market value per share, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average fair market value per share, Granted", "verboseLabel": "Exercise price per share, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r234", "r259", "r260", "r261", "r262", "r265", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Payment Arrangements" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Warrants Exercisable, Number Exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Total unvested restricted shares, Outstanding at ending (in Shares)", "periodStartLabel": "Total unvested restricted shares, Outstanding at beginning (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options Outstanding, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Warrants Exercisable ,Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Warrants Exercisable, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Warrants Outstanding, Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Warrants Outstanding, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Common stock shares (in Shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Common stock granted, per share (in Dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtInterestRateIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage increase in the stated interest rate on a short-term debt instrument.", "label": "Short-Term Debt, Interest Rate Increase", "terseLabel": "Earning interest, percentage" } } }, "localname": "ShortTermDebtInterestRateIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r75", "r84" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "ACCOUNTING POLICIES AND ESTIMATES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r39", "r47", "r48", "r49", "r85", "r86", "r87", "r89", "r90", "r92", "r97", "r146", "r218", "r222", "r268", "r269", "r270", "r280", "r281", "r310", "r319", "r320", "r321", "r322", "r323", "r324", "r335", "r416", "r417", "r418" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r85", "r86", "r87", "r97", "r380" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r38", "r192", "r218", "r219", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of debt to equity (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r218", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of common stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r21", "r22", "r218", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock based option expense (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r21", "r22", "r218", "r222", "r242" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "terseLabel": "Warrants exercised (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r39", "r218", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of debt to equity" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r218", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Share issue expenses" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r21", "r22", "r218", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Restricted stock awards" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture", "terseLabel": "Stock based option expense" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r39", "r218", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Warrants exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]", "terseLabel": "Stock Options [Member]", "verboseLabel": "Options [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r25", "r26", "r81", "r132", "r143", "r317", "r346" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total equity attributable to Innovative Payment Solutions, Inc. Stockholders" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r48", "r81", "r85", "r86", "r87", "r89", "r90", "r143", "r146", "r222", "r268", "r269", "r270", "r280", "r281", "r285", "r286", "r295", "r310", "r317", "r319", "r320", "r324", "r335", "r417", "r418" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r79", "r204", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r217", "r222", "r225", "r309" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Stockholders' Equity, Reverse Stock Split", "terseLabel": "Reverse stock split, description" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "CASH PAID FOR INTEREST AND TAXES:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalDeferredPurchasePrice": { "auth_ref": [ "r71", "r72", "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.", "label": "Supplemental Deferred Purchase Price", "terseLabel": "Purchase price (in Dollars)" } } }, "localname": "SupplementalDeferredPurchasePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r8", "r202" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Common stock, shares par value (in Dollars per share)" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r134", "r135", "r137", "r138", "r139", "r194", "r216", "r308", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r439", "r440", "r441", "r442", "r443", "r444", "r445" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r98", "r99", "r101", "r102", "r103", "r104", "r105" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]", "verboseLabel": "Warrants to purchase shares of common stock [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "durationItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "https://asc.fasb.org/topic&trid=75115024" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "https://asc.fasb.org/topic&trid=2197064" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r168": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r225": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r315": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r333": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r343": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r348": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12.6(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Footnote 11(a)(3)))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r434": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r435": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r436": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r437": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r438": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r439": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r440": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r441": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r442": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r443": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r444": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r445": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r446": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(2)" }, "r447": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r96": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" } }, "version": "2.1" } ZIP 75 0001213900-22-026582-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-026582-xbrl.zip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